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SUMMARY
Carcinogens are metabolised by the mixed-function oxidase system 
of the endoplasmic reticulum, which results in the formation of 
reactive metabolites. These products exert a toxic effect upon the 
endoplasmic reticulum, causing changes in the structure and function 
of the membranes.
The degranulation 1 in vitro1 of the membranes by carcinogens has been 
studied. Two methods of assay were compared, and one used for 
further studies. The extent of degranulation varied between different 
preparations of membranes, and it was not found possible to correlate 
changes•in drug-metabolising enzyme activities with degranulation 
'in vitro1. It was shown that the density (and degree of granulation) 
of membranes was variable, and that the density profiles were little 
affected by inducing agents. Differences between different membrane 
preparations can be due to slight differences in the preparative media.
The distribution of cytochrome P-450 species within the endoplasmic 
reticulum was studied, and it was shown that cytochrome P-450 is 
found predominantly in 1 rough' membranes, whilst cytochrome P-448 
is a 'juvenile1 form found in neonates and also 'smooth' membranes.
The effect of inducing agents, and carcinogens on the cytochromes 
of 'rough1 and 'smooth' membranes was also studied.
i
Sex differences in drug metabolising enzymes indicate that cytochrome 
P-448 is also found in female rats, although the activities are low. 
Cytochrome P-450 develops from cytochrome P-448 in males during 
puberty.
The induction of cytochromes P-450 and P-448 in male rats was studied, 
and it was shown that whereas the increase in enzyme activities 
paralleled the increase in cytochrome P-450, increased enzyme activities 
were observed before detectable increases in cytochrome P-448.
The appearance of cytochrome P-448 brought about by treatment with 
carcinogens was studied during inhibition of protein synthesis.
It was shown that 'de novo' protein synthesis was not necessary 
for the appearance of the altered enzyme activities associated 
with cytochrome.P-448.
Inhibitors of cytochrome P-450 were used 'in vitro', and the 
effects upon enzyme activities in induced membranes compared. 
Further kinetic studies of ethoxycoumarin O-deethylase were 
performed after noting a stimulation of. activity. The results 
suggest that the activity is not solely mediated by the cytochrome 
as a terminal oxygenase, and that an alternative mechanism of 
oxygenation may be present.
The results are discussed in relation to the overall mechanism of 
carcinogenicity, involving changes in the membrane structure.
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Chapter 1
In tro d u c tio n
In the past two hundred years, a large number of chemicals have been 
identified as cancer-producing. No common structural characteristics 
have been discovered, and hence research has been based on the hope 
that an understanding of the neoplastic cell at the molecular and 
cellular levels can be attained.
Insight into the sequence of chemical events leading to a malignant 
tumour may not only form a solid base for the prevention and control 
of cancer, but will have implications for other areas of biology. 
Carcinogenesis involves so many fundamental properties of biological 
systems that the formulation of rational hypotheses concerning the 
mechanisms of carcinogenesis will only be possible when we have a 
full understanding of the most basic biological concepts.
One of the most important discoveries was that many chemicals require 
metabolic activation, by drug-metabolising systems, to chemically- . 
reactive forms which are the ultimate carcinogens (Miller and Miller, 
1974). As these enzymes are located in the endoplasmic reticulum of 
the cell, much of the work in recent years has involved the use of 
preparations of endoplasmic reticulum membranes.
The Endoplasmic Reticulum (E.R.)
The endoplasmic reticulum of mammalian hepatocytes is associated with 
many functions of cellular biochemistry. Within the structure are 
located numerous enzymes involved in lipid metabolism (Brenner, 1977) 
and protein metabolism, amongst others (Parke, 1981).
Regions of the membrane bear ribosomes bound to the cytoplasmic 
surface ('rough' E.R.). These areas are concerned with the synthesis 
of secretory proteins and also of proteins for incorporation into
1
intracellular membranes. (Elhammer et al, 1975; McIntosh and O'Toole,
1976). Regions devoid of ribosomes (1 smooth1 E.R.) are not involved 
in protein synthesis, but are involved in protein glycosylation and 
transport, and aspects of lipid metabolism (McIntosh and O'Toole, 1976).
The endoplasmic reticulum also carries the mixed-function oxidase 
enzymes, that are capable of oxygenating a wide variety of substrates.
They are involved in steroid metabolism, and are also capable of 
metabolising 'foreign' chemicals.
Original studies in drug metabolism led to the idea of drug oxidation 
being a detoxification mechanism leading to the excretion of the drug 
as a polar metabolite (Williams, 1959; Parke, 1968). Whilst this may 
be true in a large number of cases, there are now known to be numerous 
instances where drug oxidation leads to the formation of a more toxic 
compound.
In recent years more attention has been given to the effect of toxic 
chemicals, particularly carcinogeris, upon the endoplasmic reticulum. 
(Parke, 1981).
It is known that, in certain circumstances, treatment with toxic chemicals 
and carcinogens can cause shedding of ribosomes from the rough 
endoplasmic reticulum (degranulation) (Williams and Rabin, 1969;
Shires, 1978) which may have serious consequences upon glycoprotein 
synthesis. Damage to the endoplasmic reticulum has been associated 
with pathological changes including lipid peroxidation (Shires, 1978), 
and may be a fundamental process in malignant transformation and 
carcinogenesis.
Protein Synthesis: Induction and Inhibition
The rough endoplasmic reticulum is concerned primarily with the 
synthesis of secretory and transported proteins, which are normally 
discharged to the exterior of the cell. The smooth endoplasmic 
reticulum may be concerned with the production of intracellular 
proteins and transport of extracellular protein. (McIntosh and O'Toole, 
1976). Some intracellular proteins may pass from the endoplasmic 
reticulum into the cytosol for incorporation into new endoplasmic 
membranes (Elhammer et al, 1975).
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Most secreted proteins are glycoproteins in which carbohydrate 
moieties are covalently bound to the polypeptide by enzymes 
(glycosyltransferases) in the smooth endoplasmic reticulum and Golgi 
complex before leaving the cell (McIntosh and O'Toole, 1976).
Since the glycosyltransferases appear to be confined to the smooth 
endoplasmic reticulum and Golgi complex it would seem a prerequisite 
for glycoprotein synthesis to be initiated by polypeptide synthesis 
on the rough endoplasmic reticulum. Apart from secretory proteins 
other proteins may be synthesised on the rough endoplasmic reticulum 
although intracellular proteins are believed to be synthesised 
preferentially on free polyribosomes, as the proportion of smooth 
membrane increases during periods of intracellular protein demand 
(Loeb and Yeung, 1978).
Morphological and cell-fractionation studies have led to the concept 
that the ratio of free-to-bound ribosomes decreases as the cell 
differentiates, reflecting the greater need for intracellular proteins 
in rapidly growing cells compared to mature differentiated cells in
their normal physiological role of protein secretion (McIntosh and
j
O'Toole, 1976). Studies of free and bound ribosomal subunits suggest 
that there is no difference between two populations and that they 
are interchangeable (Lewis and Sabatini, 1977).
Rabin and co-workers (Sunshine, Williams and Rabin, 1971; Blyth, 
Freedman and Rabin, 1971) have suggested that steroid hormones are 
implicated in the binding of ribosomes to the endoplasmic reticulum. 
Although this concept has not gained general acceptance, the control 
of protein synthesis mediated by steroid hormones is an attractive • 
hypothesis.
The drug-induced increase in the mixed-function oxidase system results 
primarily from an increased rate of protein synthesis (Haugen, Coon 
and Nebert, 1976), which is also indicated by proliferation of smooth 
endoplasmic reticulum during phenobarbitone-induction (Remmer and 
Merker, 1963) .
Conney and Gilman (1963) have shown that the use of the protein 
synthesis inhibitors, puromycin and actinomycin D, prevents the
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induction of cytochrome P-450, suggesting that protein synthesis 
'de novo' is an important feature of enzyme induction.
Phenobarbitone-induced enzyme activities are prevented by actinomycin D, 
which suggests that induction may result from genomal derepression of 
DNA-RNA polymerase activity (Orrenius, Ericson and Ernster, 1965). 
Phenobarbitone and 3-methylcholanthrene both stimulate hepatic RNA- 
polymerase activity (Gelboin, Wortham and Wilson, 1967) and produce 
a nuclear chromatin that is a more effective template than usual. 
Phenobarbitone also induces an acidic nuclear protein which may play 
a role in increased transcription (Ruddon and Rainey, 1970).
Wold and Steele (1969) , have suggested that phenobarbitone primarily 
affects transcription of ribosomal-RNA, whereas methylcholanthrene 
affects transcription of messenger-RNA.
Alternatively, increased translation could produce induction, and 
may result from stabilisation of messenger-RNA (Stolman and Loh, 1970), 
due to the phenobarbitone inhibition of ribonuclease activity. In 
contrast, 3-methylcholanthrene does not inhibit microsomal ribonuclease 
activity (Louis-Ferdinand and Fuller, 1972).
Ribosomes and Degranulation
Ribosomes may be either 'free' cytoplasmic or 'bound' to the 
endoplasmic reticulum. It has been suggested that free ribosomes 
synthesise intracellular proteins, whilst bound ribosomes synthesise 
secretory or transported proteins (Rolleston, 1974). The membrane- 
ribosome interaction is a dynamic equilibrium that alters as the 
functional requirements of the cell demand (Ragnotti and Aletti, 1975). 
After partial hepatectomy in rats there is an increase in the propor­
tion of free ribosomes, consistent with the requirement for 
regenerating tissue (Loeb and Yeung, 1978).
The binding of ribosomes to the endoplasmic reticulum of the liver
requires the presence of steroid hormones. A definite sex-effect
/
being observed in that male 'smooth' membranes require the presence 
of corticosterone or oestradiol, whereas female 'smooth' membranes
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require either corticosterone or androgens (James, Rabin and Williams, 
1969).
Steroid hormones can exert a protective effect against the degranulation 
of 'rough' membranes by aflatoxin (Sunshine, Williams and Rabin, 1971). 
Other steroids can degranulate 'rough' membranes in the absence of
aflatoxin, and it has been suggested that aflatoxin and steroids
compete for the same binding site.
The degranulation of 1rough' membranes has been shown to be effected 
by a large number of carcinogens (Williams and Rabin, 1971; Lefevre,
1978), and has led to the suggestion that it may provide a simple
screening test for carcinogens. The correlation between known
carcinogenicity and degranulation in the original test was found to 
be less than desirable when examined (Purchase et al, 1976).
Nevertheless, that there is some relationship may help to explain the 
initiation of chemical carcinogenesis.
The binding of ribosomes to the endoplasmic reticulum appears to 
directly involve cytochrome P-450 (Takagi, Ï977). An increase in 
cytochrome P-450 content enhances polysomal binding, whilst loss of 
cytochrome P-450 diminishes binding. Purified cytochromes P-450 and 
P-448 also bind polysomes, so the alteration of species of cytochrome 
is not related to degranulation.
The effect of carcinogens on degranulation has been disputed (Shires,
1978), and the effect ascribed to lipid peroxidation. However, if 
carcinogens induced lipid peroxidation, these results would not be 
contradictory. Compounds that induce lipid peroxidation, are both 
metabolised by, and interact with, cytochrome P-450 (Uehleke et al, 1977) .
Glycoprotein Synthesis
One of the most essential biological functions of the endoplasmic 
reticulum is the synthesis of glycoproteins, initiation of which 
appears to be exclusive to membrane-bound ribosomes (Hallinan, Murty 
and Grant, 1968). Glycoproteins play an important role in the 
regulation of the eukaryotic organism. They are secreted into the
plasma membrane glycocalyx, regulate cell division, and secretory 
glycoproteins, such as the immunoglobulins, play a major role in 
immune surveillance (Parke, 1981).
After the assembly of the protein backbone, the sugar residues are 
added mainly after release of proteins from the ribosomes. Evidence 
has been presented for glycosylation occurring in 'rough1 and 
'smooth' membranes together with the Golgi complex, depending upon 
the residue to be added. (Schacter, 1974). Whereas protein synthesis 
is under genetic control, the synthesis of oligosaccharide prosthetic 
groups is controlled by a non-template mechanism in which genes code 
for a large variety of glycosyltransferases. Initiation, elongation 
and possibly termination of oligosaccharides appear to be controlled 
by the substrate specificities of these transferases. Every prosthetic 
group is thus assembled by the concerted action of a multiglyco- 
syltransferase system (Schacter and Roden, 1973).
Studies have shown changes in the activity of the glycosyltransferases 
in tumours (Kessel, Sykes and Henderson, 1977), and tumour-bearing 
rats (Ip and Dao, 1977). Transformed cells exhibit altered cell- 
surface glycoproteins (Warren et al, 1974), including an increased 
incorporation of sialic acid residues. Terminal sialic acid plays a 
major role in determining the survival time of serum glycoproteins 
(Ashwell and Morell, 1974). Sialic acid components also appear to 
at least partly determine many physical and biological functions of 
glycoproteins (Schauer, Buscher and Casals-Stenzel, 1974).
The combination of impaired synthesis of extracellular proteins 
(degranulation), together with altered glycosyltransferases may be an 
important factor in the growth of tumours due to the altered state 
of the immune response.
The Mixed-Function Oxidase System
Hepatic microsomal drug metabolism is carried out primarily by the 
mixed-function oxidase system. This is a multicomponent system 
comprising NADPH^, NADH, a glycohaemoprotein known as cytochrome P-450, 
and a linking electron transport chain consisting of flavoprotein­
based reductases and possibly cytochrome b5 (Coon, Strobel and Boyer, 
1973; Estabrook et al, 1973).
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The electron transport chain has not been fully elucidated but appears 
to be as shown in figure 1-1. Electrons are transported from NADPHg 
to cytochrome P-450 via the flavoprotein, NADPH^-cytochrome P-450(c) 
reductase. The involvement of cytochrome b5 has been postulated, 
and various studies (Hildebrandt and Estabrook, 1971; Correia and 
Mannering, 1973 ; Mannering, Kuwahara and Omura, 1974) have led to the 
conclusion that the second electron required in the monoxygenase 
reaction can be donated from cytochrome b5. Cytochrome b5 also provides 
electrons for acyl(stearyl)-CoA desaturase, a non-haem ferro-protein 
(Strittmatter et al, 1974).
The mechanism of hydroxylation of drugs and xenobiotics has been 
postulated to be as shown in figure 1-2. The evidence for the existence 
of a single terminal oxygenase (Cytochrome P-450) rests upon spectral 
absorption data, and is of doubtful validity as the heterogeneity of 
cytochrome P-450 is now well established.
Most drugs and chemicals react with cytochrome P-450 to give the 
so-called "Type I" spectrum, whereas other chemicals usually containing 
a nitrogen or sulphur atom produce a "Type II" spectrum. This has been
interpreted to imply that all substrates react with cytochrome P-450
either by interaction with the lipoprotein moiety (type I), or by
forming a ligand with the haem (type II).
The endoplasmic reticulum is involved in various aspects of lipid 
metabolism (Brenner, 1977), and the mixed-function oxidase system can 
affect hydroxylations of fatty acids and cholesterol. The -hydro­
xylation of cholesterol, the rate-limiting step in the biosynthesis of 
bile acids, is catalysed by a cytochrome P-450 dependent oxygenase 
which is distinctly different from that which catalyses other drug 
oxidations (Mellon, Witiak and Feller, 1978). Cholesterol cC -hydroxylase 
activity is not induced by treatment with phenobarbitone, but is 
stimulated by its substrate (cholesterol) or by natural or synthetic 
glucocorticoids (Gielen, Canfort and Kremers, 1976).
It has also been suggested that cytochrome P-450 may play a role in the 
synthesis and metabolism of prostaglandins (Tan, Wang and Leboux, 1973) , 
prostacyclins, leukotrienes and thromboxanes (Cinti and Feinstein, 1976) .
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Cytochrome P-450
Cytochrome P-450 is a haemoglycoprotein that forms the terminal oxidase 
of the mixed-function oxidase system of the endoplasmic reticulum.
When the enzyme was originally characterised. (Omura and Sato, 1964), 
it was found to be present universally in animal tissues, but was 
predominantly found in liver. Studies showed that it had a wide range 
of substrates and could be induced by administration of many drugs 
(Parke, 1975).
It was soon discovered that treatment with 3-methylcholanthrene induced 
a 1 novel1 cytochrome - named cytochrome P-448, because of the 2nm 
hypsochromic shift of the reduced-CO difference spectrum compared 
with that of cytochrome P-450 (Sladek and Mannering, 1966). It has 
become apparent that cytochrome P-450 as observed, is itself a 
heterogeneous mixture of cytochromes of similar properties, and that 
all forms are present in varying amounts in all animal tissues 
(Guengerich, 1978).
Thus it appeared that different chemicals could induce a different 
cytochrome P-450 (or P-448) and thus alter the overall metabolic 
pattern. This, however, supposes that cytochrome P-448 is produced 
by de novo protein synthesis and is genetically different from 
cytochrome P-450. Studies with strains of mice by Nebert and his 
co-workers have followed this hypothesis. Other workers have attempted 
to show that cytochrome P-448 was a modified form of pre-existing 
cytochrome P-450 (Kahl et al 1977); however, the results have never 
proven conclusive.
Cytochrome P-450 is found in both smooth and rough endoplasmic 
reticulum, and the possibility occurs that cytochrome P-448 may be . 
produced by a conformational change in cytochrome P-450 following an 
event such as degranulation. Mailman et al (1975) reported multiple 
forms of cytochrome P-450 occurring in hepatic microsomes prepared 
from untreated rats and mice. When the microsomal membranes were 
fractionated on a sucrose gradient it was found that a difference 
could be demonstrated between smooth and rough membranes. Cytochrome 
P-450 was demonstrated in rough membranes whereas cytochrome P-448 was
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demonstrated in smooth membranes. However, the appearance of cytochrome 
P-448 in endoplasmic reticulum membranes degranulated 1 in vitro1 has 
not been reported.:
The possible involvement of hormones in ribosomal binding has already 
been discussed. It has also been noted that changes in the hormonal 
status of animals may alter the predominant type of cytochrome observed.
Foetal and neonatal tissues contain cytochrome P-448 rather than P-450 
and have a higher proportion of 'smooth* to 'rough* membranes than in 
adult animals. They exhibit a lack of responsiveness to induction of 
cytochrome P-450 but are responsive to induction of cytochrome P-448 
(Guenthner and Mannering, 1977a). Studies in pregnant rats showed that 
phenobarbitone induction was decreased whereas 3-methylcholanthrene 
induction was not (Guenthner and Mannering, 1977b). These studies 
could indicate that the hormonal status of the tissues is important in 
determining the cytochrome induced. The induction pattern of foetal 
tissue is similar to that of tumour tissue, or rather the enzymes 
appearing in tumours strongly resemble those found in foetal tissues 
(Knox, 1967; Farron, Hsu and Knox, 1972).
The changes in the pattern of enzymes found in carcinogen-treated 
tissues may play an important role in the initiation of cancer as will 
be discussed later.
Regulation of Cytochrome P-450 and Induction
The steady state levels of proteins in animal tissues are regulated by 
both synthesis and degradation (Schimke and Doyle, 1970). Due to the 
metabolic and structural complexity of animal cells including rapid 
nuclear-RNA turnover (Harris, 1968), and variably stable messenger-RNA 
(Kafatos and Reich, 1968), a number of regulatory factors exist besides 
those regulating the formation of specific m-RNA.
The term "induction" is used to describe an increase in the ratio of 
the rate of protein synthesis over the rate of protein degradation.
As protein synthesis follows zero-order kinetics (Schimke, Sweeney and 
Berlin, 1965) and protein degradation is first-order (Omura, Sickevitz
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and Palade, 1967), it can be shown that during induction, the time 
taken to increase to one-half of the final steady state level is 
approximately equal to the half-life of the protein (Berlin and 
Schimke, 1965).
These concepts are much simplified, and do not take account of post- . 
translational controls, or the complex co-ordination of haem and protein 
synthesis required.
Cytochrome P-450 has a half-life of 1-2 days (Levin and Kuntzman, 1969), 
and induction should therefore result in increased levels within 24 hours 
according to the simplified concepts.
Induction of Cytochrome P-450
A multitude of studies have shown that enzyme levels in animal tissues 
can be altered by physiological, nutritional, hormonal and chemical 
manipulations. In particular, the level of the hepatic haemoprotein, 
cytochrome P-450, is increased by administration of a wide variety of 
xenobiotics, including drugs, insecticides, herbicides and carcinogens 
(Parke, 1975).
Cytochrome P-450 is involved in the oxidation of numerous drugs, as well 
as endogenous compounds such as cholesterol, steroid hormones, and 
fatty acids.
Amongst the first known inducing agents were the carcinogen 3-methyl­
cholanthrene (Conney, Miller and Miller, 1956), and the drug pheno­
barbitone (Remmer, 1959).
After a single intraperitoneal injection of phenobarbitone, the induced 
level returns to normal as the inducer is eliminated from the body. All 
known inducing agents are lipid-soluble compounds, which interact with 
cytochrome P-450 'in vitro' to give a type-1 binding spectrum. It is 
possible that the indueer-receptor site may have features in common with 
cytochrome P-450.
The induction phenomena of hepatic cytochromes following drug pretreatment 
are complex, involving many processes. Phenobarbitone-induction of 
cytochrome P-450 is accompanied by an increase in NADPH-cytochrome
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c-reductase, and can be prevented by inhibition of protein synthesis 
at the transcriptional or translational level (Ernster and Orrenius, 
1965; Gelboin, 1971; Jacob, Scharf and Vessel, 1974).
The occurrence of protein synthesis during phenobarbitone induction 
has been demonstrated by the increased 1 in vivo1 incorporation of 
amino acids into cytochrome P-450 and into NADPH cytochrome c-reductase 
(Dehlinger and Schimke, 1972; Kuriyama et al, 1969). Turnover studies 
suggest that phenobarbitone increases the rate of synthesis of NADPH 
cytochrome c-reductase, and decreases its rate of degradation (Jick 
and Shuster, 1966; Kuriyama et al, 1969). The decrease in the rate 
of degradation is however debatable as phenobarbitone also causes 
increased utilisation of amino acids (Schimke and Doyle, 1970).
From the relatively high amount and short half-life of cytochrome 
P-450 (1-2 days ; Griem et al, 1970; Levin and Kuntzman, 1969) it has 
been estimated that most of the haem synthesised in the hepatocyte is 
needed for the synthesis of cytochrome P-450 (Marver and Schmid, 1972). 
5-Aminolaevulinate synthetase (5-ALA synthetase), the rate limiting 
enzyme in haem biosynthesis, increases rapidly following phenobarbitone 
administration (Marver, 1969). This increase may not solely reflect 
the need for increased haem synthesis since 5-ALA synthetase later 
decreases when cytochrome P-450 has reached the induced steady-state 
level (Bock et al, 1971). Moreover, induction by phenylbutazone is 
not accompanied by an increase in 5-ALA synthetase (DeMatteis and 
Gibbs, 1972). However, inducing agents in mammalian liver are often 
potent inducers of 5-ALA synthetase in chick liver cell cultures 
(Granick, 1966).
The existence of a mobile microsomal haem pool has complicated the 
study of haem incorporation during induction. Levin and Kuntzman (1969) 
reported a biphasic rate of loss of radioactivity from labelled haem 
with half-lives of 7 and 48 hours. It is not known whether the fast 
turnover rate represents a form of cytochrome P-450 or a contaminant 
from the haem pool.
Evidence has been reported for a pool of free cytochrome P-450 
apoprotein (Correia and Meyer, 1975). Phenobarbitone increases the 
rate of synthesis of the apoprotein, which accumulates when haem
13
synthesis is inhibited, and is found in the "heavy" rough microsomes 
co-sedimenting with mitochondria. Whilst it is known that inhibition 
of haem synthesis leads to a decrease in cytochrome P-450, and prevents 
induction, an increased rate of haem synthesis will not induce 
cytochrome P-450 (Druyan and Kelly, 1972).
It has been reported that during induction cytochrome P-450 increases 
first in the 1 rough1 microsomal fractions, and subsequently in the 
'smooth' fractions (Ernster and Orrenius, 1965; Dallner, Siekevitz and 
Palade, 1966). Recently, using antibodies specific to cytochrome P-450, 
Craft et al (1979), have reported that cytochrome P-450 is at least 
partly synthesised by the heavy 'rough' endoplasmic reticulum, is 
translocated into the intracisternal space of the 'rough' endoplasmic 
reticulum and then passes through the light 'rough' and 'smooth' 
reticulum before insertion at its ultimate membrane locus.
Studies on the incorporation of labelled aminoacids into hepatic 
microsomal protein, in mice genetically responsive and non—responsive 
to methylcholanthrene induction, have shown that induction by 
phenobarbitone or ^ -napthaflavone results primarily in the increased 
rate of "de novo" protein synthesis, rather than a decreased degradation 
rate or conversion of existing polypeptides (Haugen, Coon and Nebert,
1976).
Strains of mice genetically non-responsive to methylcholanthrene 
(Gielen, Goujon and Nebert, 1972 ; Poland et al, 1974) respond normally 
to phenobarbitone. The lack of response is not due to a mutation in 
the necessary structural genes since these strains can be induced 
by 2,3,7,8-tetrachlorodibenzo-p-dioxin (Grieg and DeMatteis, 1973;
Poland et al, 1974). Further studies have suggested that a cytosolic 
receptor protein may be deficient (Poland, Glover and Kende, 1976).
The induction of cytochrome P-450 and P—448 involves protein synthesis 
'de novo1, but attempts have been made to show the formation of 
cytochrome P-448 without protein synthesis 'de novo' (Kahl et al, 1977), 
but the experimental design has allowed criticism that protein synthesis 
was not fully inhibited.
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Studies have however shown that purified fractions of cytochrome 
P-448 induced by 3-methylcholanthrene contain the inducing agent 
strongly bound to the cytochrome (Hashimoto and Imai, 1976; Sato 
et al, 1979). The possibility therefore exists that cytochrome P-448 
is a chemically modified form of cytochrome P-450, although the 
existence of the metabolite-complex has not been shown to be the 
cause of the altered enzyme characteristics.
Heterogeneity of Cytochrome P-450
Evidence has accumulated to show that multiple forms of cytochrome 
P-450 exist (Sladek and Mannering, 1966; Imai and Sato, 1966;
Frommer et al, 1972; Lu et al, 1973). It has been known for some time 
that phenobarbitone and 3-methylcholanthrene induce different oxidation 
reactions (Conney, 1967) .
Phenobarbitone-induced cytochrome P-450 metabolises hexobarbital, 
ethylmorphine and aminopyrine, whereas metylcholanthrene-induced 
cytochrome P-450 metabolises ethoxycoumarin, ethoxynesorufin, and 
benzo(a)pyrene. Treatment of rats with 3-methylcholanthrene induces 
a form of cytochrome P-450 with altered spectral properties called 
'cytochrome P-448' (Alvares et al, 1967) 'cytochrome P-446* (Hildebrandt 
et al, 1968) or 'cytochrome P^-45o' (Sladek and Mannering, 1966).
Purified preparations from control and induced rats (either pheno­
barbitone or methylcholanthrene) show different EPR spectra (Nebert 
and Kon, 1973; Nebert, Robinson and Kon, 1973 ; Witmer et al, 1974), 
behave differently under isoelectric focussing (Conney et al, 1973) 
and resolve into different molecular weight bands by SDS-polyacrylamide 
gel electrophonesis (Alvares and Siekevitz, 1973). Comai and Gaylor 
(1973), have also separated fractions of cytochrome P-450 with differing 
spectral properties by diethylaminoethyl cellulose chromatography.
Kinetic evidence has been given that multiple species of cytochrome 
P-450 are present in liver microsomes, and that different species are 
induced by a variety of different agents (Powis, Talcott and Schenkman,
1977) .
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The presence of multiple species with different catalytic activities 
is now firmly established by the purification of forms of cytochrome 
P-450 induced by phenobarbitone, p-napthoflavone, methylcholanthrene 
and other agents (Hashimoto and Imai, 1976; Haugen and Coon, 1976; 
Huang, West and Lu, 1976; Thomas et al, 1976; Johnson and Müller- 
Eberhard, 1977; Guengerich, 1978).
The mechanism of induction of cytochromes P-450 and P-448 may be 
different, with different inducers acting by different mechanisms. 
Although most agents induce only one predominant type of cytochrome, 
some halogenated biphenyls induce both cytochromes P-450 and P-448 
simultaneously (Alvares, 1977; iDannan et al, 1978).
The Appearance of Cytochrome P-448 during Induction
The induction of cytochrome P-448 by various carcinogens has led to 
investigations to determine whether it is an entirely new protein, or 
a modified form of pre-existing cytochrome P-450. The major types of 
cytochromes P-450 and P-448 have been purified and their differences 
are being characterised. Whether or not this will answer the problem 
remains to be seen.
Certain compounds (e.g. Safrole) form a ligand-complex with cytochrome 
P-450, and in doing so, alterations to the P-448 type spectra are seen 
(Parke and Rahman, 1970; Gray and Parke, 1973). Long-term feeding of 
safrole leads to initial induction of cytochrome P-448, whereas long­
term feeding of phenobarbitone results in sustained induction of 
cytochrome P-450 (Crampton et al, 1977a,b; Parke and Gray, 1978).
The possibility exists that cytochrome P-448 results from a metabolite, 
ligand/complex with P-450. This has been discounted by Fujita and 
Mannering (1971), who observed that purified, soluble cytochrome P-448 
from rats treated with 3-methylcholanthrene contained only 0.04mol.
3-MC per mol. P-448. However, more recently Sato et al (1979) 
demonstrated a mol/mol. ratio, as reported earlier by Hashimoto and 
Imai (1976).
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A study of the dééthylation of 7-ethoxycoumarin (Ullrich, Frommer , 
and Weber, 1973) showed that this activity was minimal in control 
rat liver microsomes, that activity with anomalous binding spectra 
was present in phenobarbitone-induced microsomes, and that activity 
with type-I binding was also present in methylcholanthrene-induced 
microsomes. This suggests the presence of at least three cytochromes, 
that may be different at the active site.
A commonly used indicator of the presence of cytochrome P-448 has been 
the altered spectral binding of ethyli socyanide. Alvares and 
Mannering (1967) noted an increase in the 455nm peak, with respect to 
the 430nm peak, following administration of 3-methylcholanthrene to 
rats. It has been shown that during phenobarbitone induction, the 
increase in N-demethylase activity parallels the increase in 
cytochrome P-450, whereas during methylcholanthrene induction the 
increase in activity and changes in the ethyl isocyanide spectra occur 
long before there is any increase in total haemoprotein (Alvares,
Porli and Mannering, 1973). Similar results were reported by Imai 
and Siekevitz (1971), who also showed that the administration of 
aminotriazole, (a competitive inhibitor of haem biosynthesis), 
completely inhibited induction by methylcholanthrene but not the 
appearance of the altered ethylisocyanide spectra. The authors 
interpret these findings to show that haem synthesis is not necessary 
for the appearance of cytochrome P-448. Furthermore, the inhibition 
of the induction, but not the appearance, of cytochrome P-448 by 
eyeloheximide suggested that the synthesis of proteins other than 
apocytochrome P-450 is necessary for the change in the ethylisocyanide 
spectra (Imai and Siekevitz, 1971).
The use of protein synthesis inhibitors is discussed elsewhere, but 
has provided evidence that protein synthesis is not necessary for the 
appearance of cytochrome P-448. However, the results have been 
inconsistent and no definite evidence has been presented.
The use of haem and protein synthesis inhibitors has also been studied 
during induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin (Kitchin and 
Woods, 1978). The authors suggest that the results suggest that 
'de novo1 synthesis is not required. The inconclusiveness of these
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experiments rests partly with the fact that complete inhibition of 
protein synthesis has not been demonstrated during the experimental 
procedure.
Evidence has been put forward that cytochrome P-448 is a different 
protein from cytochrome P-450. Shoeman, Vane and Mannering (1973) 
reported that cytochrome P-420 derived from cytochrome P-448 was 
different in substrate binding and in electrophoretic properties 
from P-420 derived from cytochrome P-450. Comai and Gaylor (1973) 
isolated three spectrally-distinct forms of cytochrome P-450 by 
DEAE-cellulose chromatography. The relative amounts of these forms 
varied according to the inducing agent used, and different rates of 
incorporation of radiolabelled 5-aminolaevulinic acid was shown.
This argues against these forms being the same cytochrome complexed 
with different tightly-bound substrates.
Many studies have been performed using SDS-polyacrylamide gel 
electrophoresis to separate different forms of cytochrome P-450 
(e.g. Hongen, Coon and Nebert, 1976; Ivanetich and Bradshaw, 1977; 
Guengerich, 1978; Coon et al, 1977; Warner, La Marca and Neims,
1978). These experiments have been interpreted to indicate that 
different forms have different molecular weights, and are hence 
different proteins, but it should be remembered that haem-free 
polypeptide fragments of the cytochromes and not the cytochromes 
themselves, are examined. Similarly, immunological studies have 
indicated non-cross-reactivity between anti-P-450 antibodies and 
cytochrome P-448 (Levin et al, 1977a; Guengerich, 1978; Thomas et al,
1979). However, none of these techniques are indicative of different 
enzymes as the same results may be found in soluble isoenzymes. 
Furthermore, it must be remembered that cytochrome P-450 is knownto be
a haemoglycoprotein, and that an alteration in the carbohydrate residues 
may change both the molecular weight, and the immunological properties.
Table 1-3 Differences in sites of hydroxylation
by Cytochromes P-450 and P-448
Cyt. P-450 
(phenobarbitone-indue ed)
Cyt. P-448 
(methylcholanthrene-induced)
6 r
vv OHHO'
Bromobenz ene
\ /
Biphenyl
16 <X -hydroxylation 7 oC -hydroxylation
Testosterone
H OH H0H OH
Benzo(a)pyrene
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Differences in the sites of hydroxylation by Cytochromes P-450
and P-448
Cytochromes P-450 and P-448 have been shown to hydroxylate certain 
chemicals at different molecular positions (table 1-3), the essential 
difference being the ability of cytochrome P-448 to hydroxylate in 
bay-regions of polycyclic hydrocarbons, and at other sterically- 
hindered positions^Ln addition to those non-hindered positions 
hydroxylated by cytochrome P-450. This has led to the Bay-region 
theory of carcinogenesis (Sims et al, 1974; Jerina et al, 1978).
Studies of benzo(a)pyrene carcinogenicity showed that the most potent 
tumorigenic metabolite was the 7,8-diol-9,10-epoxide, which is 
probably formed by the mechanism shown in figure 1-4. The initial 
metabolism by cytochrome P-450 and epoxide hydratase results in a 
7,8-dihydrodiol, which is then further metabolised only by cytochrome 
P-448 to the 7,8-diol-9,10-epoxide. This results in a reactive oxide 
that is not a substrate for epoxide hydratase, or any other detoxicating 
enzyme (e.g. glutathione-transferase, glucuronyi-transferase).
The ability to hydroxylate sterically-hindered positions would indicate 
that cytochrome P-448 probably possesses a different oxygenation 
mechanism to cytochrome P-450, in that oxygenation via the normal 
substrate-binding site is not the only mechanism. It is possible 
that this may be due to uncoupling of the cytochrome from its 
reductase, resulting in a less specific oxygenation.
Inhibition of Cytochrome P-450
The inhibition of drug metabolism has been reviewed by Mannering 
(1971). Whilst drug metabolism may be inhibited 1 in vivo1 by a wide 
variety of conditions, only those concerning the interaction with 
the mixed-function oxidase system are dealt with here.
Two substrates of cytochrome P-450 will be likely to inhibit each 
other's metabolism by competition for the substrate binding site.
This has been found to be the case for a wide variety of structurally 
unrelated drugs. Hexobarbitone, chlorpromazine and zoxazolamine 
competitively inhibit N-demethylation of ethylmorphine. However, it
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Cytochrome P-45010
Benzo(a)pyrene BP 7,8 oxide
epoxide hydratase
Cytochrome P-448
OHOH
BP 7,8-dihydrodiol BP-7,8-diol-9,10-epoxide 
(ultimate carcinogen)
Figure 1-4 Biological activation of Benzo(a)pyrene
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was noted that chlorpromazine inhibition was not a matter of simple 
substrate competition (Mannering, 1971).
Further early studies revealed that inhibition was not always 
competitive, and the existence of more than one drug-metabolising 
system would be a possible explanation. The kinetics of competitive 
inhibition do not demand that only one system be involved, as the 
same kinetics will be seen if two systems share a rate-limiting 
co-factor. In a multienzyme system, different components of the 
system may be rate-limiting when different drugs are substrates; 
which would yield mixed inhibition kinetics, and could be explained 
in the way in which different drugs bind to cytochrome P-450.
The use of SKF525Â (2-diethylaminoethyl 2,2-diphenylvalerate 
hydrochloride) as an inhibitor of cytochrome P-450 has been 
extensively used. However, SKF525A does not inhibit the metabolism 
of all drugs known to be metabolised by the mixed-function oxidase 
system and its use subsequently induces the mixed-function oxidases 
as do all other competitive inhibitors. The effects of SKF525A
are dependent upon a number of factors.
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Species differences are obvious from the ability of SKF525A to inhibit 
the O-dealkylation of phenacetin by rat microsomes (Burns, 1966) 
but not by rabbit microsomes (Axelrod, 1956). Inducing agents can 
cause changes in the system so that the inhibitory effect of SKF525A 
may be increased or decreased. SKF525A inhibits the N-demethylation 
of 3-methyl-4-methylaminoazobenzene by control microsomes, but has 
little effect on metabolism b^ 3-methylcholanthrene-treated microsomes 
(Sladek and Mannering, 1966).
SKF525A acts as a competitive inhibitor at the active site of cytochrome 
P-450 (Anders and Mannering, 1966), but may also act as an uncoupling 
agent, although experimental evidence for this is lacking. SKF525A 
is known to bind irreversibly to microsomes (Rogers and Fouts, 1964) , 
and results in the disappearance of the type-1 binding site 
(Mannering, 1971) .
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Halogenated Phenols as inhibitors of cytochrome P-450
A number of antibacterial polyhalogenated phenols, including 
hexachlorophene (2,2'-methylenebis(3,4,6-trichlorophenol)), have 
been shown to significantly prolong hexobarbitone sleeping time 
in rats by the inhibition of drug metabolism (Condie and Buhler;
1979).
'In vitro1 reaction with cytochrome P-450 is characterised by 
type-1 binding spectra, and it was found that the 1 in vitro' 
inhibition of drug.metabolism increased with increasing incubation 
times. A high affinity binding of hexachlorophene to cytochrome 
P-450 is thought to exist, and a reactive metabolite of hexachlorophene 
has been shown to be covalently bound to hepatic microsomal protein 
(Miller, Henderson and Buhler, 1978).
^Chlorophenol pesticides have also been shown to inhibit drug oxidation.
Pentachloropheno1 is known as an uncoupler of mitochondrial oxidative 
phosphorylation (Weinbach, 1954), and has recently been shown to 
uncouple microsomal electron transport (Arrhenius et al, 1977).
The mixed-function oxidase system catalyses the N-demethylation of 
N ,N-dimethylaniline, but the uncoupling of electron transport by 
pentachloropheno1 caused inhibition of N-demethylation, whilst 
stimulating N-oxygenation. A similar change from C- to N-oxidation 
of 2-acetylaminofluorene is self-induced by administration to rats, 
resulting in the formation of the active carcinogenic metabolite 
(Malejka-Giganti et al, 1978).
The intact microsomal oxidase system is an important link in the 
protection against toxic substances, and some carcinogens may exert 
their effects by means of metabolites formed by damaged detoxification 
systems (Arrhenius, 1974).
Free Radicals in Biological Reactions
Oxygen radicals (either superoxide, or hydroxyl) have been postulated 
as playing a role in a number of biological systems, but their detection 
remains difficult (Bors et al, 1978).
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Hydroxyl radicals have been demonstrated in a purified NADPH- 
cytochrome c (P-450) reductase system (Lai, Grover and Piette, 1979) 
using spin-trap methods. These radicals may then affect the 
endoplasmic reticulum by initiating lipid peroxidation, which is 
known to be a chain reaction (Dahle, Hill and Homman, 1962).
Studies using a purified oxidase system (Lai, Grover and Piette, 1979)
showed that the hydroxyl radical was indirectly produced from
superoxide anions generated during the oxidation of NADPH. The 
generation of radicals being summarised as:
a) oxidised P-450 reductase + NADPH — > reduced P-450 reductase 
+NADP+.
b) reduced P-450 reductase +09 — > oxidised P-450 reductase +0*"
_ _  +  2 1
c) 0£ + H <==» H02
d) Oj + HO* 02 + H202 + OH™
e) Oj + H202— > 02 + OH™ + OH*
The formation of hydroxyl radicals is dependent upon the formation 
of hydrogen peroxide, thus catalase should inhibit the production of 
OH*, whereas the addition of superoxide dismutase (which enhances 
H202 formation) should enhance the production of OH*.
Further evidence has demonstrated the production of hydroxyl radicals 
during microsomal electron transfer (Cohen and Cederbaum, 1979), 
and that hydroxyl radical scavengers (such as dimethylsulphoxide, 
mannitol, benzoate, thiourea) inhibit the catalase-independent 
oxidation of ethanol by rat liver microsomes (Cederbaum, Dicker and 
Cohen, 1978) .
Using a reconstituted system, Ohnishi and Lieber (1978) have shown 
that hydroxyl radicals may participate in the oxidation of ethanol, 
whereas superoxide anions are not involved.
Superoxide anions have been shown to be produced by liver microsomes, 
probably by the reduced cytochrome P-450 oxygenated complex, rather 
than directly by the reductase (Auclair, DeProst and Hakin, 1978).
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The production of superoxide anions from the oxygenated complex 
has also been suggested by Estoubrook et al (1978).
Whilst this is slightly different from the method of production 
suggested by Lai, Grover and Piette (1979), it can be assumed that 
the superoxide anion is produced by the P-450 reduction - cytochrome 
P-450 complex.
Membrane Lipids: structure and function
The membranes that constitute the endoplasmic reticulum comprise an 
asymétrie bilayer of lipid. The outer layer consists mainly of 
phosphatidyl choline, sphingomyelins and cholesterol, whilst the 
inner layer is mainly phosphatidylserine, phosphatidylethanolamine, 
and glycolipids (Bretscher, 1981). Transmembrane proteins are 
embedded in the membrane either as globular proteins, or as a 
simple <X -helix passing through the bilayer, and are free to diffuse 
laterally.
R
(NADPH)
e (NADH or 
NADPH)
Studies with reconstituted mixed-function oxidase systems have shown 
the necessity for a lipid component, essential for enzyme activity 
(Depierre and Dallner, 1975).
It has been suggested that membrane lipids are present as rigid or 
fluid areas, and that rigid areas form haloes around the components 
of the mixed-function oxidase system (Stier, Kuhle and Rosen, 1977), 
thus maintaining the coupled electron transport system. Lipid states 
may determine the assemblage of the system and thus affect the 
metabolism of drugs.
As the lipid is in a metastable state, any alterations in the equilibrium 
towards a fluid state may uncouple units of the multienzyme complex 
(Stier, 1976) . Sex, age and nutrition may thus all be related to 
variations in drug-metabolism due to alterations in lipid state 
(Belina et al, 1975; Norred and Wade, 1972).
In the coupled state, the flavoprotein can be assumed to act 
predominantly as a cytochrome P-450 reductase and the cytochrome 
as an oxygenase; whereas in the uncoupled state the flavoprotein 
could act directly as a hydroxylase (Aust, Roerig and Pederson,
1972) and the cytochrome as a peroxidase (Kadlubar, Morton and 
Ziegler, 1973). Substrate, ligand and inhibitor binding could 
thus be different in the coupled and uncoupled states, and 
multiple forms of cytochrome P-450, as differentiated by binding 
criteria (Werringloer and Estabrook, 1975), may represent a single 
form in different environments.
Drugs and carcinogens may affect the coupling dynamics by triggering 
a phase shift, or by initiating lipid peroxidation.
Lipid peroxidation
Lipid peroxidation has been linked with carcinogen-induced 
degranulation (Shires, 1978), although the correlation is disputed. 
Microsomal preparations undergoing lipid peroxidation show loss of 
cytochrome P-450 (DeMatteis, 1978). Antioxidants, inhibit lipid 
peroxidation 1 in vitro1 with inhibition of the loss of cytochrome 
P-450. Superoxide dismutase also inhibits lipid peroxidation 
1 in vitro1 (Autor, 1974) which suggests that superoxide anions may be 
involved in the reaction. The integrity of the endoplasmic reticulum 
is usually maintained by the presence of the antioxidant, -tocopherol 
(vitamin E), and retinol (vitamin A). Sporn (1977) has reported that 
retinoids confer a protective effect against chemical carcinogenesis.
In addition, it has been shown that cytotoxic drugs decrease liver 
vitamin A levels by an unknown mechanism (Poole, Dunbar and Dickerson, 
1979). This may be related to the destruction of vitamin A as a 
protecting agent preventing membrane destruction.
The balance between free-radical generation and membrane stability 
is thus critical to the proper functioning of the mixed-function 
oxidases.
Changes during Induction
From the earliest studies, it has been recognised that phenobarbitone 
not only stimulates the synthesis of drug-metabolising enzymes, but 
also leads to a marked proliferation of the smooth endoplasmic 
reticulum to which these enzymes are bound (Remmer and Merker, 1963), 
and to an increase in liver mass (Conney et al, 1960). On the other 
hand, 3-methylcholanthrene induces a smaller number of enzymes and 
does not lead to a significant proliferation of the endoplasmic 
reticulum (Conney, 1967).
Several microsomal enzymes functionally linked to the mixed-function 
oxidase system are also inducable. Phenobarbitone produces a marked 
increase in NADPH^-cytochrome c reductase but hardly any change in 
cytochrome b5 (Arias, Doyle and Schinke, 1969).
The rate of synthesis of certain proteins of the endoplasmic reticulum 
may be decreased by phenobarbitone treatment, and a mechanism has been 
advanced by Venkatesan, Arcos and Argus (1971) .
Phenobarbitone treatment also results in a decreased microsomal 
phosphalipase activity (Stein and Stein, 1969), which results in 
increased phospholipid content. Increased biosynthesis of 
phosphatidylcholine also follows phenobarbitone treatment (Young, 
Powell and McMillan, 1971)y and this may be a necessity to ensure 
optimum activity of induced cytochrome P-450.
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Chapter 2
M a te r ia ls  and M e th o d s
MATERIALS :
DL-isoCitric acid, trisodium salt; isocitrate dehydrogenase ;
NADP; NADPH; RNA; ribonuclease and 1,2,3,4-dibenz(a,c)-anthracene 
were purchased from Sigma Chemical Co., Poole, Dorset. 
2-Acetylaminofluorene and 1,2,5,6-dibenz(a,h)-anthracene were 
purchased from Ralph N. Emmanuel and Co., Wembley, Middlesex.
4-Acetylaminofluorene, c<-naphthylamine and f-naphthylamine were 
from Koch-Light Laboratories Ltd., Colnbrook, Buckinghamshire. 
Ethylmorphine hydrochloride was a gift from May and Baker Ltd., 
Dagenham, Essex. [6-^^c]-Orotic acid was purchased from the 
Radiochemical Centre, Amersham, Bucks. Hexachlorophene was from 
Sigma Chemical Co., Poole, Dorset, and pentachlorophenol (technical 
grade) from B.D.H. Chemicals Co., Poole, Dorset.
All other chemicals were of Analar or higher grade, or were purified 
as necessary.
Preparation of purified sucrose
Household sucrose (Tate and Lyle) was purified for centrifugation 
use by dissolving it in deionised water to form a solution of 
approximately 2.5M. When the sucrose was fully dissolved, 17g of 
activated charcoal (Norit-A, B.D.H. Chemicals, Poole, Dorset) per 
mole of sucrose was added. The mixture was stirred magnetically 
for 30 min whilst maintaining gentle heating. The hot mixture 
was then filtered through two layers of Whatman No.l filter paper 
using a Buchner flask and funnel with vacuum assistance.
An aliquot of the purified solution was taken for density 
determination. Molarity of the purified solution was then 
calculated from standard sucrose density tables. The purified 
sucrose was stored as a 2.3M solution at 4°C. At this temperature 
and.molarity, growth of micro-organisms is negligible for over 
3 months storage.
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TKM Buffers
1) TKM Buffer: was prepared to give final concentrations of
25mM KC1, 5mM MgClg and 50mM Tris-HCl, titrated to pH 7.5 
with 1M HC1.
2) TKME Buffer: was prepared as for TKM buffer but also contained 
ImM EDTA.
3) STKM Buffer: was prepared as for TKM buffer but also contained 
purified sucrose (at a concentration of 0.25M unless otherwise 
indicated, i.e. 1.35M STKM contains 1.35M sucrose in TKM buffer).
4) STKM #  2 Buffer: was prepared to give final concentrations of
0.25M sucrose unless otherwise stated, 150mM KC1, 5mM MgCl^ and
40mM Tris-HCl, titrated to pH 7.5 with 1M HC1.
All buffers were stored at 4°C for periods of no more than one week
before use.
Purification of Pentachlorophenol
Pentachlorophenol (B.D.H. Chemicals Co., Poole, Dorset: technical 
grade) was dissolved in hexane: diethyl ether (1:1 v/v) until a 
brown saturated solution was obtained. The solution was shaken 
with an equal volume of aqueous NaOH (0.1M) to extract the neutral 
components found in the technical grade. The slightly pink aqueous 
phase was separated from the organic phase, and was acidified by 
the addition of sulphuric acid (1.0M) until a pH of about 2 was 
reached. The aqueous solution was then shaken with an equal volume 
of chloroform divided into two portions. The chloroform extractions 
were separated from the aqueous phase, and combined. The solution 
was evaporated to dryness and the crystalline residue purified 
further by recrystallisation from methanol: water (1:1 v/v) twice.
This method is claimed to yield chrcmatographically pure 
pentachlorophenol (Arrhenius, Renberg and Johansson, 1977).
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iPreparation of Ethoxycoumarin
The method followed was basically that of Prough, Burke and Meyer
(1978). 7-Hydroxycoumarin (3.24g) (Umbelliferone, Sigma Chemical
Co.) was dissolved in 100ml absolute alcohol. The sodium salt was
formed by the addition of approx. 0.8g NaOH pellets, dissolved one
at a time, until.the solution became slightly alkaline to Camlab
indicator paper.. The mixture was heated to boiling point in a
round-bottom flask and ethyl iodide (4.8ml) added. The mixture was
heated under reflux for 12h, cooled and an equal volume of ice-cold
deionised water added. The mixture was left to stand overnight at 
o
4 C, and the white crystals that formed were filtered off using a 
Buchner funnel with Whatman No.l filter papers.
The product was recrystallised three times from 45% methanol, and 
finally dried in a vacuum dessicator for 3 hours. The m.p. of the 
product was determined to be 88°C, confirming the product as being 
pure ethoxycoumarin.
Preparation of Hydrolysed RNA
A weighed sample of RNA was dissolved in 0.1M HC1 to give a 
concentration of 15 - 20 mg/ml. After heating for 1 h in a boiling 
water-bath, the solution was cooled and 0.1M NaOH added dropwise 
^til the solution was neutralised. The solution was then diluted 
with deionised water to give a final concentration equivalent to 
5mg RNA/ml, and stored frozen until used.
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METHODS
Animal Pretreatment
In studies related to age and induction of cytochrome P-450 
haemoproteins, male Wistar-albino rats of varying weight (age) 
were used. In the age studies, animals were allowed food and 
water ad libitum prior to death. In the induction studies, the 
animals were starved for* 24 h before death.
Pretreated animals were given a single ip injection (unless stated 
otherwise in the results) of either phenobarbitone (SOmg/kg, in 
saline), 3-methylcholanthrene (25mg/kg in corn oil), 2-acetamido- 
fluorene (25mg/kg, as a 1% w/v solution in 5% v/v dimethylsulphoxide 
in corn oil) , or safrole (75mg/kg, in corn oil). Control animals 
received an equal volume of solvent. No differences were observed 
between control animals given either saline or corn oil.
Preparation of microsomal membranes (general)
Wistar-albino rats (University of Surrey Animal Unit) were killed 
by cervical dislocation and the livers removed quickly, washed with 
ice-cold 50mM Tris-HCl buffer, containing 1.15% w/v KC1, pH. 7.5, 
and finely scissor-chopped in the same buffer.
A 30% w/v homogenate was made using a motor-driven teflon pestle in 
a Potter-Elvehjem homogeniser (2400 rpm at 4°C). Three passes of 
10 sec each were usually sufficient to ensure complete disruption of 
the tissue.
The homogenate was centrifuged in a MSE High-Speed 18, using an 
8 x 50 ml rotor, at 10,000 rpm (11,500 g") for 20 min at 4°C.
The post-mitochondrial supernatant thus obtained was decanted into 
25 ml polycarbonate centrifuge tubes. Microsomes were sedimented by 
centrifuging either at 60,000 rpm (180,000 g^—) for 35 min in a 
Beckman L5-65 ultracentrifuge, or at 40,000 rpm (115,000 9aV) in a 
MSE Super Speed 50 ultracentrifuge, at 2-4°C.
The resulting microsomal pellet was resuspended in buffer and re­
centrifuged. The washed microsomes thus obtained were suspended in 
appropriate buffers for use. No significant differences were found 
in the properties of membranes obtained by these two methods.
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Fractionation of membranes (for Radiometric Use)
Male Wistar-albino rats (University of Surrey Animal Unit) were killed 
by cervical dislocation and the livers removed quickly, washed with 
ice-cold 0.25M STKM and finely chopped in the same buffer. A 30% w/v 
homogenate was made using a motor-driven teflon pestle in a Potter- 
Elveh jem homogeniser (2400 rpm at 4°C). Three passes of 10 sec each 
were usually sufficient to ensure complete disruption of the tissue. 
The homogenate was centrifuged in a MSE High Speed 18, using an 
8 x 50 ml rotor, at 10,000 rpm (11,500 g ) for 20 min at 4°C.
The post-mitochondrial supernatant thus obtained was decanted and 
layered over a discontinuous gradient of 5 ml 2.0M STKM under­
lying 10 ml 1.35M STKM in 25 ml polycarbonate centrifuge tubes.
The membranes were spun to equilibrium in an MSE Super Speed 50, 
using an 8 x 25 ml rotor, at 40,000 rpm (115,000 g ) for 4 h at 
2-4°C.
The membranes at the interfaces of the gradient steps were harvested 
using a Pasteur pipette, and were pelleted through 0.5M STKM for 
Ih under the same conditions.' The pellets of fractionated microsomes 
were resuspended in 0.25M STKM by hand to give a final protein 
concentration of approx. IQmg/ml.
Preparation and Fractionation of Microsomes (for distribution studies)
The animals were killed by cervical dislocation and the livers were 
rapidly removed and washed in ice-cold 0.05M Tris - 1.15% KC1 buffer, 
pH 7.5. The livers were weighed, pooled and scissor-minced.
A 30% w/v homogenate was made in the same buffer. The post- 
mitochondrial supernatant was obtained by centrifuging at 10,000 g_^ _ 
for 20 min at 4 C in a MSE High Speed 18 using an Angle 8 :x 50ml 
rotor.
The supernatant was centrifuged at 180,000 g for 35 min at 2-4°C
av
in a Beckman L5-65 ultracentrifuge, using a 60Ti rotor, to pellet 
the microsomal membranes. The pellets thus obtained were re- 
suspended either in 0.25M STKM buffer or in 0.25M Sucrose-15mM CsCl.
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The microsomal suspension was layered onto 10 ml of either 1.05M
STKM or 1.05M Sucrose-CsCl. in 25 ml polycarbonate centrifuge tubes.
The gradients thus obtained were centrifuged at 105,000 g 
o av,
2-4 C, for 140 min in a Super Speed 50 centrifuge using an Angle
8 x 25 ml rotor.
The smooth membranes were harvested using a 10 ml syringe and were 
repelleted at 180,000 g_^ _ for 35 min at 4°C, in a Beckman L5-65 
ultracentrifuge.
The pellets of rough and smooth microsomes thus obtained were
resuspended in 0.05M Tris-1.15% KOI buffer, pH 7.5, and used
immediately if possible. If necessary, the microsomes were stored
oovernight under at -20 C.
Microsomal Cytochromes bg and P-45Ô assay
Cytochromes P-450 and b5 were measured by the method of Ullrich 
(1969). The microsomal suspension (3ml of l-2mg protein/ml) was 
pipetted into 2 x 10mm glass stoppered cuvettes. A difference' 
spectrum base-line was recorded using a Perkin - Elmer 356 spectro­
photometer in the split-beam mode, scanning from 520 nm to 400 nm. 
NADH (10 ^ 1 of 20mg/ml in STKM buffer) was added to the test cuvette 
and the difference spectrum recorded. The amount of cytochrome b5 
was calculated from the absorption difference OD 424 - 409 nm 
using a molar extinction coefficient of IVOmM^cm""1.
The test cuvette was then saturated with CO by allowing the gas to 
bubble through the suspension for 30 sec. A few mg of sodium 
dithionite was then added to both cuvettes and the difference 
spectrum recorded again. The amount of cytochrome P-450 was
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calculated from the absorption difference OD 450 - 500 nm using
-1 -1a molar extinction coefficient of 9ImM cm
Estimation of the peak wavelength of the reduced - CO spectrum was 
made by the method of Mailman et al. (1975). The spectrum was 
recorded at a scan speed of 10 nm/min, with a chart speed of 
240 mm/min, giying a chart scale of 24 mm/nm. Only the peak from 
460 nm to 440 nm was scanned, using a chart full scale deflection 
of 0.1 OD Unit. A line parallel to the chart ordinate was.drawn 
0.01 - 0.015 OD units below the peak, and the midpoint of the segment 
calculated. Where the line intersected the spectrum, tangents to 
the spectrum were constructed and the wavelength at which these 
intersected was also calculated. The average of the two calculated 
values was taken as the peak wavelength. This method of calculation 
has the advantage that any assymmetry of the spectral peak throws 
the two values in opposite directions, and thus averaging the two 
"values minimises errors in estimation that are due to the shape 
of the peak.
Ethylmorphine N-demethylase assay
Ethylmorphine N-demethylase was assayed by the method of Yang and 
Strickhart (1974).
Incubation mixtures contained 5mM ethylmorphine hydrochloride, lOmM 
isocitric acid, trisodium salt, 0.2 lU/ml isocitrate dehydrogenase, 
150mM KC1, 5mM MgOl^, 4QmM Tris — HC1 pH 7.4, and 2 — 4mg microsomal 
protein. The mixture was preincubated at 37°C for 1 min and the 
reaction started by the addition of NADP, to give a concentration of 
0.5mM in a final volume of 2ml.
The mixtures were incubated for 15 min at 37°C in a shaking water-bath 
and the reaction stopped by the addition of 0.25ml 25% ZnS04 followed 
by 0.25ml saturated Ba(OH)2 • The tubes were vortex-mixed and 
centrifuged at 2,000 rpm for 10 min. Clear supernatant (1.5ml) was 
added to 1.5ml Nash reagent (2M ammonium acetate, 0.05M acetic acid, 
0.02M acetylacetone), mixed rapidly and heated for 15 min at 60°C 
in a water-bath.
The absorbance at 412 nm was measured using a Cecil-272 spectro­
photometer . Standards containing up to 8 p.g formaldehyde per ml
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were run in parallel to provide a standard curve. Nash reagent was 
prepared within 24h of use and stored at 4°C.
Ethoxycoumarin O-deethylase assay
The method used was based upon the discontinuous assay of Aitio 
(1978). The method employed has the advantages of enabling a high 
number of individual assays to be performed simultaneously, whilst 
the technique reduces the chance of errors due to fluorescence of 
NADP in the reaction, or interference from microsomal protein.
Substrate buffer was prepared by dissolving 7-ethoxycoumarin in 
0.1M Tris-HCl pH 7.4 to form a 0.2mM solution. The solution was 
stored at 4°C and is stable for at least 3 weeks.
A freshly prepared cofactor solution contained 14.9mg NADP, 51.6mg 
isocitric acid trisodium salt, 6.0ml Tris-0.15M KC1 pH 7.4, 2.0ml 
0.ImM MnClg, 2.0ml 0.1M MgCl^, 20 IU isocitrate dehydrogenase, and 
deionised water to a final volume of 16.0ml.
The incubation mixture consisted of 0.4ml fresh cofactor solution,
0.5ml substrate buffer and the reaction was started by the addition
of 0.1ml tissue suspension, containing approx. 2mg microsomal protein.
oAfter 15 min incubation at 37 .the reaction was stopped by the 
addition of 1.0ml 0.3IN trichloracetic acid. After mixing thoroughly, 
the pH was adjusted to about 10 by the addition of 8ml of 0.5N 
NaOH-glycine pH 10.3. The protein precipitate was spun down in a 
bench centrifuge and the amount of 7-hydroxycoumarin was measured 
with a Perkin-Elmer MPF-3 fluorescence spectrophotometer, using an 
activation wavelength of 390nm, and measuring a fluorescence wave­
length of 440nm.
The readings were corrected for blank fluorescence measured in 
mixtures with zero incubation time, and the amount of 7-hydroxycoumarin 
calculated by comparison with readings of a standard solution of 7- 
hydroxycoumarin that had been added to blank incubation tubes.
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5-Aminolaevulinate synthetase assay (5-ALA-Synthetase)
5-ALA synthetase was measured by the method of Abbritti and DeMatteis 
(1971). Incubations were carried out in open 25ml Erlenmeyer flasks 
at 37°C in a shaking water bath at 60 eyeles/min for 30 min. Each 
flask contained liver homogenate equivalent to 150mg liver, 200pmoles 
glycine, 20pmoles EDTA, lOOjumoles Tris-HCl, SOpmoles sodium phosphate, 
lOOpmoles sodium citrate, 2jumoles ATP and 475jamole sucrose, in a total 
volume of 2.6ml at a pH of 7.3 @ 2O°C.
The reaction was stopped by the addition of 50% w/v trichloroacetic 
acid (0.25ml). 5-ALA (60 nmole) was added to some control
incubations as a standard. Blank incubations had no ATP added, other 
incubations were stopped at zero time.
The amount of 5-ALA in the incubation mixtures was determined by the 
method of DeMatteis (1971). The supernatant (2ml) of the deproteinised 
solution was pipetted into a stoppered test-tube and 1.2ml of 1M NaOH- 
1M sodium acetate buffer"(1:2 v/v) was added, followed by 40pl 
acetylacetone. The tubes were tightly stoppered and heated in a 
boiling water bath for 10 min. After cooling in cold water, fresh 
aqueous 66mM N-ethylmaleimide (0.15ml) was added and mixed well.
Thirty minutes later 10M NaOH (0.07ml) was added to adjust the pH to 
8.0,.after which the solution was rapidly transferred to a 20ml 
separating funnel and shaken with equilibrated ether (3ml) (ether, 
shaken with trichloroacetic acid, Tris-HCl, phosphate, acetate and 
NaOH in the same concentrations as present in the samples to be 
analysed).
The phases were separated as soon as possible and the aqueous phase 
(3ml) added to acetic acid (0.2ml) to bring the pH below 5. (A delay 
at alkaline pH results in high blank values). Modified Ehrlich reagent 
(3.2ml) (Ig p-dimethylaminobenzaldehyde, 15ml glacial acetic acid, 8ml 
of 70% perchloric acid (eg. 1.70) made up to 50ml with glacial acetic 
acid) was added and well mixed.
The extinction of the samples was measured at 556nm after 20min. The
concentration of 5-ALA in the incubation mixtures was calculated from
the added internal standard. The assay was checked by calculating
the concentration of 5-ALA standard in the samples using the published
- 1 - 1extinction coefficient of 56.8mM cm
36
Estimation of Protein 
(Lowry et al., 1951)
The protein suspension under assay was diluted with 0.1M NaOH to 
give a concentration of 100 - 300 ^ ig/ml. When a clear protein 
solution had been obtained, 0.5ml of the solution was added to 5ml 
alkaline copper reagent, (100ml 2% Na^COS in 0.1M NaOH to which 1ml 
1% CuSO^.SHgO,and 1ml 2% sodium tartrate, had been added. The ' 
solution was used freshly mixed).
The solution was mixed on a vortex-mixer and left for 15 min at room 
temperature. Diluted Folin-Ciocalteau reagent (1:2.5 v/v with 
deionised water, freshly prepared, 0.5ml) was added and mixed 
rapidly. The solutions were left for 30 min and the absorbance at 
720 nm measured in a Cecil - 272 spectrophotometer.
A range of bovine serum albumin standards containing 0 - 250 ^ïg 
protein was run in parallel.
Biphenyl 2- and 4-hydroxylase assay
The incubation procedure was that described by McPherson, Bridges 
and Parke (1974). The incubation mixtures consisted of 2-4mg 
microsomal protein, 3mM isocitric acid trisodium salt, 0.4mM NADP,
0.4 IU isocitrate dehydrogenase, 40mM Tris HCl-pH 7.4, 5mM MgCl^,
150mM KCl and 4mM biphenyl (added as 12mM biphenyl in 1.15% KC1-1.5% 
Tween 80), in a total incubation volume of 2ml.
The mixtures, excluding biphenyl, were incubated for 5 min at 37°C 
and then the reaction started by the addition of the biphenyl 
substrate. Incubation was continued for 10 min at 37°, and the 
reaction terminated by the addition of 0.5ml 4M HC1. Control 
incubations had biphenyl added after the incubation had been 
terminated.
The formation of the hydroxyl metabolites was assayed by a minor 
modification of the method of Creaven, Parke and Williams (1965).
To the assay mixture was added 7ml n-heptane containing 1.5% isoamyl 
alcohol. The mixture was extracted on a rotating vertical wheel for 
10 min, and the tubes centrifuged at 2000 rpm for 15 min to aid 
separation ; of the two layers. The heptane layer (2ml) was then 
added to 5ml 0.1M NaOH and extracted for 15 min as before. The layers
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were separated and the organic layer aspirated using a Pasteur 
pipette attached to a suction pump. The alkaline layer (2ml) was 
added to 0.5ml 0.25M succinic acid in a fluorimetric cell. Samples 
were assayed in a Perkin-Elmer MPF—3 fluorimetric spectrophotometer 
at two wavelengths.
4-Hydroxybipheny1 was assayed using an excitation wavelength of 
275nm with a fluorescence wavelength of 338nm. The combined 
fluorescence of 2- and 4-hydroxybipheny1 was measured using an 
excitation wavelength of 290nm and a fluorescence wavelength of 
410nm.
The concentrations of 2- and 4-hydroxybipheny1 in the incubation 
mixture were calculated according to the formulae described by 
Creaven, Parke and Williams (1965). /
Puromycin degranulation
The method used was based on an adaption of the method of Borgese
et al (1974), by Dani, Fielder and Rabin (1976). An analysis of the
ribosome-membrane association, using rat liver microsomes (Adelman
et al, 1973), demonstrated that there are two factors which are
involved in maintaining ribosomes bound to microsomal membranes :
ionic bonds, disruptable by high concentrations of monovalent ions,
and a link provided by the nascent polypeptide chain. In the presence 
2+
of Mg ions, ribosomes can be removed from the membranes through the 
combined action of puromycin and moderately high concentrations of 
monovalent ions. This provides a mechanism for the non-destructive 
disassembly of "rough" microsomes.
Freshly prepared "rough" microsomal membranes were resuspended in
puromycin buffer; containing 0.25M sucrose, 50QmM KCl, 50mM Tris-HCl,
-42.5mM MgCl2, 5 x 10 M puromycin hydrochloride, pH 7.5; to give a 
protein concentration of 5 - 10 mg/ml. The membranes were incubated , 
for 1 h at 0 C, followed by 10 min at 25°C. Sucrose-high salt buffer 
(5 vol.); containing 0.25M sucrose, 500mM KCl, 5mM MgCl^, 50mM Tris- 
HCl pH 7.5 was added, and the degranulated membranes were then 
recovered by centrifuging for 30 min at 115,000g_^ in a MSE Super speed 
50. The degranulated membranes were resuspended in TKM buffer to give 
a protein concentration of 10mg/ml. Control incubations omitting 
puromycin and/or using STKM buffer instead of high-salt buffer were 
run concurrently.
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Protein-Disulphide Isomerase Assay
The method used was as described by Dani, Fielder and Rabin (1976).
The principle of the assay is based upon the activation of oxidised 
(inactivated) ribonuclease by a protein-disulphide isomerase enzyme 
that is buried in the microsomal membrane. This enzyme is usually 
masked from exogenous substrates by the binding of ribosomes to the 
membrane. In "smooth" or degranulated membranes the enzyme is 
exposed and its activity can be measured. The activation rate of 
oxidised ribonuclease being an indication of the amount of isomerase 
enzyme exposed. The activation of the ribonuclease is itself 
measured by its effect in hydrolysing ribonucleic acid.
Fractionated rat liver microsomes were prepared as described 
previously. Primary incubations were carried out in test-tubes at 
25°C in a water-bath. The primary incubation mixture contained 
25 ^ ul 2-mercaptoethanol solution (10 jil 2-mercaptoethanol/7ml 
deionised water), 50 jil oxidised ribonuclease solution (lmg/ml R^O), 
and TKM buffer to give a final volume of 1ml. The reaction was 
started by the addition of the membrane suspension, containing 
0.1 - 0.4 mg microsomal protein.
Samples of the primary incubation were removed at 5 min intervals for 
use in the secondary incubation.
The secondary incubation was carried out in a 10mm quartz cuvette, 
which contained 3.0ml 0.25M STKM buffer and 50 jil ribonucleic acid 
solution (5mg/ml, freshly prepared). An aliquot (10 jil) of the 
primary incubation was added to start the reaction, which was measured, 
after thorough mixing, in a Perkin-Elmer 356 double-beam spectro­
photometer in the dual-wavelength mode. The absorption wavelength 
used was 260nm, with a reference wavelength of 280nm, together with 
a chart expansion of 0.1 OD units. The reaction was followed for a 
period of 2 min.
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Radiometric Assay
method of determining degranulation is based upon calculation 
of the RNA/protein ratio of the microsomal membranes. The estimation 
of RNA is simplified by pre-labelling RNA 'in vivo1 using (6-14C)- 
OE'otic acid. The method followed was based upon the method of 
Lefevre (1978), with only minor modifications.
Male Wistar-albino rats, 160-180g, were starved for 24h to deplete 
pyrimidine precursors before receiving an intraperitoneal injection 
of 15pCi (16— C)—orotic acid in water. Food was returned to 
stimulate uptake of label, and the animals killed by cervical dis­
location 17h later. This interval is required for effective labelling 
of ribosomal RNA, which has a half-life of /w 5 days.
Liver microsomal membranes were prepared and fractionated as 
previously described, and the "rough" and "smooth" fractions 
resuspended in 0.25M STKM buffer to give a protein concentration of 
approximately 10mg/ml. Membranes were used immediately after 
preparation.
Incubation mixtures consisted of 2Qmg "rough" microsomal protein, 3mM 
isocitric acid trisodium salt, SOQmM NADP, 5mM MgSO^, 2.4 IU 
isocitrate dehydrogenase, and 0.25M STKM buffer to a final volume of 
6ml. Test compounds were dissolved in dimethylsulphoxide (DMSO) to 
give a concentration of lmg/ml, and 75pl of this solution was added 
to each incubation tube. DMSO (75>il) was added to control tubes.
The mixtures were incubated for 2h at 20 C in a shaking water-bath at 
60c/min, and the incubation stopped by plunging the tubes into ice- 
water and adding 1.35M STKM (5.0ml), thus adjusting the sucrose 
concentration to 0.7M.
The incubation mixtures were layered over a gradient consisting 
of 6ml 2.0M STKM underlying 4ml 1.35M STKM in 25ml polycarbonate 
centrifuge tubes. The tubes were centrifuged at 70,000g
av
(30,000 rpm) in a MSE Superspeed 50 for 12h at 2 - 4°C. The 
membranes in the 1.35M STKM layer were removed using a syringe, 
diluted with 0.25M STKM and pelleted by centrifuging at 115,000g 
for 1 h as above. The microsomal pellets thus obtained were then 
suspended in deionised water by ultra-sonication.
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Diagramatic representation of Radiometric assay of degranulation
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Aliquots of the suspension were taken for protein estimation by the
Lowry method, and further aliquots (0.5ml) were mixed with Packard
14
Instagel (3ml) for C estimation in a LKB Ultabeta liquid 
scintillation counter.
The activity of each sample was calculated as c.p.m./mg protein, 
and degranulation calculated by the following formula.
% degranulation =
RER control activity - degranulated * RER test activity
------------------------------------------ — -----   x 100
RER control activity - SER control activity
The specific activity (or RNA/protein ratio) of the SER establishes 
the lowest value that can be reached by totally degranulated RER.
The difference between the specific activity of SER and RER represents 
the theoretical maximum degranulation. Therefore, the difference in 
values between test and control incubations can be expressed as a 
percentage degranulation caused by a particular compound.
Spectral Binding Studies
Microsomal fraction from control and treated animals were prepared 
by the usual methods, and were resuspended in buffer and frozen at 
-20°C in small aliquots.
For use, aliquots were thawed by the addition of buffer at room 
temperature, and then kept in ice.
Microsomal suspension (2.5ml) was pipetted into each of two stoppered 
quartz cuvettes and a baseline difference spectrum obtained from 
520nm - 350nm, in a Varian Cary-272 spectrophotometer using micro­
processor controlled baseline compensation.
Aliquots (1yul) of the compound to be studied were added to the test 
cuvette, and an equal volume of solvent added to the reference 
cuvette. Multiple scans were performed up to a maximum of 10-15 ;ul 
of added substrate.
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Chapter 3
D e g ra n u la t io n  o f the E n d o p la s m ic  R e t ic u lu m  by C a rc in o g e n s  
INTRODUCTION ;
Membrane-Ribosome Interaction
The intracellular membranes known as the endoplasmic reticulum are 
usually considered to be subdivided into two types, "rough" and 
"smooth", according to whether or not the membrane carries ribosomes 
bound upon it. The structural and functional integrity of cells 
depends upon, amongst other factors, the rates of synthesis and 
degradation of proteins and the pattern of protein synthesis, which 
is partly regulated by the ratio of "smooth" to "rough" endoplasmic 
reticulum. It has been suggested that free ribosomes are responsible 
mainly for the synthesis of intracellular proteins, whilst bound 
ribosomes (rough endoplasmic reticulum) synthesise mainly secretory 
proteins (Rolleston, 1974).
The membrane-ribosome interaction is a dynamic equilibrium that 
shifts as the functional requirements of the cell demand (Ragnotti 
and Aletti, 1975). It has been recently shown that in the 
regeneration of rat liver following partial hepatectomy there is 
an increase in the proportion of free ribosomes (with subsequent 
increase in the "smooth" endoplasmic reticulum), consistent with 
the increased requirement in regenerating tissue for the synthesis 
of intracellular proteins (Loeb and Yeung, 1978). When an animal is 
treated with the microsomal enzyme-inducing agent, phénobarbital, 
the rate of protein synthesis by the membrane-bound polyribosomes 
of rat liver is substantially increased, whilst that of the free 
ribosomes is unchanged (Ragnotti and Aletti, 1975) .
The administration of most carcinogens causes degranulation of the 
"rough" endoplasmic reticulum 'in vitro', that is detachment of 
bound polyribosomes (Williams and Rabin, 1971). In a study of the 
various effects of inducing agents on the liver, one of the first 
changes observed during administration of the carcinogen, safrole,
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was an increase in the mixed-function oxidase activity of the 
endoplasmic reticulum, coupled with hypertrophy of the "smooth" 
endoplasmic reticulum (Parke and Gray, 1978). This observation 
is of interest because, after transformation, neoplastic cells 
(like foetal cells), often have a characteristically low proportion 
of ribosomes bound to the endoplasmic reticulum (Webb et al 1965).
Degranulation and Carcinogenesis
Treatment of rats with the proximate-carcinogen N-hydroxy- 
acetylaminofluorene results in disarray of the endoplasmic 
reticulum, and disaggregation of polyribosomes (Popp and Shinozuka, 
1974). Similarly, the treatment of HeLa cells with the carcinogens, 
dimethylnitrosamine and thioacetamide, results in fragmentation of 
the endoplasmic reticulum with a marked increase in the proportion 
of free ribosomes, their disaggregation, and a consequent shift 
in the metabolism of the cell to the synthesis of a greater 
proportion of endogenous proteins (Delaunay and Schapira, 1974).
It appears that in cancer cells, possibly concerned with the actual 
process of malignant transformation, there is a loss of bound 
ribosomes with a concomitant increase in free ribosomes. This would 
imply a shift in the pattern of protein metabolism in a cancer cell 
towards the synthesis of intracellular proteins, and an impairment 
in the membrane-synthesised glycoproteins with its possible 
implications to changes in the glycocalyx and possibly the immune 
system.
Steroids and riboscmal binding
The binding of ribosomes to the endoplasmic reticulum requires 
corticosteroid and/or sex hormones. Male rat liver "smooth" microsomes 
bind ribosomes only under the influence of corticosterone or 
oestradiol, and female "smooth" microsomes require corticosterone 
or androgenic hormones (Sunshine, Williams and Rabin, 1971) .
Studies have shown that the sex-specific binding sites have a very 
high affinity for the correct hormone (Blyth, Freedman and Rabin,
1971). The regulation of the pattern of protein synthesis, that is
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the ratio of secretory proteins to intracellular proteins, thus 
appears to be under the control of steroid hormones. There is some 
evidence that this is certainly true for tissues other than liver, 
(Saarni, 1978; Parke and Symons, 1977).
It also appears that the site of action of carcinogens on the 
endoplasmic reticulum is the same as that of the binding of steroid 
hormones, since the two classes of chemicals appear to act in 
competition with each other. The prior addition of the correct 
steroid to promote binding of the ribosomes to the endoplasmic 
reticulum can prevent carcinogen-induced degranulation 'in vitro', 
(Sunshine, Williams and Rabin, 1971). Carcinogens may degranulate 
"rough" endoplasmic reticulum by displacing the necessary steroids, 
and then binding to the steroid binding site.
It has been shown that the amount of polyribosome binding in an 
'in vitro1 binding system varied according to the amount of the 
microsomal mixed-function oxidase, cytochrome P-450, (Takagi, 1977) 
and it has been suggested that cytochrome P-450 may itself be part 
of the steroid-ribosome binding site.
Degranulation as a carcinogenic screening test
The toxic changes afflicted on the endoplasmic reticulum by the 
exposure to carcinogens may constitute one of the most significant 
events in malignant cell transformation. Since the endoplasmic 
reticulum is the intracellular site of enzyme activation of 
carcinogens it is logical to expect that the endoplasmic reticulum 
may also be the site of greatest damage caused by the highly reactive 
proximate and ultimate carcinogens. Damage to the endoplasmic 
reticulum may thus bring about the changes in drug-metabolising 
enzyme activities that are observed after treatment with carcinogens, 
although no correlation between enzyme activity and degranulation has 
been demonstrated. This may in part be due to the inherent problems 
associated with the available methods for determining degranulation.
The methods all rely upon the calculation of the ratio of RNA to protein 
in the isolated membranes. All methods require the fractionation of 
liver microsomal membranes by gradient centrifugation, with the
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subsequent harvesting of "rough" and "smooth" membranes. "Rough" 
membranes are then treated with the chemical under test, and the 
degranulated membranes are centrifuged on another gradient, to remove 
the free polysomes, and then harvested. Calculation of the extent of 
degranulation is then performed by comparing the RNA/protein ration 
of the degranulated membranes with the calculated ratios of the 
"rough" and "smooth" membranes.
Whilst the estimation of the protein content of the membranes is easy
and reliable, the estimation of RNA content is less so. The original
method of Schmidt and Thannhauser (1945) involved the extraction of
RNA from the membranes for estimation, which proves labour-intensive
and subject to many errors. The usual method of RNA estimation used
currently involves 1 in vivo * radio-labelling the RNA by administration 
14of C-orotic acid (Lefevre, 1978). The amount of RNA is then
14proportional to the activity of C measured in the individual samples 
from any one source.
One method not relying upon the estimation of the RNA protein ratio 
has been described by Williams and Rabin (1969). The degranulation of 
"rough" membranes by aflatoxin was followed by assaying a protein- 
disulphide isomerase enzyme that was masked by the bound ribosome, but 
which, after degranulation, becomes available to exogenous substrates.
It has been suggested that'a correlation may exist between protein- 
disulphide isomerase activity and carcinogenic potency, which may form 
a useful screening technique for carcinogens (Williams and Rabin, 1971).
The use of these techniques, and the results obtained, have been 
investigated, together with the possibility of a correlation between 
degranulation and the altered drug-metabolising enzyme activities seen . 
after administration of carcinogens.
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RESULTS
Disulphide isomerase assay
"Rough", "smooth" and puromycin-degranulated membranes were prepared 
on sucrose gradients, and were tested for disulphide isomerase activity 
in the system described. In all preparations, no discernable enzyme 
activity could be determined. Although there was an observed increase 
in absorbance in several experiments, the rate of increase was so 
small that accurate measurement was impossible, (rate of increase 
observed was less than 0.001 OD/min).
The assay described relies upon the difference in absorbance between 
RNA and free nucleotides for its sensitivity. The degradation of RNA 
into nucleotides being dependent upon the enzymic activation of the 
oxidised ribonuclease by the isomerase enzyme in the membranes. The 
degradation of RNA and the activation of ribonuclease are thus the 
two most important parts of this assay. Failure of either of these 
events to take place as intended would prevent the assay from working 
properly. Due to the inability to obtain any meaningful results the 
assay system was examined in detail to attempt to explain the lack of 
response.
An investigation of the absorbance of RNA and hydrolysed RNA was 
carried out at 280nm and 260nm in a Perkin-Elmer 356 spectrophoto­
meter. STKM buffer (3ml) was pipetted into each of two quartz 10mm 
cuvettes. After recording a base level the compound under test was 
added in lOpl aliquots. Both RNA and hydrolysed-RNA were prepared in 
saline to give a concentration of 5 mg/ml, and used for all spectro­
scopic investigations.
Figure 3-1 shows that at concentrations lower than those used in the 
normal assay, the absorbance of both compounds was proportional to 
concentration. At both wavelengths, the absorbance of hydrolysed-RNA 
was slightly higher than that of the equivalent concentration of RNA.
As the assay relies upon the differences in the absorption 
characteristics of the two compounds these results are of particular 
interest.
47
o50 100 150
~yUg/3ml:: ;
50
jug/3 ml
Figaare 3-1. The effect of Increasing Concentration of RNA and
Hydrolysed-RNA on Absorbance at'280nm and 260 nm.
STKM buffer (3ml) was pipetted into a cuvette, and 10 pi aliquots of 
a solution of either RNA or hydrolysed-RNA were added. After each 
addition the absorbance of the solution was measured at 260nm and 
280nm in a Perkin-Elmer 356 spectrophotometer.
( RNA; hydrolysed-RNA)
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Using a Perkin-Elmer 356 in the dual-beam mode, additions of either 
RNA or hydrolysed-RNA were made to a single cuvette containing STKM 
buffer. The absorbance wavelength was set to 260 nm, and the 
reference wavelength to 280 nm. The difference in absorption of 
RNA was found to be linear over the concentration range found in the 
normal assay (figure 3-2). Whilst the absorbance of hydrolysed-RNA 
became non-linear at higher concentrations, these levels were unlikely 
to be reached under normal conditions. At lower concentrations, 
however, the absorbance differences of the two solutions were 
virtually identical. This result indicates that the sensitivity of 
the assay would be very low, which would provide a reason for the 
apparent lack of enzyme activity in the initial experiments.
An experiment was therefore performed to mimic the relative changes 
in concentrations of the two compounds in the assay. STKM buffer 
(3 ml) was pipetted into a cuvette and varying amounts of RNA and 
hydrolysed-RNA added, such that the final concentration of RNA was 
constant at 250 ^ il/3ml. Figure 3-3 shows that as the relative 
proportion of RNA was decreased the difference in absorption increased 
slightly and then decreased. The range of concentrations likely to be 
encountered under the isomerase assay conditions lies in the region 
between the first two points, as it is highly unlikely that more than 
20% of the RNA would be hydrolysed enzymically in the test system.
Having established that the sensitivity of the assay was very low, the 
method was tested using active ribonuclease-A, instead of the randomly- 
oxidised enzyme, in the assay system. Microsomes were also omitted 
and the volume of the primary incubation mixture was made up with STKM 
buffer. Figure 3-4 shows that thé rate of change of absorbance 
measured was non-linear over the range of ribonuclease concentrations 
studied.
The low sensitivity of the system also led to a wide variation in the 
estimation of the rate of change of absorbance at lower enzyme 
concentrations. This raises doubts as to the usefulness of the assay 
method as the lowest concentration of enzyme studied (0.1 pg 
ribonuclease/ml) represents the equivalent of 100% activation of 
oxidised-ribonuclease by protein-disulphide isomerase.
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Figure 3-4. Effect pf Increasing Concentration of 
Ribonuclease-A on the hydrolysis of RNA.
Varying amounts of active RNase were added to a mixture of 
TKM buffer (1ml) and 2-mercaptoethanol solution (25pl of lOul/7ml 
water) at 20 C in a test-tube. Aliquots of IQjjI were removed 
and added to a cuvette containing STKM buffer (3ml) and RNA 
(50pl of 5mg/ml water solution). The absorbance at 260nm 
with respect to 280nm was measured for a period of 2 min. 
in a Perkin-Elmer 356 double-beam spectrophotometer.
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Figure 3-3. Change in Absorbance at 26Qnm with respect to 
280nm with Decreasing Concentration of RNA and Increasing 
Concentration of Hydrolysed-RNA.
STKM buffer (3ml) was pipetted into a cuvette and various 
quantities of RNA or hydrolysed-RNA solutions were added, 
such that the total quantity added was equivalent to 250jig 
RNA. The absorbance at 260nm with respect to 280nm was 
measured for each mixture in a Perkin-Elmer 356 double beam 
spectrophotometer.
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Figure 3-2. The Change in Absorbance at 260nm with respect to 280nm 
with Increasing Concentration of either RNA or hydrolysed-RNA.
STKM buffer (3ml) was pipetted into a cuvette and lOpl aliquots of a 
solution of either RNA or hydrolysed-RNA were added. After each 
addition, the absorption at 260nm with respect to 280nm was measured 
in a Perkin-Elmer 356 double-beam spectrophotometer.
(— ♦ — RNA; — 51—  hydrolysed-RNA)
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The assay described was found to be both of -low sensitivity and of 
poor accuracy, and therefore was not ideal as a reproducible and 
convenient method for estimating degranulation.' It was therefore 
decided that an alternative method for measuring degranulation 
should be investigated.
Radiometric assay
As the commonest index of degranulation used by many workers is a 
change in the RNA/protein ratio of the membranes it was decided to 
test the radiometric method as used in the degranulation carcinogen- 
screening test (Lefevre, 1978).
When ribosomes are released from the endoplasmic reticulum membranes
there is a corresponding loss of ribosomal RNA. Pre-labelling
14ribosomal RNA with C 'in vivo' enables the amount of RNA in the 
membrane to be determined easily, and hence simplifies the calcula-.. 
tion of the RNA/protein ratio, which is the commonly used index of 
ribosomal degranulation. However, it must be borne in mind that, 
under certain conditions, free ribosomes may bind to previously 
"smooth" membranes, and aggregations of free polyribosomes may also 
occur. The apparent degranulation of the endoplasmic reticulum may 
thus be different to the true effect due to these and other artifacts.
To check for possible spurious results in the proposed method, hepatic 
microsomes were prepared by the usual methods and were then 
fractionated on sucrose gradients. The membranes were then harvested 
and aliquots of "smooth" and "rough" membranes were assayed for 
protein and - radioactivity. The "rough" membranes were then 
either stored in ice for 2h, or incubated at 20°C for the same time. 
The membranes were centrifuged overnight onto a 2.0M sucrose bed to 
separate membranes from free ribosomes.
Table 3-5 shows that incubation with dimethylsulphoxide (used as a 
solvent for test compounds in this system) at 20°C resulted in a 
lowering of the specific activity equivalent to 19% degranulation.
This sample would normally form the "rough" control sample in the 
radiometric assay. A similar figure of 18% degranulation induced
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Table 3-5. Effect of DMSO and Incubation upon the Apparent 
Degranulation of Endoplasmic Reticulum Membranes.
Sample RNA/Protein
(CPM/mg)
% Degranulation
RER
SER
3200
1000
0
100
RER + DMSO 
(incubated) 2780 19
RER + Buffer 
(incubated) 4200 (45)
RER + Buffer 
( stored in ice) 3880 (31)
(* indicates specific activity higher than control)
Membranes were isolated by the usual methods. Samples of "rough"
and "smooth" membranes were assayed for protein and 14C-activity
immediately after preparation to give control values. Samples of
"rough" membranes were either incubated at 20°C for 2h, with or
without DMSO, or were stored in ice for the same period.
The membranes were harvested by centrifugation overnight, and
14samples assayed for protein and C-activity. % degranulation was 
calculated as described under "methods".
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by DMSO has recently been reported in a different degranulation 
system by Fey, White and Rabin (1980). These workers detected a 
change in the Rf value of sucrose that had been dissolved in DMSO, 
when subjected to thin-layer chromatography. The hypothesis put 
forward was that a degranulating material was being produced from 
sucrose upon interaction with DMSO.
Incubation of the microsomal membranes with buffer only, or storage, 
in ice, each resulted in an increase in the specific activity which 
can only be explained as either artifact or error. The recombination 
of ribosomes with membranes, or the formation of ribosomal aggregates, 
can produce an increase in the specific activity. Also, ribosomes 
may be released from the membrane, and combine to form large aggregates 
of polyribosomes (McIntosh, Clark and Rabin, 1975) which are in­
separable from membranes by density gradient fractionation. These 
aggregates may lead to an increase in the specific activity of a 
sample if the recovery of aggregates from a gradient is greater than 
the recovery of protein. As the density of membranes varies greatly 
this is a possible occurrence. Incubation of membranes in degranu­
lation studies is commonly of the order of 2 hours ; whilst being 
optimal for some compounds to give the desired effect, it may also 
allow the formation of artifactual results due to recombination or 
ribosomal aggregation.
In. a short study of degranulation with time, "rough" membranes were 
incubated with 1,2,3,4-dibenz Ca,c)-anthracene. At various intervals, 
aliquots were assayed for radioactivity and protein. Figure 3-6 
shows that degranulation may take place within several minutes, but 
there is also a wide variation in the results obtained initially which 
is much reduced after 2h incubation. Further results from other 
experiments gave similar results at the 2 h period.
Whilst carginogens have been shown to degranulate "rough" membranes, 
non-carcinogens should only be weak degranulatory agents. A study 
with three paired sets of compounds showed that this is generally 
true (table 3-7). Tests with the carcinogens 2-acetylaminofluorene,
1,2,5,6-dibenz(a,h)anthracene and -naphthylamine gave values of
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Figure 3-6. Effect of Incubation Time on the apparent 
Degranulation of HER membranes by Dibenzanthracene.
Membranes were prepared as described under methods, and were 
incubated with 1,2,3,4-dibenz(a,c)anthracene dissolved in DMSO. 
At various intervals, samples were taken and after centrifuging 
overnight on a sucrose gradient the membranes were assayed for 
protein and "C-activity. Samples of RER and SER membranes were 
also assayed, as controls, after incubation for a similar time 
without carcinogen. The difference in activity between the RER 
and SER controls represents 100% degranulation. The points 
shown (B) were obtained in 2 similar experiments, and are 
included for comparison. Points shown are means, vertical bars 
show SEM.
i. X
10 20 40 80 120
Incubation Time (miris.)
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Table 3-7. Degranulation of RER Membranes by Paired (carcinogen/ 
noncarcinogen) Compounds determined by Radiometric Assay.
Known
Compound % Degranulation Carcinogenicity
2-acetylaminofluorene 25+ 1 (8) +
4-acetylaminofluorene 1 7 + 3  (8) -
1,2,3,4-dibenz(a,c)-
anthracene 3 3 + 8  (12) ?-
1,2,5,6-dibenz(a,h)-
anthracene 2 3 + 1  (8) +
cK-naphthylamine 1 4 + 1  (4)
^-naphthylamine 27 + 2 (4)
RER and SER membranes were prepared as described in the text.
The compounds under test were dissolved in DMSO and added to a 
suspension of the RER membranes in STKM buffer. After 2h 
incubation at 20°C, the degranulated membranes were harvested by 
centrifugation and assayed for protein and ^C-activity.
The % degranulation was calculated as described under methods.
Values shown are the mean + SEM for the number of experiments 
shown, (n).
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approximately 25% degranulation, whilst the non-carcinogenic compounds 
4-acetylaminofluorene and <X-naphthylamine gave values of approximately 
15%. However, 1,2,3,4-dibenz(a,c)anthracene (a non-carcinogen?) gave 
values consistently in the region of 30-35%. Whilst it is known that 
degranulation does not predict all carcinogens or non-carcinogens 
(Purchase et al, 1976; Lefevre, 1978) the results give doubts as to 
whether degranulation is linked with carcinogenicity, or whether the 
assay system is at fault. It has been suggested (Palmer, Rabin and 
Williams, 1978) that only about 16% of the membrane-bound ribosomal 
population can be removed by carcinogens (or in some instances, by 
high speed centrifugation techniques) and that no further degranulation 
can then occur. As values greater than 16% have been obtained in this 
study, this figure must remain in doubt. More recently, values 
greater than 16% have been reported (Lefevre, 1978; Fey, White and 
Rabin, 1980) which suggests that the hypothesis of a sub-population of 
ribosomes removable by carcinogens, as originally postulated, is no 
longer acceptable.
To test the absoluteness of degranulation, "smooth" membranes were 
incubated with dibenzanthracene. Table 3-8 shows that a further loss 
of radioactivity was detected, equivalent to a further 20% degranula­
tion. This indicates that "smooth" membranes as prepared are either 
not totally devoid of ribosomes (i.e. not "smooth"), or are an impure 
preparation. The fractionation of endoplasmic reticulum membranes on 
a discontinuous sucrose gradient presupposes that the membrane ' 
population can be conveniently split into two distinct sub-populations 
of "rough" and "smooth". It is unlikely that this is the case, and a 
distribution between ‘roughest' and 'smoothest' following a 'normal 
distribution' curve would be more likely.
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Table 3-8. Dégranulation of "Smooth" Microsomes by Dibenzanthracenes
RER and SER membranes were isolated as described in the text.
The compounds under test were dissolved in DMSO and added to
a suspension of the SER membranes in STKM buffer. After 2h
incubation at 20°C, the membranes were harvested by centrifugation
14
and assayed for protein and C-activity. RER and SER controls 
were incubated with DMSO only. % degranulation was calculated as 
described under Methods.
The values shown are the mean + SEM for four experiments.
Compound . * % Degranulation
1,2,3,4-Dibenz(a,c)-
anthracene 120 + 9
1,2,5,6-Dibenz(a,h)-
anthracene 119 + 5
SER control 100
RER control 0
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Microsomal density distribution
Experiments using a series of discontinuous gradients were performed 
and the recovery of microsomal protein at both the interface and in 
the pellet was calculated. This enabled an approximate calculation 
of the proportion of membranes having a density within a particular 
range. The results were then graphically represented in the form of 
a histogram to enable a comparison between the results obtained, and 
normal distribution graphs. The results (figure 3-9) show that the 
concept of only "rough" and "smooth" membranes is incorrect. One 
would expect to see twin peaks at either end of the density range if 
the concept were true, instead figure 3-9A (control microsomes) shows 
an approximation of a normal distribution. Treatment with pheno- 
barbitone gives an increase in the proportion of membranes having a 
median density (figure 3-9B), and a similar effect is seen after 
3-methylcholanthrene treatment (figure 3-9C). In no case is a large 
increase observed at the less dense end of the scale, corresponding 
to "smooth" membranes. It may be that the proliferation of "smooth" 
membranes seen microscopically after inducing agents is not really 
very smooth. ^
The median density range for rat liver microsomes was found to be 
equivalent to 1.0 - 1.4 M sucrose (1.13 - 1.18 g/ml), and this did 
not change appreciably after treatment with inducing agents. The 
method usually used for fractionating membranes uses a gradient step 
of 1.35M sucrose (1.17 g/ml), which is in the region of the median 
density. Rather than preparing rough and smooth microsomes, it would 
be preferable to term the preparations 1rougher' and 1 smoother'. It 
is clear from the density distributions that the preparation of 
"rough" membranes requires the use of a gradient step of 1.6M sucrose 
(1.21 g/ml), whilst the preparation of "smooth" membranes requires 
a step of 1.05M sucrose (1.13 g/ml).
Pretreatment of animals with phenobarbitone results in a decrease in 
the proportion of denser membranes with an increase in the proportion 
of membranes at the median density (figure 3-9B). This could represent 
a decrease in the roughest membranes coupled with proliferation of 
newly synthesised smoother membranes which have not been fully
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granulated, and is consistent with observations made by electron 
microscopy.
Methylcholanthrene pretreatment (figure 3-9C) gives similar results 
to those of phenobarbitone, with no evidence of a large increase in . 
the less dense membrane population due to mass degranulation 
'in vivo'.
Ribosomal binding and membrane density
Examination of the RNA/protein ratio of these populations of membranes 
indicates how progressive fractions of the microsomal membranes are 
sedimented. Table 3-10 shows that as microsomes prepared from 
untreated animals are sedimented, the first membranes to form a pellet 
have a very high specific activity. This is a combination of "rough" 
membranes with free polyribosomes contaminating the sample to increase 
the activity further. As the less dense (less granulated) membranes 
are sedimented, the specific activity is reduced. This is the 
expected pattern.
At the gradient interface a different profile is seen. There is an 
initial decrease in activity followed by an increase. This may be 
explained as representing the initial loss of rough membranes from 
the interface, which is then followed by the loss of smoother ■ 
membranes to the pellet; however, as the density of the membranes 
retained at the interface decreases so the number of free mono­
ribosomes retained will increase as previously these will have been 
retained in suspension within the upper gradient layer.
Animals pretreated with inducing agents show similar results except
for an initial increase in the activity of the membranes retained at
the interface, (tables 3-11 and 3-12). This pattern is probably a
reflection of a change in the pattern of labelling brought about by
the administration of the inducing agents. Following administration
of the agents there would Jbe an increased synthesis of endoplasmic
reticulum membranes in a smooth state. As the membranes are formed
free polyribosomes would be attached to the membranes. The
attachment of free polyribosomes to membranes would be preferential
to the newly synthesised membranes which would thus become highly 
14labelled with C-RNA. Existing rough membranes would not receive
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14Table 3-10. Recovery of Ribosomal C-RNA on Sucrose
Gradients daring Fractionation of Control microsomes
Male Wistar-albino rats were given an ip. injection of
corn-oil CSml/kg) and starved for 24h before death.
Each animal also received an ip. injection of 12nCi 
14
C-orotic acid 2Oh before death. The animals were killed 
by cervical dislocation and microsomal ■membranes prepared 
by the usual methods. The membranes were fractionated on 
discontinuous sucrose gradients of varying molarity and 
the membranes from the pellet, and interface, of each 
gradient were harvested separately. The membranes thus 
obtained were assayed for protein and ^C-activity, and 
the specific activity calculated.
14Lower Gradient Step C-RNA/Protein
(M. Sucrose) (CPM/mg)
Pellet Interface
2.0 
1.8 
1.6 
1.4 
1.2 
1.0 
0.5 
0.25
31000
17000
8100
9100
8800
6200
5800
6500
8500
9900
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14Table 3-11. Recovery of Ribosomal C-RNA on Sucrose Gradients
during Fractionation of Phenobarbitone microsomes.
Male Wistar-albino rats were given an ip. injection of
phenobarbitone (80mg/kg) and starved for 24h before death.
Each animal also received an ip. injection of 12pCi
C-orotic acid 20h before death. The animals were killed
by cervical dislocation and microsomal membranes prepared
by the usual methods. The membranes were fractionated on
discontinuous sucrose gradients of varying molarity, and the
membranes from the pellet and interface of each gradient were.
harvested separately. The membranes thus obtained were assayed 
14
for protein and C-activity, and the specific activity 
calculated.
Lower Gradient Step 
(M. Sucrose)
14C-RNA/Protein
(CPM/mg)
Pellet Interface
2.0
1.8
1.6
1.4
1.2
1.0
0.5
0.25
38100
13700
12300
11000
12000
2100
9000
8500
7700
6500
5100
14Table 3-12. Recovery of Riboscmal C-RNA on Sucrose Gradients 
during Fractionation of Methylcholanthrene Microsomes.
Male Wistar-albino rats were given an ip. injection of
3-methylcholanthrene (25mg/kg) and starved for 24h before
death. Each animal also received an ip. injection of 12uCi 
14
C-orotic acid 2Oh before death. The animals were killed
by cervical dislocation and microsomal membranes prepared
by the usual methods. The microsomes were fractionated on
discontinuous sucrose gradients of varying molarity, and the
membranes from the pellet and interface of each gradient
harvested separately. The membranes thus obtained were assayed 
14
for protein and C-activity, and the specific activity 
calculated.
Lower Gradient Step 
(M. Sucrose)
14
C-RNA/Protein
(CPM/mg)
Pellet Interface
2.0
1.8
1.6
1.4
1.2
1.0
0.5
0.25
56500
20600
20100
19400
18200
7900
13500
13500
11600
9100
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a high dose of label and would thus show a lower activity than normal, 
consistent with untreated smooth membranes rather than rough 
membranes. As these membranes are pelleted there would thus be an 
increase in the specific activity of the membranes remaining at the 
interface as these would be more highly labelled. As these membranes 
are pelleted there is a consistent decrease in the activity retained 
at the interface. The activity seen in the pellet will be very high 
from the start due to contamination with free polyribosomes.
Degranulation and drug metabolism
Treatment of microsomal membranes with carcinogens can produce 
alteration in the activities of the drug-metabolising enzymes when 
carried out both 'in vivo' (Parke, 1975) and 'in vitro1 (McPherson 
et al, 1976). It has also been shown that within untreated membranes, 
the drug-metabolising activity varies according to the relative 
'rough-smooth' state of the membranes used (Mailman et al, .1975).
This feature is dealt with in more depth in chapter 4.
No correlation has been proven between the change in drug-metabolising 
enzyme activities and the degranulation of the endoplasmic reticulum.
A study performed in which post-mitochondrial supernatant was 
incubated with carcinogens failed to show any definite correlation.
The use of post-mitochondrial supernatant was to avoid the possibility 
of degranulation occurring during preparative high-speed centri­
fugation (Palmer, Rabin and Williams, 1978). Following the incubation, 
the buffer was made 2.0M with respect to sucrose and layered under 
0.25M STKME buffer in polycarbonate centrifuge tubes. The membranes
were harvested by flotational centrifugation at 40,OOOg for 16h at
o av
4 C, and the membranes removed using a syringe.
Table 3-13 shows that there was little change in cytochrome P-450 
concentration or 'X max, although 3-methylcholanthrene caused a 
significant change in both ethylmorphine N-demethylation, ethoxy- 
coumarin O-deethylation (table 3-14) and biphenyl 4-hydroxylase, 
whilst 2-acetylaminofluorene only affected ethylmorphine N-demethylase. 
The specific activity of the membranes was in fact increased after 
incubation, and degranulation could not be measured. This may be due
66
en
g
g
•HO
uC
u
<d
0 ■H
1
5
•H
I
•H
>
•S
§
•H
4Jtd
ü
fi
H
H-4
O
+J
ü0)
4-1
4-1W
roi—I I
ro
3
E-t
-P
X
0)
•p
D
<D T3 eu
'd •H eu
•d U 01
td td —
0) ü 4-1
u •H fi
<u P eu
S 4-1 ■H
■H T3 44
rfi U td X
U 0 p eu
•H 01 en 44
rfi •H
5 eu eu
fi 01 rfi
td O 44
'd p
0) 44 o fi
-P 0 fi •P
(d 01
u 0) 43
•H 01 td eu
-d fi rfi
f i O •p
•H 0) 44 p
-,C fi ü
01 4-> O 01
'd eu
fi >i 43 43 01
fi X eu ip
0 44 01 O
A 0) 01 td p
S P eu 44
0 fi > 44 f i
u -P p 9 O
td O U
0) •H X
6 43 B+J eu (U O
fi p •P P
X i O eu P 44V •P & P
•H 44 td LD
5 td 01 ü O
A eu
U fi f i eu d
0 U td p
KO f i p eu V
CM •H rfi & A
B
-P (D eu 01 *
td rfi B >i
-p td
X i—i 01
un fi td 01
•H S < 01CM rfi O >1
4-> 01 td
U •H O 01
0 P 01
4-1 ü td td
•d •P en
'd 0) S 01 Tf
0) -p td
4-> td tu p
I 5 S
u eu f i N S
fi en 0 fi M
•p eu •p tu C/l
p 44
01 td p +  1
td 01 rfi O
5 td 9 44 fi
5 O td
44 fi P tu
fi ta •P eu S
eu A 44
44 Q P 44 eu
td < eu fi p
fi S 44 X td
P 44
eu <
A
fi O 0
01 çn B E-i rfi
S eu 01
i—i Q 44 fi
td 01 ■P 01
•p fi >1 0)
p •P 01 43 •p
43 eu 44
fi f i eu 43 •P
Q O 01 fi >X •P td eu •P
U 44 fi A 44
0 fi tu en ü
44 rH en fi td
•P 0 0 01
S 01 p eu eu
1 43 p B44 td tP
01 rfi 43 N
O 01 eu fi fi
A td 43 td H
fi
•P
eu
44
0
p Q
A O
CD
en ro
S
\
S
A
U
43
\
eu eu O
fi 01 m
■p td p 1
43 ip i
A îp A
P 43 rH
0 44 0
S eu s
H B fi
> i eu
43 43 Ip
44 i 0
H 2
1
c<
o
m fi
•P
I eu
A 44
0
eu p
B A
O
p tn
43 S
ü "N
O rP
44 O
> i
U -Ë
T3
fi
!u
oLf)
en
un
I—I
5
fiO
U
0
1
om
en
ro
O
O
m
roLD
0)
g
!
r—1
s
ü
rH
I(D
f
ro
Ovû«y
CD
*
ip CM
rH ro CD
+  i +  l +  1
CD O f"
en O C'­
00 00 en
O
m■sr
meû
I
o 0) “ fi (d 0)o
n  (d
§ S 
5 sQ  (d
TT
ro
CM
67
2-
Ac
et
yl
am
in
of
lu
or
en
e 
0.
66
 
44
9.
9 
82
3 
+ 
46 
* 
45
20
Ta
bl
e 
3-
14
. 
Ef
fe
ct
 
of
 
In
cu
ba
ti
on
 
'i
n 
v
i
t
r
o
1 
of
 
Mi
cr
os
om
es
 
wi
th
 
Ch
em
ic
al
 
Ca
rc
in
og
en
s
A
0) ow in<d TfrH 1>1 A
rH X rH>i 0 0G u s0) no G\A rG rH•H I 0m CM1
CM CM on 00
ro rH O CM
+  1 +  1 +  i +  I
ro o ro in
<n CM m in
CM CM CM CM
rH
0 rGu 0)
■p cn OG td in
O rH
Ü >1 1
rH X As >1 O rH
0 G U O
u o no
4H rC >1
A  Æ \
in •H 1 rH
O ffl ^ 0
O
N
A
*
CM r- r~-
rH rH rH
+  1 +  1 +  1 + 1
00 in ID 00
(Jt ro 00
CM CM CM CM
to
>i
id
ro to
i—1 to
1 id
ro
<D
rH k
p O
td P
p
S
SH w
O CO
4H
+ 1
no
0) G
P id
•H to
iH . S
U
M to
0) k
id
W G
td 5
0
cn rG
rH to
•H
id to
p to
<D •H
p
•H
i—1 >
id •H
P P
G U
0) id
e
•H to
k 6
0) >i
A N
X G
M M
rG
G•H ok to inid toi  id I rH
3  rH AO >1i—1 into Æ O>1 p + 1X toO to \ 00Æ no i—1P I 0 IDw o 'd1
I
I
U
0
1
ou
0
1
*
00
o
+ 1
CO
CMH
0)
s
5
S-
rH
I
rH
I
sI
ro
ro
+ I
in
in
ro
+ I
in
in
ro
1 to
G
to to
to k
id G Oto G
to rHN id P
G k Oto rG G
p P •H
•H G
Q
1
id
rH
>1p
ro to
to
CM <1
i— l CM
68
to the use of post-mitochondrial supernatant which would allow the 
formation of polyribosomal aggregates during incubation, as well as 
the recombination of free polyribosomes with smooth membranes - 
both of which would lead to an increase in the specific activity of 
the membranes. The presence of carcinogens in the incubation mixture 
may aid the formation of aggregates in some way, and the effect of 
the carcinogens upon the membranes may have been affected by the 
presence of EDTA in the buffer. This was included to prevent lipid 
peroxidation destroying the membranes during the incubation, but the 
degranulation of membranes by carcinogens has also been linked with 
lipid peroxidation (Shires, 1978). The results described cannot 
confirm any correlation between degranulation and changes in enzyme 
activities.
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DISCUSSION
The initial studies on the protein-disulphide isomerase assay showed 
the method to be both inaccurate and of low sensitivity. As a method 
for screening carcinogens it shows an accuracy of prediction of only 
70% (Purchase et al, 1976). In addition, the use of this enzyme as 
a measurement for degranulation has been thrown in doubt by several 
findings. The original report of Williams and Rabin (1969) suggested 
that the enzyme was directly masked by bound ribosomes, but, if so, 
one would expect disulphide formation to be the first covalent 
modification of nascent proteins, which is not the case (Freedman and 
Hawkins, 1977) . The enzyme can also be solubilised from microsomal 
membranes with enhancement of activity, and can be activated without 
removal of bound ribosomes (Freedman and Hawkins, 1977) . These 
observations would be explicable only if the enzyme was situated on the 
lumen side of the endoplasmic reticulum, which is more probable.
An enzyme catalysing protein-disulphide interchange has also been 
reported to be present in liver cell supernatant (Rafter and Harmison, 
1979), thus the measurement of activity could'only be carried out with 
certainty in well-washed microsomes for fear of contamination.
However, prolonged centrifugation may itself be responsible for the 
removal of ribosomes (Palmer, Rabin and Williams, 1978) which would 
then lead to false results. Various groups of workers using the assay 
system have measured activities in rough membranes comparable to those 
in smooth membranes, these results have been ascribed to a wrong 
centrifugation technique, the correct technique being apparently 
critical and unpublished in detail (R. Freedman, personal communication).
The observations tend to imply that the enzyme is latent and can be 
activated by a variety of treatments, degranulation being only one.
For this reason the use of this method is not to be preferred for the 
assay of degranulation by carcinogens.
The presently preferred method for measuring degranulation is based 
upon the radiometric assay of ribosomal RNA as described by Lefevre 
(1978). A modification of this method has recently been reported as 
a possible screening method for carcinogens by Fey, White and Rabin 
(1980). Whilst this method of measurement is more sensitive than the
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isomerase assay, there is still some variation in results obtained 
with different preparations of rat liver microsomes. These could 
result from changes in the density distribution of microsomes from 
different sources, as it has been demonstrated here that the 
preparation method for fractionated microsomes does not provide pure 
rough and smooth membranes, but rather it divides the population of 
membranes into two halves. The assay is also prone to the arguments 
against RNA assay techniques - namely, the effects of high-speed 
centrifugation and the possibility of ribosomal aggregation.
The results reported here also show that great care is needed in 
deciding what fractions should be isolated as being "rough" and 
"smooth" membranes. The choice of density gradient can determine 
whether the differences sought are found, this is also applicable to 
differences in enzyme activities (Mailman et al, 1975).
A relationship between degranulation and changes in drug-metabolising 
enzyme activity still remains to be confirmed. Whilst carcinogens 
have been shown to alter drug—metabolising enzymes 'in vitro1 the effects 
have also proven difficult to reproduce when repeated.
In the studies reported here, no activation of biphenyl 2-hydroxylase 
was observed, unlike previously reported studies (McPherson et al,
1974). Whether the changes are due to degranulation has been 
questioned. Shires (1978), has reported that carcinogens fail to cause 
degranulation in systems where lipid peroxidation is inhibited. Indeed 
it has been suggested that it is lipid peroxidation that leads to 
degranulation.
The relationship between carcinogens and degranulation still remains 
to be elucidated, but it seems likely that a simple displacement of the 
binding steroid is not the total explanation.
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' Chapter 4
E f fe c t  o f A g e , In d u c in g  A g en ts  and C a rc in o g e n s  on the  
D is tr ib u t io n  o f M ic r o s o m a l P -4 5 0  h a e fn o p ro te in s  .
INTRODUCTION
Heterogeneity of Cytochrome P-450
Within a few years of the characterisation of Cytochrome P-450 as a 
haemoprotein, a new form was reported (Sladek and Mannering, 1966) 
following treatment of rats with 3-methylcholanthrene. It soon became 
apparent that the new form exhibited different enzymic properties, 
and was marked by a change in the peak wavelength of the reduced-CO 
spectrum which led to it being termed cytochrome P-448. By 
diethylaminoêthylcellulose chromatography, three spectrally- 
distinguishable forms were isolated from rat liver microsomes (Comai 
and Gaylor, 1973). Furthermore, the relative amounts of the three 
forms were altered by pretreatment with inducing agents, one form 
(possibly cytochrome P-448) being increased after pretreatment with
3-methylcholanthrene, another being increased after phénobarbital, 
and the third after ethanol. Different rates of incorporation of 
radiolabelled 5-aminolaevulinic acid into the haem moieties of the 
three forms suggests against their being the same cytochrome complexed 
with tightly bound endogenous substrates (Comai and Gaylor, 1973) , 
but suggests that there is a family of haemoproteins differing in the 
nature of the apoenzyme and their enzymic characteristics, but of 
similar spectral behaviour. In recent years, many investigators have 
revealed up to seven haemoproteins present in cytochrome P-450 
fractions solubilised from untreated rat liver microsomes. Evidence 
for the multiplicity of cytochrome P-450 has come from kinetic and 
spectral studies (Powis, Talcott and Schenkman, 1977) , electrophoretic 
purification on polyacrylamide gels (Coon et al, 1977), immunodiffusion 
(Guengerich, 1978; Thomas et al, 1979), as well as combinations of 
all these methods (Levin et al, 1977).
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Distribution of cytochromes P-450
The discovery of the heterogeneity of cytochrome P-450 was followed 
by studies of the distribution of the various forms within the 
microsomal membranes. Mailman et al (1975) demonstrated that when 
hepatic microsomes were fractionated on a discontinuous sucrose gradient 
little difference could be found between the activities and spectral 
characteristics of cytochrome P-450 in 1 rough' and 1 smooth1 membranes. 
However, by varying the lower sucrose layer (decreasing the sucrose 
molarity) it was shown that the 'smooth' fraction contained a 
cytochrome of different spectral character from that of the 1rough1 
fraction. The reduced-CO spectrum in this instance gave a peak at 
449nm, furthermore differences in the substrate-binding spectra of 
'rough* and 'smooth1 microsomes were also found. It was suggested 
that liver microsomes contain more than one cytochrome P-450, and 
that the different cytochromes may be located in different parts of 
the endoplasmic reticulum (Mailman et al, 1975). It is of interest 
.to note that no differences between the cytochromes of the 1 rough' 
and 'smooth' fractions could be demonstrated in preparations 
fractionated on a 1.35M sucrose layer, but that the differences only 
became apparent when the molarity of the sucrose layer was decreased. 
This is in accord with the results on the density distribution of 
microsomes reported in the previous chapter.
Studies on the multiplicity of hepatic cytochromes following pre­
treatment with inducing agents revealed that, after phenobarbitone 
induction, two.distinct populations of cytochrome P-450 can be 
separated, each being characteristic of -microsomes of different 
density (Mailman et al, 1977a). Furthermore, phenobarbitone induction 
caused changes in the density distribution of the microsomal sub­
fractions (Mailman et al, 1977a). Pretreatment with 3-methylcholan-. 
threne results in a significant change in the spectral characteristics 
of the isolated -microsomes, and subfractionation revealed that at least 
two different populations of cytochrome P-448 occur, each being a 
characteristic of microsomes of different densities. These cytochrome 
P-448 fractions differ from those isolated from control or pheno­
barbitone treated animals (Mailman et al, 1977b).
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In addition, cytochrome P-448 has been partially purified and 
characterised from homogenates of human foetal livers (Kitada and 
Kamataki, 1979), and has been shown to be refractive to phenobarbitone 
induction but not 3-methylcholanthrene induction (Guenthner and 
Mannering, 1977a).
Postnatal development of Cytochrome P-450
It is relevant to consider the development of cytochrome P-450 
haemoproteins from foetal to adult tissue. In the foetal tissue the 
activity is low but rises rapidly following birth. In the foetus and 
neonate the predominant cytochrome found is P-448 . As the animal matures 
the predominant form found is cytochrome P-450, although P-448 may 
still be present in 1 smooth * endoplasmic reticulum membranes. This 
could imply that the development of cytochrome P-450 is linked to the 
sexual development of the animal.
In studies with mice. Van den Berg et al (1978) found that sexual 
differences in ethylmorphine N-demethylation and spectral binding 
occurred between 3-7 weeks of age. Prior to this time, no differences 
were found between male and female mice, whereas afterwards the 
difference became pronounced. In female rats, it has been reported 
that the postnatal development of microsomal cytochrome P-450 reached 
a maximum around 40 days of age, corresponding to the age of puberty 
(Mukhtar, Philpot and Bend, 1978). The involvement of the pituitary 
was demonstrated by Burke, Orrenius and Gustaffson (1978).
Implantation of a male or female rat pituitary into an immature male 
rat caused a change in mono-oxygenase activity to a more typically 
female pattern. In addition, hypophysectomy of adult male rats 
decreased the inducibility by 3-methylcholanthrene of cytochrome P-448 
activities.
Sex Differences in Cytochrome P-450
In adult rats, the female exhibits characteristics of cytochrome 
P-448 compared with cytochrome P-450 in male rats (Kahl, Buecker and 
Netter, 1977). Thus the development of different forms of cytochrome 
P-450 appears to be at least partially under pituitary control.
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Changes in steroid hormone metabolism could thus produce changes in 
the expression of characteristics of the normal cytochromes. In female 
rats, these changes can be found during pregnancy and lactation.
In pregnant rats, the inducibility of cytochrome P-450 dependent 
activities by phenobarbitone is greatly decreased (Guenthner and 
Mannering, 1977b). This impairment occurs within 3 days of conception 
and disappears within 5 days after parturition. Methylcholanthrene 
inducibility of cytochrome P-448 was not impaired during the period 
of pregnancy. The similarity of response between maternal and foetal 
livers leads to the suggestion that a common regulatory mechanism may 
operate in both the foetus and the pregnant female (Guenther and 
Mannering, 1977b). Rodent mammary tissue is highly susceptible to 
carcinogenesis by polycyclic aromatic hydrocarbons, and is known to be 
capable of metabolising these compounds (Ciaccio and DeVera, 1975;
Fysh and Okey, 1978) .
Rats are resistant to induction of mammary tumours by polycyclic 
aromatic hydrocarbons during pregnancy and lactation (Dao, 1971).
It was shown that the inducibility of benzo(a)pyrene hydrocylase 
(the so called AHH activity, a P-448 type activity) increased 
dramatically towards the end of pregnancy and in early lactation, 
whereas the inducibility of liver benzo(a)pyrene hydroxylase activity 
was fairly constant (Fysh and Okey, 1979). The increased inducibility 
of mammary benzo(a)pyrene hydroxylase may thus contribute to the 
resistance to chemical carcinogenesis that female rats exhibit during 
pregnancy and lactation, as the balance between local 1 activation1 and 
1detoxification' may be important in determining susceptibility to 
carcinogenesis. It is interesting to note that 2,3,7,8,Tetrachloro- 
dibenzo-p-dioxin, one of the most potent inducers of cytochrome P-448, 
produces changes in steroid hormone metabolism in rat liver microsomes 
(Gustafsson and Ingelman-Sundberg, 1979). The changes observed were 
more pronounced in female rats, although whether the alterations in 
steroid hormone metabolism precedes, or is preceded by, the induction 
of cytochrome P-448 has not been reported.
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RESULTS
Preparation of microsomal membrane fractions
Preparation of microsomal subfractions is usually achieved by 
centrifugation on a sucrose gradient. The exact composition of 
gradient used varies from one investigator to another, but is usually 
one of two types: a sucrose-based buffer or sucrose-solution sometimes 
containing Caesium chloride. Initial experiments were carried out 
to compare the two preparation techniques and the effects upon 
microsomal cytochromes. Untreated male rats were killed by cervical 
dislocation and a liver homogenate made in Ô.05M.Tris-HCl, 1.15% KC1 
pH 7.5. The homogenate was centrifuged for 20 min at.ll,500g •
(10,000 rpm) in a MSE Highspeed 18 to prepare post-mitochondrial 
supernatant. Liver microsomes were prepared by centrifuging the post- 
mitochondrial supernatant at 235,000g^ for 35 min in a Beckman L5-65 
ultracentrifuge. The microsomal pellets were resuspended in 0.25M 
STKM buffer or 0.25M sucrose-15mM CsCl. The suspensions were layered 
over 10ml 1.05M STKM or 1.05M sucrose-15mM CsCl respectively, in 25ml 
polycarbonate tubes, and centrifuged at 115,000g^ (40,000 rpm) for 
140 min in a MSE Superspeed 50. The 1 smooth' membranes at the interface 
of the two layers were removed with a syringe and diluted with 
0.05M Tris - 1.15% KC1 buffer pH 7.5, followed by centrifugation at 
235,000gav for 35 min to pellet the membranes. 'Rough* and 'smooth' 
membrane pellets were resuspended in Tris-KCl buffer. It was found 
that there were differences in the cytochrome P-450 concentrations 
of the membranes prepared by the two -methods (table 4-1), which were 
greater than could be accounted for by experimental variation. It was 
found that the cytochrome P-450 concentration of 'rough* membranes 
prepared on STKM buffer gradients was lower than that found in 'rough' 
membranes prepared on the sucrose-CsCl gradient. In smooth membranes 
the concentrations were similar in membranes prepared in both gradient 
media.
The concentration of cytochrome b5 in rough membranes prepared from 
100-120g rats by both methods was the same, whereas the concentration 
in 'smooth' membranes from the same animals was higher in membranes
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prepared on STKM buffers. The possible causes of these differences 
include the buffering properties of the media, cation concentrations, 
and the relative stabilities of the heterogeneous forms of cytochrome 
P-450 localised in different parts of the membrane. As the 
preparation of fractionated microsomes is time-consuming, the final 
preparations are often stored overnight before use. An experiment was 
therefore performed to check the stability of the microsomes in 
storage. After preparation, P-450 haemoproteins and protein were 
assayed in an aliquot of the microsomal suspension, and the remainder 
bubbled with oxygen-free nitrogen for 1 minute, and frozen at -40°C 
under a atmosphere.for overnight storage. The following morning
the microsomes were thawed and the assays repeated. Whilst there was 
no decrease in protein concentration, there was a considerable loss 
(35%) of P-450 haemoproteins in the 'smooth' fraction, with a smaller 
loss (13%) in the 'rough1 fraction (table 4-3). There was also a 
corresponding increase in cytochrome P-420 in the 'smooth' fraction 
(data not shown). This suggests that the P-450 haemoprotein found in 
'smooth' membranes is more labile than that found in 'rough* membranes. 
As will be demonstrated later, the 'rough' membranes contain 
predominantly cytochrome P-450 whereas the 'smooth' membranes, contain 
predominantly cytochrome P-448. These findings contrast with the view 
that cytochrome P-448 is more stable than cytochrome P-4 50; however, 
it may be that natural cytochrome P-448 is more labile than carcinogen- 
induced cytochrome P-448.
In the studies that follow, microsomal membranes were fractionated on 
sucrose-CsCl gradients, as it was found that the results were more 
reproducible than with STKM buffer gradients, and were assayed 
immediately after preparation so that degradation of 'smooth' membrane 
P-450 haemoproteins was minimal. Even so, it was often noted that 
'smooth' membrane preparations showed higher levels of cytochrome P-420 
than 'rough' preparations, although the levels were not significantly 
high when compared to the cytochrome P-450 sample in the same sample.
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Effect of age on cytochrome P-450
In a study of the effect of age on the distribution of P-450 haemo­
proteins (table 4-4) it was found that in young immature animals the 
predominant form of P-450 haemoprotein in both 1 rough' and 1 smooth1 
fractions was cytochrome P-448. As the animals matured the predominant 
form in the 'rough1 microsomes changed to cytochrome P-450 soon after 
sexual development commenced. In 1 smooth1 membranes, the predominant 
form remained cytochrome P-448 and only changed to predominantly 
cytochrome P-450 after full sexual maturity.
Effect of Inducing Agents on cytochrome P-450
Studies performed with inducing agents in adolescent (100-120g) male 
rats showed that phenobarbitone induced the predominant form of P-450 
haemoprotein found in each fraction (table 4-5). Thus, cytochrome 
P-450 was induced in 'rough1 fractions and cytochrome P-448 in 
'smooth1 fractions. Treatment with carcinogens induced cytochrome 
P-448 in both fractions. It is interesting to note that no inducing 
agents significantly affected the concentrations of cytochrome b5 
in the 'rough * fraction, but in the 1 smooth * fraction it was decreased 
after '3-methylcholanthrene treatment, and increased by 2-acetylamino- 
fluorene treatment. This may be indicative of different types of 
induction by different classes of carcinogen. A study of biphenyl 
hydroxylation (table 4-6) showed that in immature animals the activity 
of biphenyl' 4-hydroxylase is high in both 1 rough1 and * smooth1 fractions, 
and falls as the animals mature. A similar effect is seen 
with biphenyl 2-hydroxylase. With both enzymes, the activity in the 
1 smooth* fractions is always higher than in the 'rough1 fractions, and 
falls less rapidly than in the 1rough1 fractions. The results, therefore, 
mimic the change from cytochrome P-450 to P-448 in the respective 
membrane fractions. Treatment of immature (100g) animals with inducing 
agents produces a more varied pattern of response (table 4-7). 
Phenobarbitone induces biphenyl 4-hydroxylase and biphenyl 2-hydroxylase 
in both 'rough' and 'smooth' fractions, whereas 3-methylcholanthrene 
treatment slightly decreased the activity of biphenyl 4-hydroxylase, 
whilst inducing the levels of biphenyl 2-hydroxylase.
81
k
S 0
in 44
O
tn
d O
o
O
-H
in
•d O
0) rH
k
fd -P
a fd
0)
k r-4
to a U
0) to
E to U
0 to
to E
0 0
u to in
Ü 0 H
•rl k I
s u to
•H to
k E 0
0) k
> k o
•H to 3
r—1 > W to
•r4 to
4-1 r4 S 3
td O
k 43 i— 1 k
C 0
C td r-4 44
•H
c 44 k
o 0 0 to
in *H 44
T? 44 a 44
1 fti to 3
P4 U -P rQ
0 to
T? i-4 r-4
C to +4 u
(ti e K
43 to 1
in •H to
r-4 43 -r4
td fd k
to u k
0) ■H cn
S > c
o k fd •r4
k to
£J u C 43
Ü 0 to
0 > i 43
+J rQ 43 3
>i to to
u 43 -P a
to td to
Ik r-4 C 3
0 r-4 0 to
•H *t4
c 44 43
0 O 3
-H to td td
4-1 k k
3 to 44 43
A to
-H . to 44
k to k to
4-1 cn to to
to fd 5 >
•H k
'O Cn to fd
c to r3
0) E
> i 0 to
+J k to k
td 0 to
C > k
0 u
44 •H to
01 0 S to
Cn 3
fd to fti
44 k
44 fd in rQ
0 k E
r~ to
4-1 0 S
U C m
01 •H a
44 A
44 r-4 r-4 u
H td u 0
i « CN
k
td cV -P
44 in td
1 to i-4
•H 3
S r-4 •H
01 1 Ë
r4 to to
A r-4 •H O
fd fti k Tf
Eh . s E-f iH
C
yt
o
ch
ro
m
e 
b
5 
(n
m
ol
/m
g 
p
ro
te
in
)
i
0.
45
 
+ 
0
.1
9
0.
83
 
+ 
0
.1
4
1
.0
3
rH iH voXtd o o dE
H <rt 'a + 1 +  i + 1O 3 m vo r~- CN
ffi. in *—B CD 00 00 cn
O 1 ’tf TT TP
8
A TP TT TP
Ui o C
in .H7  to• -PA 0
k O CD og a rH H cns o o O
+ 1 +  1 +  I
o h
o o ID cn cn44 g H o CN> igU«H O H H H
3-ktoin 4J
•Q o
«r k H
2 A H oS
p tn o o
ÿ S I + 1 + 1
0  H
o o in 0044 g in r">t §U — d d O
X rH ntdft S o O o
H < r < i +  i +  1 + 1
m o — m H r- VOÜ m
D CD cn cn <n
O i Tf ’a* TP
p; A
o 'Hm -h
Q)
1 44
A 0
k in CN cn
2 A H CN H
s
p tn o O ok g
\ +  1 + 1 + 1P  H
0  o Tf CN 00 cn-P g l—1 cn cn 00
>i 3
U  — H d d d
44 o o
5 CN r"o H H +
>i 'tn cn 1 143 ^ i o o o
0 O o in in
m CD rH H CN*
S'
g
1
is
I
I
1
M
+J
1
Ü
I
m
m
o
8 
+ 1
to
gQ)
B
0)
:
to
0)
3
>
82
Ta
bl
e 
4
-
5
. 
Ef
fe
ct
 
of
 
in
du
ci
ng
 
ag
en
ts
 
on 
th
e 
di
st
ri
bu
ti
on
 
of
 
cy
to
ch
ro
me
s 
bg
 
an
d 
P-
45
0 
in 
ra
t 
li
ve
r 
mi
cr
os
om
es
.
a k0) 0)
y >
rG •H
4J H
C
fti t
iH 0)
0 ■P
Æ fd
O ti
rH 0
>1 •H
-P
+J Ü
0) td
s u
1 h
ro
.» .
c
» 0
X •H
\ +J
Cn fd
ü
0
00 rH
to
•H
0)
ti
O rH
4J td
•H Ü
A •H
U >
td U
A Q)
O Ü
e
<u >i
A
A
rO
>H 0)
0) rH
rC i— 1
4J •H
•H
0)
O'
4H C
O •H
0)
C A
0
•H to
+J k
U O
0) 4H 1
•n to
C A
•H to
to rH
$H rQ
A £ td
•H O 4->
0) £
rH •H
Cn CN
£ t
•H to
to Cn A
•H
fd \ k
Cn O
t 6 to
0) in to
> CN t
•H
0) to
u to td
<u £
u to to
k to
O £
t 1 £o rH ko 4H 0
rH O 4H
'— £
ro
4-J(ti
U
I
Ai—I
fdI
N
m
&
Q)
rH
s
rH
£
0)0
fd1
CN
8
S’
ï
CN
rO
0)
8
S'
&
<D
to
0)
§to
o
8•H
6
C
y
t.
 
b
'5
(n
m
o
l/
m
g
 
p
r
o
te
in
);
O
6
+1
UD
in
O 0.
3
5
 
+ 
0
.1
8
0
.2
4
 
+ 
0
.1
1
0
.8
2
 
+ 
0
.1
2
« % rH • r~ 00 infd
W E o O o O
B C <  - + 1 + 1 +  1 + 1
O o 5 ID CO 00 ino in —
2 CO cn 00 00W I Tf TP . TP
k
• ^
£
•H
to
4-1
0 CN CO o
^  k rH CN CNO ftin o o o
TP
1 +  1 +  1 + 1
ft V.
rH CN CO 'd1 cn
• o G\ CN o 00
■P E
> i £ o rH rH rHU
'g
to
4-1 r- ID T f
O O rH rH ok
ft O O o o
«  S ' +  1 + 1 + 1 + 1in g
40 \ m o IDrH ID in ID
: °
>1 i O O O 6
u  —
. % H  ' rH co CN
Ph fd
S o O O 6
m ^  s
+  1 +  1 +  1 + 1
u O £ m 00 ID
5 ino 'sf Ch cn r - 00
« i TT Tf
ft 'sh 'd* Tf Tf
. ^
£
•H
to
4->
O
_  k in ID m rHO ft rH rH rH CNin
•sr O' o o o o
+ 1 +  1 + 1 + i
• O cn o 00 CN
f  i cn O rH>i £
u  — ' O H rH rH
1
0
1 £
# to O to •H
to £ r£ £ 6 to
4-1 0 U to ro £
fd 1 4-> rH k rH to
to 0  -H >1 r£ >1 k
k £  A 40 4-1 4-> 0
4-1 to k 4-> £ to £
£ r£ fd to fd U rH
D ft A S rH ft, 44
to
I
>
83
ar
e 
me
an
s 
+S
D 
of
 
3 
ex
pe
ri
me
nt
s.
. T
ab
le
 
4-
6.
 
Ef
fe
ct
 
of
 
ag
e 
on 
bi
ph
en
yl
 
hy
dr
ox
yl
at
io
n 
by 
ra
t 
li
ve
r 
mi
cr
os
om
es
m
I
!
£
01
id
-<4
5
0)
'd
VD
i—l i—l o
0) +  1 4- 1 4-1
tn w
td U2 r-~ i— 1 O o
i—i
> i 00 VÛ in CN
X
o
CN
Ch CN
i—l
>1 O O O
a
0) +  1 4- 1 4-1
& Pi 00 Ch Ch 00
•H W
m « ro ro i-4
O ID ID
CN i-4 r4
+  1 4-1 4-1
0) Pi in in CN
tn w l£> Ch ID o
td M i—i i-4 r4 ID
i— i
> t
X
0
t
>1
f
I—l CTi r - Tf
& i-4
i-4 r-4
0) 4-1 4-1 4-1
p4 Pi CN CN 00
•H w ro r4 O r~
m Pi r4 i-4 i—l ro
+ j o O
CN ; ID
o i—l i-4 4-
cn 1 1
T) I O O O
O O O in in
m 00 i-4 r-4 CN
*
+J
e
0)
e
i4
k
0)
&
X
0)
i-4
*
•P
f t
<D
Ü
X
<u
to
-p
a
CD
E
i4
M
0)
|
ro rC
P o
O in
44 Tf
O f t
02
i—i
4-1 0
to 0
C
id 4-)
0) U
E 2
0) O
rC P
-P f t
to to
P to
td i-4
O
C -
to
>
•H to
th P
td
to
to TO
2 4J
i—l -H
td C
> D
84 ‘
<
Cl
01
s
o
to
0
U
o
-H
8
01
>
•H
rH
+1
id i • ;
u
A
o
*H
+J
td
iH
X
o
u
t
>1
I—1
>1 1
t i
01
rC 01
A I™1
-H A
rQ to
4-1
c
o U
O
to 44
4->
to
01 id
tin
td to
rH
tin •H
C id
H +1
o 01
iH
•H td
4-1
m C
0 01s
4-1 *r4
o Q
0) 01
*H A
44 XH H
r~ITP
I
cn l£> » iH
O rH O CN
+  I + 1 +  1 +  |
01 « cn cn in cnto w
id w co r - COiH
X
0
t
>1
f
CN
in m o cnrH
>1 O i—i I—1 CNC
5
+ 1 + 1 + 1 +  1
A « r - CQ o•H Hm K CQ r~ ID CQ
rH
CQ t^ CQ CO
CN iH CN i—1
+  1 +  1 +  1 +  1
<D 03 CN CQ O CDco H CN TT o intd CQ r4 1—1 rH CNr-4
>1
X
0
lti5
>1
f
rH r - rH CO oiH iH iH CQ
+  1 +  1 +  1 +  1
A 05 CO rH•H W rH in O CN
m K iH rH rH CN
•
01
01 C
c 01
01 54
54 O
01 rQ 2
ti 4-1 rH
0 C 44
4-» id O
•H rH C
A O •H
01 54 rQ
4-1 id u
td rQ rH r—1
01 O > . >1
54 t i rQ 4-1
4-1 01 4-> 01
C rQ 01 O
D A S <
85
Va
lu
es
 
ar
e 
me
an
s 
+ 
SD 
fo
r 
3 
ex
pe
ri
me
nt
s. 
Un
it
s 
ar
e 
nm
ol
/n
mo
l 
P-
45
0/
h.
2-Acetylaminofluorene treatment dramatically increased biphenyl 
4-hydroxylase in both 1rough' and 1 smooth' fractions, whilst also 
increasing the activity of biphenyl 2-hydroxylase in both fractions.
The induction of biphenyl 2-hydroxylase by both 3-methylcholanthrene 
and 2-acetylaminofluorene was greater in the 'rough * fraction than in 
the 1 smooth1 fraction. This may indicate that cytochrome P-448 
induced by carcinogens is itself heterogeneous, and that induction 
is preferential in * rough1 membranes.
This could indicate that carcinogen-induction affects existing 
cytochrome P-450 rather than existing cytochrome P-448. It may also 
result from preferential induction of cytochrome in * rough1 membranes, 
which is consistent with the suggestion that cytochrome P-450 is 
synthesised in 1rough1 membranes and is then translocated to its 
eventual membrane locus (Craft et al, 1979).
Effect of sex on cytochrome P-450
The influence of hormonal status upon cytochrome P-450 is shown in 
table 4-8. Both the concentration and 'Xmax of cytochrome P-450 in 
female rats was found to be different to those of male rats. Female 
rats have a lower concentration of cytochrome P-450 than male rats, 
and this decreases further in pregnant females. The 'Xmax is also at 
a lower wavelength in female rats, and during pregnancy changes to an 
even lower wavelength.
The response to inducing agents is also different in female rats 
(table 4-8). Male rats respond to phenobarbitone induction with a 
greater response than to 3-methylcholanthrene, whereas in female rats 
the response is greater to 3-methylcholanthrene, although the overall 
response is much lower than that observed in male rats. The response 
to 3-methylcholanthrene in pregnant females is greater than in male 
or female rats, whilst the response to phenobarbitone is much lower.
These results compare with those reported by Guenthner and Mannering 
(1977b), but are not identical.
The induction of ethylmorphine N-demet±ylase activity by phenobarbitone 
is more pronounced in female rats than in male rats, and the inhibition 
by 3-methylcholanthrene is unchanged (table 4-9), despite the alterations
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Table 4-8 Effect of Sex and Inducing Agents on Cytochrome P-450
in rat liver microsomes
Wistar-albino rats (150-180g) were given a single ip injection of either 
phenobarbitone (80mg/kg) or 3-methylcholanthrene (25mg/kg), and were killed 
24h later. Control animals received an equal volume of solvent. Washed 
liver microsomes were prepared, and all assays carried out by the methods 
described previously.
Sex Treatment Cytochrome P-450
'X max (nm) (nmol/mg protein)
Male Control 449.6 ± 0.1 0.72 ± 0.10
Phenobarbitone 449.6 + 0 . 1 1.39 + 0.15
3-Methylcholanthrene 447.9 + 0.1 1.23 + 0.07 .
Female Control 449.2 + 0.2 0.53 + 0.02
11 Phenobarbitone 449.2 + 0.1 0.63 + 0.04
3-Methylcholanthrene 448.5 + 0.3 0.69 + 0.05
Pregnant
female Control 448.9 + 0 . 0 0.25 + 0.04
i Phenobarbitone 449.2 + 0 .6 0.48 + 0.06
3 ~M ethylcholanthrene 447.8 +0.3 0.70 + 0.02
(Values given are mean + SEM for 4 animals)
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Table 4-9 Effect of Sex and Inducing agents on rat liver
microsomal ethylmorphine N-demethylase and 
ethoxycoumarin O-deethylase in vitro
Experimental details as for table 4-8.
Sex Treatment Ethylmorphine 
N-demethylase 
(nmol/nmol P-450/h)
Ethoxycoumarin 
O-deethylase 
(nmol/nmol P-450/h)
Male Control " 379 + 25 42 + 2
Phenobarbitone 331 + 41 34 + 2
3-Methylcholanthrene 206 + 25 104 + 2
Female Control 139 + 9 14 + 1
Phenobarbitone 181 + 15 13 + 1
3-Methylcholanthrene 88 + 21 66 + 4
Pregnant
female Control 64 + 5 13 + 1
Phenobarbitone 105 + 3 14 + 2
3-Methylcholanthrene ,47 + 7 88 + 2
88
in A max and concentration.
Induction of ethoxycoumarin O-deethylase by 3-methylcholanthrene was 
also found to be greater in female rats than in male rats (table 4-9). 
These results are at some variance with those of Guenthner and Mannering 
(1977b), who found pregnant female rats to be non-responsive to 
phenobarbitone induction.
Female rats were found to be more responsive to induction of biphenyl 
4"-hydroxylase^ by both phenobarbitone and 3-methylcholanthrene, than 
male rats, although the absolute values of activity were lower 
(table 4-10). In contrast, induction of biphenyl 2-hydroxylase by 
3^methylcholanthrene was lower in female rats, but the initial activity 
in untreated females was twice that found in untreated male rats.
Ethyl isocyaLnide binding to cytochrome P-450
A series of spectral binding studies were carried out to determine 
further the differences in P^450 haemoproteins in * rough * and 1 smooth1 
endoplasmic reticulum membranes. Ethyl isocyanide binds to cytochrome 
P-450 in the reduced form to give a characteristic spectrum with two 
peaks, at 455nm and 430nm. The ratio of the peak heights can give an 
indication of the type of cytochrome present, as cytochrome P-448 
binding produces a higher peak at 455nm than does cytochrome P-450.
The results shown in table 4-11 indicate that in untreated 100g 
animals the peaks ratio is much greater in the 1 rough * membranes than 
in the 1 smooth1 membranes. This indicates the presence of cytochrome 
P-450 in the ’rough1 fraction, and cytochrome P-448 in the ’smooth’ 
fraction. Treatment with phenobarbitone does not change the relative 
peak heights greatly, whereas treatment with 2 -acetylaminofluorene 
slightly increased the ratio in the ’smooth’ but dramatically decreased 
the peaks ratio in the ’rough’ to that found in the ’smooth’ fraction. 
These effects can be clearly seen in figures 4-12 and 4-13 which are 
tracings of the spectra : from which the results in table 4-8 were 
calculated.
The appearance of the 455nm peak, and resultant decrease in the 430/455 
ratio has been ascribed to the carcinogen-induction of cytochrome 
P-448 (Imai and Sato, 1966), and has been used to characterise purified
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Table 4-10. Effect of Sex and Inducing agents on rat liver
microsomal biphenyl hydroxylase in vitro
Experimental details as for table 4-8.
Sex Treatment Biphenyl 
4-hydroXylase 
(nmol/nmol P-450/h)
Biphenyl 
2-hydroxylase 
(nmol/nmol P-450/h)
Male Control 51 + 4 6 + 1
II Phenobarbitone 27 + 2 5 + 1
II 3-Methylcholanthrene 6 9 + 6 23 + 2
Female Control 14 + 2 13 + 3
II Phenobarbitone 24 + 5 12 + 1
II 3-MethyIcholanthrene 33 + 3 24 + 2
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Figure 4-12 Difference absorption spectrum of ethyl isocyanide
binding to smooth microsomal membranes
Animals were treated, and microsomes prepared as described in table 4-11. 
(Control 1 / Phenobarbitone , Acetylaminofluorene —  — — — )
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Figure 4-13 Difference Absorption spectrum of ethyl isocyanide 
binding to rough microsomal membranes
Animals were treated, and microsomes prepared as described in table 4-11.
(Control " , Phenobarbitone . ... * , Acetylaminof luorene-------)
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forms of cytochrome P-450 haemoproteins (Levin et al, 19771.
It has been suggested that the appearance of the 455nm peak results 
from ethyl isocyanide interaction with the haem iron atom with weak 
lipophilic interaction with the protein'(Dahl and Hodgson, 1978). 
The data presented in table 4-11 shows that cytochrome P-450 is 
present in untreated and phenobarbitone-treated 'rough* microsomes, 
•whereas cytochrome P-448 is present in 'smooth' microsomes of all 
animals and also in the 'rough * membranes of animals treated with 
carcinogens. ^
Substrate binding to cytochrome P-450
Substrate-binding studies were carried out in fractionated microsomes 
using SKF525A as a type-I binding substrate, and pyridine as a 
type-II substrate.
Fractionated microsomes from lOOg immature male rats were prepared on 
a 1.05M Sucrose-15mM CsCl discontinuous gradient, and resuspended in 
0.05M Tris HC1, 1.15% KC1 buffer pH 7.4. The microsomal suspension 
(3ml) was pipetted into 2 x 10mm quartz cuvettes and a base-line 
difference spectrum obtained from 520nm to 400nm in a Perkin-Elmer 
356 spectrophotometer operating in split-beam mode. Aliquots (lj-il) of 
aqueous SKF525A, or pyridine (10% v/v in DMSO) were added, and the 
spectrum recorded after each addition. In the case of SKF525A the 
absorbance difference (Aon) was measured between the peak at 390nm 
and the trough at 420nm. For pyridine the respective wavelengths were 
425nm and 485nm. Double reciprocal plots of absorbance difference 
against substrate concentration were drawn, and the lines calculated by 
linear regression trend analysis ; the correlation of fit to experimental 
points was greater than 0.9 in all experiments used for calculation of 
the apparent dissociation constant (Ks).
Figures 4-14 to 4-21 show the double reciprocal plots obtained in 
several experiments. It can be seen clearly that in each case the 
binding characteristics of 'smooth' membranes differ from those of 
rough membranes in both treated and untreated rats.
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Figure 4-14 shows the reciprocal-plot of pyridine binding to 1 rough1 
and 1 smooth1 hepatic microsomal membranes in the immature (lOOg) male 
rat. It can be seen that the binding to, 'rough1 membranes is much 
higher than to 1 smooth' membranes and that the apparent Ks of the 
1rough' membranes is half that of the 1 smooth *. In the mature (150g) 
rat, the apparent Ks was found to be the same for both membrane 
fractions (Figure 4-15), and was lower than for membranes from lOOg 
rats (see table 4-22 for summary).
Pretreatment with phenobarbitone in immature male rats decreased 
the apparent dissociate constant (Ks) dramatically, to values 
approximately one-third of those found in the untreated animal, in 
both * rough1 and 'smooth1 fractions (figure 4-16).
Similar results were found in animals pretreated with 3-methyIcholan- 
threne (figure 4-17) where it was found that the Ks in both * rough' 
and 'smooth1 membranes decreased to approximately 60% of that calculated 
for untreated animals. In untreated, phenobarbitone-, and methyl- 
cholanthrene-treated animals the ratio of the 'smooth * Ks to 1 rough1 
Ks was found to be almost constant. This is surprising in the case of
3-methylcholanthrene-treated animals as it would be expected that with 
the induction of cytochrome P-448 in the 1rough' fraction, the Ks 
would change similarly to that seen in 2-acetylaminofluorene-treated 
animals (Figure 4-18). In this instance the Ks in the * smooth' fraction 
was not appreciably different from the Ks in 'smooth* untreated 
microsomes, whereas the Ks in the 'rough' fraction was increased 
approximately two-fold to a value slightly greater than that calculated 
for the 'smooth' fraction.
Repeat experiments gave similar results to those shown here, and all 
binding results are summarised in table 4-22. Due to the availability 
of only a small yield of 'smooth' membranes in each preparation, binding 
spectrum were only carried out at one protein concentration,as further 
dilution of the membrane suspension would have resulted in errors in 
calculating Ks from very small changes in absorbance. The protein 
concentrations of 'rough* and 'smooth' suspensions were adjusted to be 
approximately equal for each preparation to reduce any errors that could 
result in alterations in the apparent Ks.
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Binding studies with SKF525A Ca type I binding substrate) were only 
successfully carried out in three studies. In other preparations 
no appreciable difference spectrum was detected.
There was little difference between the Ks calculated for * rough' 
and 'smooth * microsomes isolated from untreated animals (Figure 4-19), 
but after pretreatment with either phenobarbitone (Figure 4-20) or
2-acetylaminofluorene (Figure 4-21) there was a three-fold increase 
in the Ks of the 'rough1 fraction, with* only slight increases in the 
Ks of the 'smooth1 fraction. These results are summarised in table 4r22.
It can be seen that there is effectively no difference in the Ks for 
SKF525A binding to untreated 150g rats, whereas treatment with either 
phenobarbitone or 2-acetylaminofluorene results in the Ks of 1rough1 
membranes being double that of ’smooth1 membranes, despite the fact 
that different cytochromes are induced by these compounds.
The Ks of type II (pyridine) binding appears to vary according to the 
cytochrome present. In lOOg rats, the Ks is higher in 'smooth' than 
’rough1 membranes, and is lower still in 150g animals. This mirrors the 
conversion of post-natal cytochrome P-448 to cytochrome P-450 (see 
table 4-4 ). Treatment of lOOg rats with phenobarbitone decreases 
the Ks of both ' rough1 and * smooth * membranes from the untreated values. 
Treatment with 3-methylcholanthrene whilst decreasing the Ks from the 
untreated levels, still results in a value higher than for untreated 
150g rats. Acetylaminofluorene, a potent inducer of cytochrome P-448, 
causes an increase in the Ks of the ’rough1 membranes to a value higher 
than for 1 smoothf membranes, and similar to that for 'smooth' membranes 
in untreated rats. From these results it would appear that the 
appearance of cytochrome P-448 is consistent with a higher Ks than 
for cytochrome P-450.
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DISCUSSION
The study of the heterogeneity of P-450 haemoproteins and the 
distribution of these within the different density fractions requires 
careful study, not only with regard to the investigations made, but 
also to the preparative methods used. The use of discontinuous sucrose 
gradients, whilst used widely, is not ideal for the preparation of 
fractionated membranes for detailed study. As was shown in the previous 
chapter, the microsomal population is not easily divided into two pure 
fractions, and the choice of the gradient step greâtly affects the 
appearance of the differences looked for (Mailman et al, 1975).
A triple gradient as used does not allow ideal separation of the 
membranes into various fractions - it would be preferable to use a 
gradient with 4-6 steps such that the -membranes can be divided into 
different density ranges, or even a continuous gradient in a zonal 
rotor. Another problem that occurs with the use of discontinuous 
gradients in an angle-rotor is the quantity of material that can be 
handled in one preparation. In the experiments described here, the 
pooled livers of 6 animals resulted in the final preparation of 
approximately 50-6Qmg of * smooth * microsomal protein. This was found 
to be barely sufficient if experiments were to be performed in duplicate, 
and insufficient for experiments in triplicate. This limited the number 
of studies that could be undertaken upon any one preparation.
A criticism of the experiments described is that the study has been 
made of the 'smoothest' membranes that could be prepared as a ' smooth1 
fraction whereas the 'rough1 fraction contains a population varying from 
•roughest* to ’fairly smooth1. This could have an effect -upon the - '
results obtained for the * rough• fraction, and may be the cause of the 
several unexpected, and otherwise -unexplainable,-inconsistencies^in 
results for 'rough* fractions. Nevertheless, a difference between the 
two fractions has been demonstrated, and improvements in preparation 
methods are likely to increase this difference.
The development of cytochrome P-r450 haemoproteins in the foetus and 
neonate has been studied by several workers in many animals including 
rats (Henderson, 1971; Wilson and Frohman, 1974), guinea-pig (Kuenzig 
et al, 1974), rabbit (Rane et al, 1973; Vainio, 1975) hamster(Nebert 
and Gelboin, 1969) and ferret (loannides and Parke, 1975).
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With few exceptions these species have a very low capacity to metabolise 
drugs and other foreign compounds until after birth, when the activity 
of drug-metabolising enzymes increases dramatically. Studies by Winsnes 
(1970) and Vainio (1975) indicated that the properties of the 
endoplasmic reticulum membranes in newborn rats were different from 
those in adult animals, since surfactants have different effects upon 
the drug-metabolising enzymes. The foetal hepatic drug-metabolising 
enzymes are not only refractive towards phenobarbitone "induction 
(Guenthner and Mannering, 1977a) but the inducibility of aromatic 
hydrocarbon hydroxylase (associated with induction by carcinogens of 
cytochrome P-:448) also changes as a function of foetal-age (Schlede and 
Merker, 1972). The inducibility of the mixed-function oxidases in 
neonatal rats rises quickly during the first few weeks. Benford and 
Bridges (1979) investigating the hydroxylation of biphenyl showed that 
the activity of both biphenyl 2- and 4-hydroxylase increased rapidly 
after birth, but after three weeks the activity of biphenyl 2-hydroxylase 
fell whilst the activity of the 4-hydroxylase remained constant. These 
activities are thought to be medicated by cytochromes P-448 and P-450 
respectively. Thus a large body of evidence has been gathered to 
demonstrate that the cytochromes found occurring in foetal and neonatal 
liver are different from those occurring in adult liver. The results 
presented here indicate that in the neonate, cytochrome P-448 is the 
predominant cytochrome, whereas cytochrome P-450 is predominant in the 
adult liver. The change from one cytochrome to the other corresponds to 
that period where biphenyl 2^hydroxylase activity peaks before falling 
(Fig. 1 in Benford and Bridges, 1979), a similar decrease in activity 
having been shown in this study.
Treatment of immature rats with inducing agents whilst generally 
increasing the activities of biphenyl 2- and 4-hydroxylases did not 
indicate any great differences between the activities in rough and 
smooth membranes. Of surprise, however, was the large increase in 
biphenyl 4—hydrocylase following 2-acetylaminofluorene administration.
As this compound is know to induce a change in its own metabolism, this 
may indicate an activity effected by a different mechanism from the usual. 
The spectral reaction of microsomes with ethyl isocyanide indicates 
clearly the differences in cytochromes found in these studies. It is 
known that reduced cytochrome P-450 exhibits a dual peak spectrum with
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ethyl isocyanide, with a large peak at 430nm and a: smaller peak at 
455nm. Cytochrome P-448 exhibits an increased peak at 455 with 
subsequent lowering of the ratio of the two peak heights. It has been 
clearly demonstrated that in the untreated animal cytochrome P-450 is 
predominant in the 'rough' fraction, whilst cytochrome P-448 is 
predominant in the 'smooth' fraction, this is also true for animals 
treated with phenobarbitone. After treatment with 3-methylcholanthrene 
or 2-acetylaminofluorene, however, cytochrome P-448 is also found in 
the 'rough' fraction. Further differences in the substrate binding 
spectrum reinforce this difference.
Whilst it is possible to distinguish between cytochrome P-450 and 
cytochrome P-448 in these studies, it is not possible to distinguish 
between different forms of cytochrome P-450 or cytochrome P-448.
Thus the cytochrome identifiable as ofa particular type spectrally 
may be of another form from one isolated froms.aldlfferentssonrceLhUt 
of the same spectral type. It is possible that there are several forms 
of both cytochrome P-450 and P-448 that are similar spectrally, but of 
slightly differing enzyme specificity. This would explain why induced 
cytochrome P-448 does not exhibit the same type I and type II spectral 
binding constants as the naturally occurring cytochrome P-448.
108
Chapter 5
In d u c tio n  o f C y to c h ro m e  P - 4 5 0 ,  and the e ffe c t o f P r o te in
S yn th es is  In h ib ito rs
INTRODUCTION 
Induction by Chemicals
A multitude of studies have shown that cytochrome levels in animal 
tissues can be altered by the administration of a wide variety of 
xenobiotics, including drugs, insecticides, herbicides and 
carcinogens (Parke, 1975).
Amongst the first known inducing agents were the carcinogen
3-methylcholanthrene (Conney et al, 1956) and the drug pheno­
barbitone (Remuer, 1959). Other inducing agents were later 
classified by comparison with these two compounds as they stimulate 
the synthesis of two different cytochromes P-450.
Heterogeneity of Cytochrome P-450
Evidence has accumulated to show that multiple forms of cytochrome 
P-450 exist (Sladek and Mannering, 1966; Imai and Sato, 1966;
Frommer et al, 1972; Lu et al, 1973) It has been known for some ■ 
time that phenobarbitone and 3-methylcholanthrene induce different 
oxidation reactions (Conney, 1967). Phenobarbitone-induced 
cytochrome P-450 metabolises hexobarbital, ethylmorphine and 
aminopyrine, whereas 3-methylcholanthrene-induced cytochrome P-450 
metabolises ethcnxycoumarin, ethoxyresorufin and benzo (a) pyrene.
The latter form also has altered spectral properties which have 
resulted in the term cytochrome P-448 (Alvares et al, 1967) , 
cytochrome P-446 (Hildebrandt et al, 1968) and cytochrome 1^ -450 
(Sladek and Mannering, 1966).
/
Purified rat liver cytochromes P-450 and P-448 showed different EPR 
spectra (Nebert and Kon, 1973; Nebert, Robinson and Kon, 1973;
Witmer et al, 1974), behaved differently under isoelectric focusing 
(Conney et al, 1973) and resolved to different molecular weight 
bands by SDS-polyacrylamide gel electrophoresis (Alvares and Siekevitz, 
1973). Comai and Gaylor (1973) have also separated cytochromes
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having differing spectral properties by diethy1aminoethyl— 
cellulose chromatography.
Kinetic and spectral evidence has been given that multiple species 
of cytochrome P-450 are present in liver microsomes, and that 
different forms are induced by different agents (Powis, Talcott 
and Schenkman, 1977) .
Cytochromes induced by phénobarbital, J3-napthoflavone and 3-methyl­
cholanthrene have been separated and purified (Hashimoto and Imai, 
1976; Haugen and Coon, 1976; Huang et al, 1976; Thomas et al,
1976; Johnson and Muller-Eberhard, 1977; Guengerich, 1978).
Cytochromes P-450 and P-448 may be induced by different mechanisms 
by differing agents. Some halogenated biphenyls, specifically 
2,4,5,2',4',5', hexachlorobiphenyl, 2,3,4,2',4*,5*, hexachloro- 
biphenyl (Alvares, 1977), and 2,4,5,3',41,51, hexabromobiphenyl 
(Hannan et.al, 1978) induce both type simultaneously.
Induction Mechanism of Cytochrome P-450
The induction of cytochrome P-450 by phenobarbitone is accompanied 
by an increase in NADPH cytochrome c-reductase, and can be prevented 
by inhibition of protein synthesis at the transcriptional or 
translational stage (Ernster and Orrenius, 1965; Gelboin, 1971;
Jacob et al, 1974).
From the relatively high amount arid short biological half-life of
cytochrome P-450 (1-2 days: Griem et al, 1970; Levin and Kuntzman,
1969) , it has been estimated that most of the haem synthesised in
the hepatocyte is needed for the synthesis of the cytochrome (Marver
and Schmid, 1972). 5-Aminolaevulinate synthetase, the rate limiting
enzyme in haem biosynthesis, is increased rapidly by phenobarbitone
(Marver, 1969). However, induction of cytochrome P-450 by
phenylbutazone is not accompanied by an increase in 5-aminolaevulinate
synthetase (Dematteis and Gibbs, 1972). The existence of a mobile 
A
microsomal haem pool has complicated the study of haem incorporation 
into cytochrome P-450.
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Evidence has been reported for a pool of free cytochrome P-450 
apoprotein (Correia and Meyer, 1975). Phenobarbitone primarily 
increases synthesis of the apoprotein, which accumulates if haem 
biosynthesis is inhibited and is found in the "heavy" microsomes 
cosedimenting with the mitochondrical fraction.
Whilst it is known that inhibition of haem synthesis leads to 
a decrease in cytochrome P-450, induction of haem synthesis will 
not induce cytochrome P-450 apoprotein (Druyan and Kelly, 1972).
It has been reported that cytochrome P-450 induction occurs 
primarily in the 1 rough1 microsomal fraction, and subsequently in 
the 'smooth1 fractions (Ernster and Orrenius, 1965; Dallner et al, 
1966). Recently, Craft et al (1979) have reported that cytochrome 
P-450 is at least part synthesised by the heavy 1rough1 endoplasmic 
neticulum, is translocated into the intracisternal space and passes 
into the light 'rough1 and 1 smooth * reticulum before insertion at 
its ultimate membrane locus. .
Mice genetically non-responsive to methylcholanthrene induction 
have been studied (Gielen et al, 1972; Poland et al, 1974) . The 
lack of response is not, however, due to the necessary structural 
genes since these strains may be induced by 2,3,7,8-tetrachloro- 
dibenzo-p-dioxin, (Grieg and DeMatteis, 1973; Poland et al, 1974) . 
Further studies have suggested that a cytosolic binding protein may 
be deficient in non-responsive mice, and that this is the receptor 
for induction (Poland et al, 1976).
These investigations tend to indicate that the induction of both 
cytochrome P-450 and P-448 involves 'de novo' protein synthesis.
Protein synthesis and Enzyme Induction
The conversion of cytochrome P-450 to P-448 without protein synthesis 
has been attempted (Kahl et al, 1977), but experiment design has 
allowed criticism that protein synthesis was not fully inhibited. 
Studies have shown that purified fractions of cytochrome P-448 induced 
by 3-methylcholanthrene contain the inducing agent strongly bound
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to the cytochrome, (Hashimoto and .Imai, 1976; Sato et al, 1979).
The possibility, therefore, exists that cytochrome P-448 is a 
chemically modified form of cytochrome P-450.
Conney and Gilman (1963) have shown that the use of puromycin and 
actinomycin D prevents the induction of cytochrome P-450, suggesting 
that protein synthesis 'de novo' was an important feature of 
induction. Phenobarbitone-induction can be inhibited by actinomycin D, 
which suggests that induction may result from increased DNA-RNA 
polymerase activity due to genomal derepression (Orrenius, Ericson 
and Ernster, 1965). Phenobarbitone arid 3-methylcholanthrene both 
stimulate RNA-polymerase activity (Gelboin, Wortham and Wilson, 1967). 
It has also been suggested that phenobarbitone primarily affects 
the transcription of zibosomal RNA whereas methylcholanthrene 
stimulates messenger RNA transcription (Wold and Steele, 1969).
Cytochrome P-448: 'de novo' synthesis or altered P-450?
In addition to the altered peak of the reduced-CO spectrum, 
carcinogen-induced cytochromes exhibit altered spectra with 
ethyl isocyanide 3-S the ligand, with an increased absorption at 
455nm rather than 430nm (Alvares and Mannering, 1967).
Safrole forms a ligand with cytochrome P-450 (Parke and Rahman,
1970; Parke and Gray, 1973) and long-term administration leads to 
an increase in cytochrome P-448, a decrease in cytochrome P-450, 
and a decrease in mixed-function oxidase activity, whereas long-term 
administration of phenobarbitone results in sustained induction of 
microsomal enzymes (Crampton et al, 1977 ab; Parke and Gray, 1978).
Evidence that cytochrome P—448 was not a metabolite—complex with 
cytochrome P-450 was given by Fujita and Mannering (1971) who found 
that purified cytochrome P-448 from 3-methylcholanthrene-treated 
rats contained only 0.04 mol 3—HC/mol haemoprotein. However,
Sato et al (1979) demonstrated a 1:1 molar ratio of carcinogen: 
haemoprotein, as reported earlier by Hashimoto and Imai (1976).
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Cytochrome P-420 derived from 3-methylcholanthrene-induced 
cytochrome P-448 differs from cytochrome P-420 derived from 
cytochrome P-450 in substrate binding, and electrophoretic 
migration, (Shoeman, Vane and Mannering, 1973) which may indicate 
a different structure.
The differences seen in the interaction of microsomal enzymes with 
various substrates suggests several forms of cytochrome P-450 exist. 
The O-dealkylation of 7-ethoxycoumarin has been studied in this 
respect by Ullrich, Frommer and Weber, (1973).
Comai and Gaylor (1973) have isolated three spectrally-distinguishable 
forms of cytochrome P-450 by DEAE-cellulose chromatography. The 
relative amounts of these forms, and rates of incorporation of 
radiolabelled haem, are both altered by inducing agents. The 
observations do not preclude there being a family of haemoproteins 
having slightly different apoenzyme moieties.
Evidence that cytochromes P-450 and P-448 are distinct forms of a 
single species comes from the observation that N-demethylase 
activity parallels phénobarbital induction of cytochrome P-450, 
whereas increases in N-demethylase activity and ethylisocyanide 
binding occur within 2-6 hours during 3-methylcholanthrene induction - 
long before there is any increase in total haemoprotein (Alvares,
Parli and Mannering, 1973).
Kitchin and Woods (1978) have reported a series of experiments with 
the potent inducing agent 2,3,7,8-tetrachlorodibenzo-p-dioxin, in 
which cobalt chloride was used to inhibit haem synthesis and 
cycloheximide used to inhibit protein synthesis. The inhibitors 
caused a decrease in cytochrome P-450 and prevented induction, but 
did not prevent the appearance of benzo(a)pyrene hydroxylase.
Studies of the biosynthesis of different cytochromes were performed 
by Imai and Siekevitz (1971). It was found that during methylcholan­
threne induction, the ethyl isocyanide binding increased prior to an 
increase in cytochrome levels, and that the use of haem and protein 
synthesis inhibitors prevented the increase in cytochrome levels
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but did not prevent the appearance of cytochrome P-448.
It is possible that these changes may all be due to alterations 
in the immediate physical invironment within the microsomal 
lipoprotein membrane, which will be discussed further in the 
following chapter.
RESULTS
Induction of microsomal cytochromes
Whilst it is clear that induction of cytochrome P-450 by pheno­
barbitone depends upon protein synthesis 'de novo1, the appearance 
of cytochrome P-448 following administration of carcinogens may be 
the result of either a) synthesis 'de novo1 of an entirely new 
protein, or b) a modification of existing cytochrome P-450.
A comparison of the induction of cytochromes P-450 and P-448 was 
carried out.
Table 5-1 shows that following a single administration of either 
phenobarbitone or 3-methylcholanthrene, the concentration of 
cytochrome P-450/448 remained relatively constant until a significant 
increase was seen after 12 hours. The maximum concentrations were 
reached within 36-48 hours after which a decrease in concentration 
was observed. This is consistent with an increase in protein 
synthesis. Cytochrome b5, also involved in some drug-metabolising 
reactions was induced only by 3-methylcholanthrene. This cytochrome 
forms part of the electron-transport chain, and its induction by 
carcinogens may aid in altering the pattern of drug metabolism.
The change in the reduced-CO spectrum of cytochrome P-450 occurs 
within 12 hours of administration of 3-methylcholanthrene (table 5-2), 
and is maintained for over 72 hours.
The use of rats of similar age (weight range within 10g) decreases 
the variation between animals and makes it possible to study the 
hypsochromic shift more closely.
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fTable 5-1 Induction of cytochromes b5 and P-450 by 
phenobarbitone or 3-methylcholanthrene
Male Wistar-albino rats were killed at intervals shown following 
a single ip injection of either phenobarbitone (PB) (80mg/kg) or 
3-methylcholanthrene (MC) (25mg/kg). Liver microsomes were prepared 
as described under "Methods" and cytochromes b5 and P-450 were 
determined as nmol/mg protein.
Values shown are calculated from the means for three animals, and 
are shown as % untreated controls. (*P -< 0.05)
Induction of Cytochrome
Time after dosing Cytochrome b5 Cytochrome P-450
(h) (% control) (% control)
PB MC PB MC
1 94 110 94 111
3 — - — 90 115
6 6 8* 65* 101 90
12 - - 146* 147*
18 6 8* 95 144* 139*
24 87 126* 168* 157*
36 119* 121* 185* 166*
48 112 135* 158* 192*
60 114 128* 169* 165*
72 111 133* 127* 179*
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Table 5-2 Spectral changes of cytochrome P-450 following
administration of either phenobarbitone or 3- 
methylcholanthrene
Male Wistar-albino rats were killed at intervals shown following" a 
single ip injection of either phenobarbitone (PB) (80 mg/kg) or 3- 
methylcholanthrene (MC) (25 mg/kg). Liver microsomes were prepared 
as described in chapter 2, and the max of cytochrome P-450
estimated as described.
Values shown are the means for 3 animals. Treated animals are shown 
as difference from controls.
Cytochrome P-450 ^max 
(nm)
Time after dosing Control PB MC
(h)
1 449.3 +0.1 +0.1
3 449.2 +0.3 0
6 448.8 +0.4 +0.3
12 449.6 -0.1 -0.7
18 449.9 -0.1 -1.2
24 449.2 -0.1 -1.2
36 448.8 +0.5 -1.2
48 449.7 0 -1.7
^60 449.4 0 -1.4
72 449.2 0 -1.5
/
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Table 5-3 shows the results of a study using rats of 100-110g body 
weight. Individual animals were killed at various intervals after 
an injection of 3-methylcholanthrene, and estimation of the 'X max 
of cytochrome P-450 showed a discernible decrease in wavelength 
within 6 hours.
Regression analysis of the results indicates a linear correlation,
0.9, with a confidence of fit P>99%. Figure 5-4 shows results 
of two such experiments expressed graphically.
The rapid appearance of cytochrome P-448 in these experiments may be 
interpreted as indicating that alteration of existing cytochrome P-450 
has taken place; more time would elapse before the results of ‘de novo1 
synthesis would be apparent.
Changes in the spectral absorption are attended by changes in the 
drug-metabolising enzyme activities. Table 5-5 shows the change in 
microsomal ethoxycoumarin O-deethylase activity during induction. 
Phenobarbitone causes no appreciable increase in the activity/mg 
protein, whereas 3-methylcholanthrene administration results in a 
significant increase in activity after only 6 hours.
When the activities are examined as a function of cytochrome P-450 
(table 5-6), it is seen that there is little increase in specific 
activity during methylcholanthrene induction, whereas phenobarbitone 
treatment has actually decreased the specific activity. Similarly, 
ethyMorphine N-demethylase activity (table 5-7) is increased by 
phenobarbitone but not by methylcholanthrene. However, the specific 
activity is unaffected by phenobarbitone and decreased by methyl­
cholanthrene. These results indicate that the increase in drug- 
metabolising activities results from an increased quantity of 
cytochromes P-450 rather than altered quality, and also invite 
further discussion regarding the heterogeneity of cytochromes P-450 
in untreated anMals.
It was noted that e thy Morphine N-demethylase (.a cytochrome P-450 
activity) was induced within 18 hours, whereas ethoxycoumarin 0 — 
deethylase (a cytochrome P—448 activity) was induced within 12 hours.
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Table 5-3 Changes in the max of cytochrome P-450 following 
a single ip injection of 3-methylcholanthrene
Male Wistar-albino rats (100-I10g) were killed at intervals shown, 
after a single ip injection of 3-methylcholanthrene (25mg/kg) in
P-450 estimated. The results shown are for one experiment with one 
animal at each time-point. A repeat experiment yielded similar 
results (see figure 5-4).
Linear regression analysis of the results gave a line with y-intercept= 
450.42nm, slope - 0.10 nm/h and a correlation of >> 0.9. The degree 
of confidence was p> 99%.
Time after dosing ^  max Cytochrome P-450
(h) (nm)
corn oil, liver microsomes prepared, and the 'Amax of cytochrome
0 450.40
1.5 450.03
3.25 450.40
4.5 450.01
6.0 449.82
7.5 449.85
8.5 449.49
10.25 449.35
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Figure 5-4 Changes in the max of cytochrome P-450 following 
a single ip injection of 3-methylcholanthrene
Experimental details as for table 5-3.
Regression analysis
Expt 1. (-0-) , Intercept = 450.42.:nm 
Slope = -0.10 nm/h 
Correlation,r = 0.90, P> 99%
Expt 2. (—•—), Intercept = 449.73 nm 
Slope = -0.07 nm/h 
Correlation,r = 0.77, P >95%
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Table 5-5 Changes in microsomal ethoxycoumarin O-deethylase 
activity following a single ip injection of either 
phenobarbitone or 3-methylcholanthrene
Male Wistar-albino rats were killed at various intervals after a 
single ip injection of either phenobarbitone (PB) (80mg/kg), or 
3-methylcholanthrene (MC) (25mg/kg). Liver microsomes were prepared 
as previously described and ethoxycoumarin O-deethylase activity 
assayed.
Control values are shown as mean + SEM for three animals.
*
Test values are shown as % control mean, ( P ■< 0.05)
Time Ethoxycoumarin O-deethylase (nmol/mg protein/h)
(h)
Control . PB MC
1 75+ 3 92 104
3 49+ 3 130 * 117
6 51+ 1 105 124 *
12 27+ 1 119 141 *
18 36+ 2 81 104
36 56+ 3 156 * 280 *
48 64+ 3 104 197 *
60 86+16 107 145 *
72 65+ 3 103 160 *
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Table 5-6 Changes in the specific activity of ethoxycoumarin
Experimental details as described in table 5-5.
O-deethylase following a single ip injection of 
either phenobarbitone or 3-methylcholanthrene
Control values are shown as mean + SEM for 3 animals.
*
Test values are shown as % control mean, ( P < 0.05 )
Ethoxycoumarin O-deethylase
Time Control PB MC
(h) (nmol product/nmol P-450 (% control) (% control)
per h)
1 69 + 2 99 94
3 6 2 + 6  145 * 101
6 49 + 7 104 136 *
12 29 + 6 79 . 9 0
18 37 + 3 771 77
24 106+12 71 98
36 41 + 1 85 169 *
48 100 +11 65 * 101
60 132 + 2 63 * 94
72 73 + 8 81 * 92
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Table 5-7 Changes in microsomal ethylmorphine N-demethylase
activity following a single ip injection of either 
phenobarbitone or 3-methylcholanthrene
Animal pretreatment was as described for table 5-5.
Liver microsomes were prepared, and ethylmorphine N-demethylase
activity assayed as described previously.
Control values are shown as mean + SEM for three animals.
*
Test values are shown as % control mean, ( P< 0.05)
Ethylmorphine N-demethylase
Time Control PB MC
(h) (nmol product/mg protein (% control) (% control)
per h)
1 511 + 26 86 .".104
3 3 3 8 + 7  110 110
6 5 1 9 + 5  93 96
12 560 + 12 124 119
18 293 + 10 130 * 93
36 428 + 7 181 * 121
48 338 + 4 187 * 120
60 436 + 8 194 * 92
72 502 + 9 138 * 97
122
Table 5-8 Changes in the specific activity of ethylmorphine 
N-demethylase following a single ip injection of 
either phenobarbitone or 3-methylcholanthrene
Experimental details as described for table 5-7.
Control values are shown as mean + SÈM for three animals,
*
Test values are shown as % control mean, ( P< 0.05 )
Time
(h)
Control PB
(nmol product/nmol P-450 (% control)
per h)
MC
(% control)
469 + 27 92 94
428 + 7 125 96
502 + 12 91 105
12 576 + 4 83 79
18 305 + 19 110 69
24 626 + 4 61 51
36 313 + 1 100 72
48 519 + 4 118 62
60 675 + 2 114 59
72 560 + 7 109 55
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The more rapid appearance of the cytochrome P-448 activity could 
also indicate a difference in induction mechanisms.
Inhibition of Protein Synthesis
If cytochrome P-448 is synthesised 'de novo' its appearance should 
be prevented by the careful use of protein synthesis inhibitors. 
Although simple in concept, this has never been conclusively proven.
Initial experiments were performed using three inhibitors; cyclo- 
heximide which blocks translation, actinomycin D inhibits DNA-dependent 
RNA polymerase, and amanitin specifically inhibits eukaryotic 
RNA-polymerase II.
Table 5-9 shows the effect of inhibition of the 3-methylcholanthrene 
induction of cytochrome P-448. The inhibitors alone did not 
significantly alter control values, whilst both actinomycin D and 
cycloheximide prevented the maximal increase in cytochrome P-448 
concentration together with a decrease in the blue-shift of the 
reduced-CO spectrum. However, the slight induction of cytochrome 
P-448 suggests that protein synthesis was not completely inhibited, 
the results thus being of debatable significance.
Table 5-10 shows the effect of inhibitors on the induction of 
microsomal drug-metabolising activities. All compounds only partially 
inhibited the increases in ethoxycoumarin O-deethylase and biphenyl
2-hydroxylase activities. When the specific enzyme activities were 
calculated (table 5-11) a similar pattern was found. The increase in 
ethoxycoumarin O-deethylase activity was partially inhibited, whilst 
the increase in biphenyl 2-hydroxylase was completely uninhibited.
These results may be interpreted to show that cytochrome P-448 appears 
even during inhibition of protein synthesis, but may also be the 
result of incomplete inhibition - the criticism of previously 
published studies.
Further experiments were carried out using an increased dose of
\
cycloheximide, with particular regard to dose-timing and experimental
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Table 5-9 Comparison of the effects of protein synthesis 
inhibitors on the induction of microsomal 
cytochromes by 3-methylcholanthrene
Male Wistar-albino rats received a single ip injection of either 
o<-amanitin (0.5mg/kg), actinomycin-D (lmg/kg) or cycloheximide (lmg/kg), 
30 min. prior to an ip injection of 3-methylcholanthrene (MC) (25mg/kg). 
The animals were killed 20 h after the final injection and liver 
microsomes prepared. Microsomal cytochromes bS, P-450, and P-450 ^ max 
were determined as previously described.
Values are mean + SEM for three animals.
( P <0.05, from control)
Treatment Cytochrome b5 
(nmol/mg protein)
Cytochrome P-450 
(nmol/mg protein)
P-450 max 
(nm)
Control 0.57 + 0.03 0.96 + 0.03 449.4
tX-Amanitin 0.65 + 0.02 * 0.96 + 0.07 449.1
Actinomycin-D 0.63 + 0.09 1.06 + 0 . 1 0 449.6
Cycloheximide 0.68 + 0.04 0.90 + 0.10 449.4
oC-Amanitin 
+ MC
0.68 + 0.02 * 1.48 + 0.03 * 448.7
Actinomycin-D 0.61 + 0.02 
+ MC
1.23 + 0.12 448.8
Cycloheximide O:70 + 0.03 * 
+ MC
0.99 + 0.01 449.1
MC 0.72 + 0.02 * 1.52 + 0.06 * 448.4
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regime. Cycloheximide (2mg/kg) was given 30 min prior to methyl­
cholanthrene, ensuring complete inhibition for about 18 hours.
The animals were killed 20 hours after the final injection, allowing 
time for induction under normal conditions but not recovery from 
protein synthesis inhibition.
Table 5-12 shows that the appearance of cytochrome P-448 was still
not completely inhibited, although induction was now totally inhibited.
The effect upon drug-metabolising enzymes (table 5-13) was similar
to the previous experiments. Comparison of methylcholanthrene to
control against inhibited-methylcholanthrene to inhibitor shows that
»
the appearance of cytochrome P-448 activities was not altered by the 
use of cycloheximide.
When the activity per nmol. P-450 was examined (table 5-14) it was 
found that the induction pattern by 3-methylcholanthrene was almost
identical under both normal and inhibited conditions.
\
The significant increases in cytochrome P-448 activities together 
with the complete inhibition of induction of cytochrome P-448 make 
it reasonable to propose that the appearance of cytochrome P-448 
does not require protein synthesis 'de novo1.
The demonstration of complete inhibition of protein synthesis during 
these experiments was also carried out as this is a vital part of 
the experiment.
The experiments were repeated with phenobarbitone induction (table 5-15), 
where it was demonstrated that induction of cytochrome P-450 was 
totally inhibited. Examination of the induction of enzyme activities 
(table 5-16) also showed total inhibition both in microsomal activity 
and in activity/nmol P-450 (table 5-17).
As a final demonstration of protein synthesis inhibition a study of 
5-aminolaevulinate synthetase was performed. This is the rate-limiting 
enzyme of haem biosynthesis, with a half-life of 1-2 hours. It is 
controlled by negative-feedback and responds rapidly to inducing
128
Table 5-12 Effect of cycloheximide on the induction of
cytochrome P-448 by 3-methylcholanthrene
Male Wistar-albino rats received an ip injection of cycloheximide 
(2mg/kg), 30 minutes prior to an ip injection of 3-methylcholanthrene 
(25mg/kg). Controls received an equal volume of vehicle i.e. saline 
(2mg/kg) and/or corn-oil (5ml/kg). The animals were killed 20 hours 
after the final injection and washed liver microsomes prepared. All 
assays were carried out on freshly-prepared microsomes.
Values shown are mean + SEM for 6 animals 
(* P <0.05 from control)
Cytochrome b5 Cytochrome P-450 \^max
(nmol/mg protein) (nmol/mg protein) (nm)
Control 0.56 + 0.04 0.75 + 0.06 449.2
3-Methylcholanthrene 0.55 + 0.02 1.02 + 0.03 * 448.0
Cycloheximide 0.61 + 0.03 0.69 + 0.04 449.4
Cycloheximide +
3-Methylcholanthrene 0.59 + 0.04 0.70 + 0.05 448.7
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Table 5-15 Effect of cycloheximide on the induction of
microsomal cytochromes by phenobarbitone
Male Wistar-albino rats received an injection of cycloheximide 
(2mg/kg.ip), 30 minutes prior to an injection of phenobarbitone 
(8Qmg/kg.ip). Controls received an equal volume of vehicle; i.e. 
saline (2ml/kg or 4ml/kg). The animals were killed 20 hours after 
the final injection and washed liver microsomes were prepared.
All assays were carried out using fresh microsomal preparations. 
Values shown are mean + SEM (t-test; * P<0.05 from control).
Cytochrome b5 Cytochrome P-450 A  max
(nmol/mg protein) (nmol/mg protein) (nm)
Control 0.60 + 0.04 0.98 +0.01 449.3
Phenobarbitone 0.54 + 0.06 1.61 + 0.14 * 449.3
Cycloheximide 0.51 + 0.03 0.72 + 0.10 449.3
Cycloheximide + 0.48 + 0.03 0.66 + 0.02 * 449.5
phenobarbitone
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Table 5-18 Induction of 5-aminolaevulinate synthetase 
following a single injection of either 
phenobarbitone or 3-methylcholanthrene
Male Wistar-albino rats were starved for 24 hours before death, and 
received a single ip injection of either phenobarbitone (80mg/kg) 
or 3-methylcholanthrene (25mg/kg) at various times before death.
A 30% w/v liver homogenate was made in 40mM Tris-HCL,8mM EDTA buffer 
pH.7.3. Each value represented the mean + SEM for 3 assays.
(t-test: *P-<0.05 from zero time) .
Time (h)
0
3
5
7
9
12
15
18
22
5-aminolaevulinate synthetase 
(nmol 5-ALA/min/g.liver)
PB
1.6 + 
1.6 + 0.2
4.3 + 0.3 *
3.6 + 0.2 *
6.8 + 0.6 *
5.8 + 1.8 *
14.7 + 3.8 *
10 . 0 + 1.2 *
9.6 + 0.3 *
3-MC
0.2
2.7 + 0.3 *
2.3 + 0.3 *
2.7 + 0.3 *
4.1 + 0.3 *
5.2 + 1.1 *
7.9 + 1.0 *
7.2 + 0.8 *
3.1 + 0.4 *
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Table 5-19 5-Aminolaevulinic acid synthetase activity
following cycloheximide treatment
Male Wistar-albino rats were starved for 24 hours before death, 
and received either an ip injection of cycloheximide (2mg/kg)
30 min prior to treatment with either phenobarbitone (SOmg/kg) or 
3-methylcholanthrene (25mg/kg). Control animals received an equal 
volume of saline, which was followed 30 min later by treatment with 
inducing agents as above or corn oil. The animals were killed 
2Oh after the last injection.
Treatment 5-ALA-synthetase
(nmol 5-ALA/min/g.liver)
Control
Phenobarbitone
Cycloheximide +
Phenobarbitone
Methylcholanthrene
Cycloheximide +
Methylcholanthrene
Values given as Mean + SEM for three animals. 
Limit of assay = 0.5 nmol 5-ALA/min/g.liver.
8.4 + 0.8
Not detected
6.2 + 0.7
Not detected
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agents, but under conditions of protein synthesis inhibition the 
activity would fall rapidly, with an equally rapid rise to elevated 
levels upon cessation of inhibition.
Table 5-18 shows that 5-aminolaevulinate synthetase activity increases 
rapidly following administration of phenobarbitone or 3-methylcho- 
lanthrene, with increased levels maintained at 22 hours. However, 
after administration of cycloheximide (table 5-19) 5-aminolaevulinate 
synthetase activity was undetectable 20 hours after co-administration 
of inducing agents.
DISCUSSION
The appearance of cytochrome.P-448 following the administration of 
3-methylcholanthrene has been shown to be independent of protein or 
haem synthesis. The use of cycloheximide pretreatment inhibits 
'de novo1 protein synthesis at the translational stage preventing 
the use of both existing m-RNA and m-RNA formed in response to the 
treatment. Cycloheximide not only inhibits the synthesis of 
apocytochrome P-450, but also inhibits haem synthesis by preventing 
the synthesis of 5-aminolaevulinic acid synthetase, the rate-limiting 
enzyme of haem biosynthesis which has a half-life of 1-2 hours, 
(Tschudy, Marver and Collins, 1965). The induction of cytochrome 
P-450 is probably not rate-dependent upon the synthesis of haem 
(lonnides and Parke, 1976), but the short half-life of 5-aminolaevu-. 
linic acid synthetase makes it a useful enzyme to use to monitor the 
inhibition of protein synthesis, as it can be expected to increase 
rapidly within 2 hours of inhibition ceasing, it is thus possible to 
state with certainty that protein synthesis was effectively inhibited 
throughout the time period described in the experiments.
Cycloheximide prevented the induction of cytochrome P-450 by pheno­
barbitone, and prevented the induction, but not the appearance, of 
cytochrome P-448 with its characteristic enzyme activities, following 
3-methylcholanthrene treatment.
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These results confirm the results of previous studies in which 
cytochrome P-448 has appeared during inhibition of protein synthesis 
(Kitchin and Woods, 1978; Alvares, Parli and Mannering, 1973;
Kahl et al, 1977), without the previous criticism that protein 
synthesis inhibition may have been incomplete.
The use of inhibitors acting upon different stages of protein 
synthesis showed that d-amànitin at the dosage given (0.5mg/kg) 
did not inhibit induction of cytochrome P-448, however, a higher 
dosage may have resulted in animal deaths as this is a powerful toxin.
The results from actinomycin-D pretreatment are essentially the same 
as those from cycloheximide pretreatment. Although there was a non­
significant increase in cytochrome P-448 concentration with 
actinomycin-D treatment, this may represent the initial utilisation 
of existing messenger-RNA in response to the inducing agent.
Studies of the spectrophotometric appearance of cytochrome P-448 . 
shows that the hypsochromic shift progresses linearly with time 
and can be observed easily within 9 hours of treatment with
3-methylcholanthrene. The rapid appearance of cytochrome P-448, 
before sufficient time for a "genetically new" apocytochrome to be 
synthesised suggests that cytochrome P-448 is a modified form of the 
existing apocytochrome. This is supported by the inhibition studies.
Therefore, whilst it is unlikely that cytochrome P-448 is an entirely 
new protein, the existence of a cytochrome in untreated animals 
(especially foetal and neonatal) with similar spectral characteristics 
must be borne in mind. There is no evidence to assume that normal 
cytochrome P-448 and carcinogen-induced cytochrome P-448 are similar 
molecular structures, or indeed different structures. Carcinogen- 
induced cytochrome P-448 may result from a complex with carcinogen 
metabolites, as suggested by some studies (Sato et al, 1979; Hashimoto 
and Imai, 1976) and opposed by others (Fujita and Mannering, 1971) , 
or the change may be in other than the apoprotein-haem structure.
The possibilities for these changes include the carbohydrate moieties 
of the apoprotein (cytochrome P-450 is synthesised as a haemoglyco- 
protein), and the fluid state of the membrane lipid environment.
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Halogenated Phenols as enzyme inhibitors
A number of halogenated phenols have recently been reported to 
inhibit the mixed-function oxidase system. Hexachlorophene 
(2,2*-methylenebis 3,4,6-trichlorophenol ), significantly prolongs 
hexobarbital-sleeping time in rats (Condie and Buhler, 1979). 
Hexachlorophene produces a type-I binding spectrum with cytochrome 
P-450, and the inhibition of drug metabolism increased with 
increasing pre-incubation times. A high-affinity binding to 
cytochrome P-450 is thought to exist, and a reactive metabolite 
is covalently bound to microsomal protein (Miller, Henderson, 
and Buhler, 1978).
Chlorophenol pesticides also inhibit drug oxidation.
Pentacholorophenol uncouples mitochondrial phosphorylation 
(Weinbach, 1954), and inhibits the N-demethylation of N,N- 
dimethylaniline (Arrhenius et al, 1977) whilst stimulating 
N-oxygenation. This effect may be comparable to the stimulation 
of N-oxygenation by 2-acetylaminofluorene, which results in the 
production of the carcinogenic metabolite (Malejka-Giganti et al,
1978) .
Free radicals in biological oxygenations
Oxygen radicals (superoxide, hydroxyl) have been implicated in a 
number of biological systems, but their detection remains difficult 
(Bors et al, 1978).
Hydroxyl radicals have been demonstrated in a purified NADPH-cytochrome 
c(P-450) reductase system, using spin-trap methods (Lai, Grover and 
Piette, 1979). These radicals may initiate a free radical chain 
reaction within the endoplasmic reticulum (Dahle, Hill and Homman, 1962).
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Studies by Lai, Grover and Piette (1979) demonstrated that the 
hydroxyl radical was indirectly produced from superoxide anions 
generated during the oxidation of NADPH.
Further evidence of the presence of hydroxyl radicals has been 
reported (Cohen and Cederbaum, 1979), and hydroxyl radical scavengers 
have been shown to inhibit microsomal drug-oxidation (Cederbaum, 
Dicker and Cohen, 1978) . Hydroxyl radical production in a purified 
system was reported by Ohnishi and Lieber (1978), who concluded 
that hydroxyl radicals, but not superoxide anions, participate 
directly in the oxidation of ethanol.
Superoxide anions are produced by the mixed-function oxidase system 
probably by the reduced cytochrome P-450 oxygenated complex (Auclair, 
DeProst and Hakim, 1978; Estabrook et al, 1978).
Microsomal Lipid Structure and Electron Transport
It has been suggested that lipids form rigid haloes around the mixed- 
function oxidation system, with fluid areas interspacing the haloes 
(Stier, Kuhle and Rosen, 1977). As the lipid is in a metastable 
state, it may influence coupling of the units of the multienzyme 
complex (Stier, 1976). In the coupled state, the flavoprotein can 
be assumed to act predominantly as a cytochrome P-450 reductase, and 
the cytochrome as the terminal hydroxylase, whereas in the uncoupled 
state the flavoprotein could act as a hydroxylase (Aust, Roerig and 
Pederson, 1972) and the cytochrome as a peroxidase (Kadlubar, Morton 
and Ziegler, 1973).:
Drugs and carcinogens may affect the dynamics of enzyme coupling, 
and, together with uncoupling agents, may cause changes in drug 
metabolism due to the uncontrolled production of free radicals giving 
rise to non-specific reactions.
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RESULTS
The effects of hexachlorophene, pentachlorophenol and radical 
scavengers upon the properties of microsomal cytochrome P-450 
from control and induced rats were studied. The aim of the studies 
was to attempt to evaluate the importance of enzyme coupling in 
induced animals.
Hexachlorophene
Hexachlorophene was found to inhibit ethylmorphine N-demethylation 
(table 6-1) in a similar manner to that reported for other cytochrome 
P-450 mediated reactions. At the highest concentration studied 
(400 /iM), the inhibition was strongest in carcinogen-induced microsomes, 
with only 1-5% of the unhibited reactivity. Phenobarbitone-induced 
microsomes were also strongly inhibited ( 15% residual activity),
whereas control microsomes were least inhibited ( 35% residual
activity).
Hexachlorophene did not inhibit ethoxycoumarin 0-deethylation 
(table 6-2), as strongly as ethylmorphine N-demethylation. Table 
6.2 shows that even at 400 the reaction was only partially 
inhibited in induced microsomes. At the lowest concentration 
(100 ^LiM) , hexachlorophene appeared to stimulate enzyme activity in 
some of the induced animals.
The hydroxylation of biphenyl was affected in varying ways by 
hexachlorophene (table 6-3). Biphenyl 4-hydroxylase was stimulated 
in control microsomes, but unaffected in induced microsomes. Biphenyl 
2-hydroxylase was slightly inhibited in control microsomes, partially 
inhibited in phenobarbitone-induced microsomes, and slightly inhibited 
in carcinogen-induced microsomes. These results were unexpected for 
reactions that are supposedly mediated by hepatic cytochromes.
Hexachlorophene was shown to inhibit ethylmorphine N-demethylase 
(a P-450 reaction), particularly where cytochrome P-448 was 
predominant. Inhibition of ethoxycoumarin O-deethylase (a P-448 reaction)
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Table 6-1 Effect of hexachlorophene on the activity
of ethylmorphine N-demethylase in vitro
Male Wistar-albino rats were starved for 24h and then received an
ip injection of either phenobarbitone (80mg/kg), 3-methylcholanthrene
(25mg/kg), or safrole (75mg/kg), for three consecutive days. Control
animals received equal volumes of vehicle. The animals were killed
24h after the final injection and hepatic microsomes prepared in
STKM No.2 buffer containing 0.25M sucrose, 40mM Tris, 5mM MgCl9
2 /
150mM KC1 pH 7.4. Hexachlorophene was added to the enzyme assays in 
50 p.1 acetone to give the final concentration indicated.
Ethymorphine N-Demethylase 
(nmole HCHO/nmol P-450/h)
Hexachlorophene (^iM) : 0 100 200 400
Treatment
Control 351,304 313,292 140,115 131,99
Phenobarbitone 219,292 142,186 78,99 31,51
Methylcholanthrene 193,200 86,101 32,32 3,1
Safrole 464,367 237,189 122,88 12,21
Values are for two animals.
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Table 6-2 Effect of hexachlorophene on the activity
of ethoxycoumarin O-deethylase in vitro
Experimental details as described in table 6-1.
Ethoxycoumarin O-deethylase. 
(nmol/nmol P-450/h)
Hexachlorophene concn.(pM): O 100 200
Treatment
Control 57,80 71,73 38,51
Phenobarbitone 20,23 24,28 23,23
Methylcholanthrene 115,119 116,145 114,141
Safrole 154,163 152,191 142,160
/
Values are results for two animals.
400
10,18
7,11
29,83
91,94
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was demonstrated in P-450 containing microsomes only. This may 
indicate that either a) hexachlorophene does nof bind to cytochrome 
P-448, or b) that the activity of cytochrome P-448 does not evolve 
from the cytochrome itself.
The studies of biphenyl hydroxylation complicate interpretation as 
the P-450 reaction (4-hydroxylase) was not inhibited, whereas the 
P-448 reaction (2-hydroxylase) was partially inhibited.
Pentachlorophenol
Studies with pentachlorophenol showed it to inhibit ethylmorphine 
N-demethylation and ethoxycoumarin O-deethylase in both control and 
phenobarbitone-induced microsomes (table 6.4). Ethylmorphine N- 
demethylation was also inhibited in carcinogen-induced microsomes, 
however, ethoxycoumarin O-deethylation was less strongly inhibited, 
and showed signs of a possible stimulation at 0.25mM pentachloro­
phenol in methylcholanthrene-induced microsomes. At the highest 
concentration of pentachlorophenol, ethyoxycoumarin O-deethylase was 
95% inhibited in cytochrome P-450 microsomes, but only 65-70% 
inhibited in cytochrome P-448 microsomes. This indicates the 
heterogeneity of ethoxycoumarin O-deethylation, which is only 30% 
dependent upon cytochrome P-450 in carcinogen-induced animals.
Studies of the inhibition of biphenyl hydroxylation (table 6-5) 
showed that 4-hydroxylation was inhibited by approximately 50% in 
all treatment groups, whereas 2-hydroxylation was inhibited by 
60-65% in the P-450 containing microsomes, and inhibited by 40-45% 
in the P-448 containing microsomes.
Both chlorinated phenols appeared to inhibit cytochrome P-450- 
mediated reactions more strongly than cytochrome P-448-mediated 
reactions. In addition, there were signs of stimulation of activity 
in methylcholanthrene-treated microsomes and further studies were 
performed to investigate this phenomenon.
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Pentachlorophenol: Inhibition kinetics
The inhibition by pentachlorophenol of ethoxycoumarin was studied, 
and double-reciprocal (Lineweaver-Burke) plots obtained. In control 
microsomes (figure 6-6), the pattern at the lower inhibitor 
concentrations resembles that of non-competitive inhibition, but at 
the highest concentration an anomalous plot is obtained with the 
intersect of the ordinate below the abscissa. In phenobarbitone- 
indiiced microsomes (figure 6-7) the pattern again resembles non­
competitive inhibition, with an identical anomalous plot at the 
highest inhibitor concentration. Methylcholanthrene-induced 
microsomes gave plots that were not readily analysable; however, the 
anamalous plot was again present. It is of interest to note that 
these three anomalous plots are identical within the accuracy of each 
experiment. This may indicate that a second enzyme system, not 
inhibited by pentachlorophenol, is responsible for the residual 
level of activity. However, pentachlorophenol may effectively 
represent an irreversible inhibitor, in which case Michaelis-Menten 
kinetics are not applicable, a situation that recalls the warning 
of Dixon and Pouts (1962).
To determine the apparent dissociation constant (Ki) of the
inhibitor, the results were replotted. The graphs revealed that
there was little difference in the Ki for control and phenobarbitone-
microsomes (figures 6-9, 6-10), but for methylcholanthrene-microsomes
non-linear graphs were obtained (Figure 6-11). The pattern suggests
/
that the rate of reaction at the lower inhibitor concentrations is 
higher than should be expected. This may be due to uncoupling of 
microsomal electron transport (Arrhenius et al, 1977) leading to a 
non-specific activity mediated from the flavoprotein.
It was decided to compare the results from carcinogen-induced microsomes 
with those containing natural cytochrome P-448.
)
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Figure 6-6 Double-Reciprocal plot showing effect of Pentachloro­
phenol on Ethoxycoumarin O-deethylase in hepatic microsomes from 
control male rats.
(A= OmM PCP, Q= 0.25 mM PCP, ■= 1.25 mM PCP, #= 2.5 mM PCP)
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Figure 6-7 Double-Reciprocal plot showing effect of Pentachloro­
phenol on Ethoxycoumarin O-deethylase in hepatic microsomes from 
phenobarbitone-treated male rats.
( ▲= OmM PCP, 0 =  0.25 mM PCP, ■ =  1.25 mM PCP, * =2.5  mM PCP)
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Figure 6-8 Double-Reciprocal plot showing effect of Pentachloro­
phenol on Ethoxycoumarin O-deethylase in hepatic microsomes from 
methylcholanthrene-treated male rats.
( A= OmM PCP, O  = 0.25 mM PCP, ■= 1.25 mM PCP, •= 2.5 mM PCP)
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Figure 6-9 Change in Ethoxycoumarin O-deethylase with change in 
inhibitor concentration at various substrate concentrations, in 
hepatic microsomes from control rats.
(Concentration of substrate: Q= 0.8 mM , 0 = 1.2 mM )
)
A= 1.6 mM , • = 2.0 mM )
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Figure 6-10 Change in Ethoxycoumarin O-deethylase activity with 
change in inhibitor concentration at various substrate concentrations, 
in hepatic microsomes from phenobarbitone-treated rats.
(Concentrations of substrate : O = 0.8 mM , N = 1.2 mM )
)
A = 1.6 mM / •= 2.0 mM )
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Figure 6-11 Change in Ethoxycoumarin O-deethylase activity with 
change in inhibitor concentration at various substrate concentrationsf 
in hepatic microsomes from methylcholanthrene-treated rats.
(Concentrations of substrate: O = 0.8 mM , ■ = 1.2 mM )
)
A= 1.6 mM , # =  2.0 mM )
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Pentachlorophenol: Inhibition in female microsomes
It was found that pentachlorophenol strongly inhibited ethylmorphine 
N-demethylase in female microsomes (table 6-12). Ethoxycoumarin 
O-deethylase was also inhibited, but less strongly in methylcholanthrene- 
induced microsomes.
Biphenyl 4-hydroxylase (table 6-13) was unaffected by the lowest 
concentration of pentachlorophenol in both control and methyl­
cholanthrene-treated microsomes, whereas there was 50% inhibition in 
phenobarbitone-treated microsomes. Biphenyl 2-hydroxylase was 50% 
inhibited in control and phenobarbitone-microsomes, but was unaffected 
in methylcholanthrene-microsomes.
In pregnant female rats, biphenyl hydroxylation was too low for 
accurate measurement. Ethylmorphine N-demethylase (table 6-14) was 
lower than in non-pregnant controls and was very strongly inhibited 
in all treatment groups. Ethoxycoumarin O-deethylase was only 
slightly inhibited at the lowest concentration of inhibitor, and 
inhibition at higher^concentrations was not as effective as in non­
pregnant animals.
Kinetic studies of the inhibition of ethoxycoumarin O-deethylase in 
pregnant rats gave anomalous non-interpretable results for both 
control (figure 6-15) and phenobarbitone-induced microsomes (figure 
6-16). Studies on methylcholanthrene-induced microsomes (figure 6-rl7) 
gave two pairs of parallel plots, similar to those obtained with male 
methylcholanthrene-induced microsomes (figure 6-8).
These results tend to indicate that whilst cytochrome P-450 mediated 
reactions are inhibited, the kinetics are not accountable for by 
Michaelis-Menten equilibria, which could be indicative of uncoupling 
of the terminal oxidase under certain conditions.
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Figure 6-15 Double-Reciprocal plot of effect of Pentachlorophenol 
on Ethoxycoumarin O-deethylase in hepatic microsomes from control 
pregnant female rats.
( ▲= OmM PCP, 0= 0.25 mM PCP, ■= 1.25 mM PCP, *= 2.5 mM PCP)
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Figure 6-16 Double-Reciprocal plot of effect of Pentachlorophenol 
6n Ethoxycoumarin O-deethylase in hepatic microsomes from 
phenobarbitone-treated pregnant female rats.
( ▲= 0 mM PCP, O = 0.25 mM PCP, ■ = 1.25 mM PCP, # = 2.5 mM PCP)
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Figure 6-17 Double-Reciprocal plot of effect of Pentachloro­
phenol on Ethoxycoumarin 0~deethylase in hepatic microsomes from 
methylcholanthrene-treated pregnant female rats.
( ▲= O mM PCP, 0= 0.25 mM PCP, E = 1.25 mM PCP, # = 2.5 mM PCP)
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Effect of Pentachlorophenol on substrate binding
A series of studies with induced microsomes were carried out on 
substrate binding, using a C a r y —Varian 272 spectrophotometer with 
microprocessor-controlled baseline correction.
Pentachlorophenol was found to produce a type-I binding spectrum 
with both phenobarbitone and phenobarbitone-induced microsomes 
(figure 6—18) but without a peak at 380—390 nm. The apparent binding 
affinity to phenobarbitone-induced microsomes being higher than for 
methylcholanthrene-induced microsomes (figure 6-19).
The binding spectra of ethylmorphine to induced microsomes (figure 6-20) 
was obtained, and further studies involved measurement of the trough- 
peak absorbance at the wavelengths thus obtained. It was noted that 
the two spectra exhibited differences of wavelengths at peak and 
trough which would lead to errors if not checked.
The binding constant (Ks) of ethylmorphine with phenobarbitone- 
microsomes (figure 6-21) is little changed by pentachlorophenol, 
although the binding spectrum is decreased. With methylcholanthrene- 
microsomes (figure 6-22) thé Ks is lower than for phenobarbitone- 
microsomes, but the addition of pentachlorophenol increases it to a 
level comparable to phenobarbitone-microsomes.
The binding spectra of 7—ethoxycoumarin to phenobarbitone-microsomes 
(figure 6-23) is little changed by the addition of pentachlorophenol, 
whereas that with methylcholanthrene-microsomes (figure 6-24) is much 
decreased. Further study showed that the Ks of binding to 
phenobarbitone-microsomes was decreased in the presence of penta­
chlorophenol (figure 6-25), whereas with methylcholanthrene-microsomes 
(figure 6-26) the Ks was increased by 0.2mM and decreased by 0.5mM 
pentachlorophenol. This correlates with the observed stimulation of 
ethoxycoumarin O-deethylase activity shown previously.
The differences in the substrate-binding spectra suggest that the 
reaction with methylcholanthrene-induced microsomes is different to 
that with phenobarbitone-induced microsomes. This difference may lie
162
♦ 0,02
450
-0,02,
Figure 6-18 Spectrum of Pentachlorophenol binding to microsomal 
membranes
Microsomal membranes from animals treated with inducing agents were 
prepared by the usual methods. Aliquots were stored frozen at -20°C, 
and thawed immediately before use. Binding spectra were obtained using 
a Cary-Varian spectrophotometer with microprocessor-controlled baseline.
The figure shows traces obtained with phenobarbitone- (---- ) and
methylcholanthrene-treated (-----) microsomes in the presence of 300 uM
pentachlorophenol.
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Figure 6-20 Binding spectrum of Ethylmorphine to 
microsomal membranes
Microsomal membranes were prepared as per usual methods, and the 
binding spectrum obtained using a Cary-Varian spectrophotometer 
with 200 /iM ethylmorphine.
Phenobarbitone microsomes -------
Methylcholanthrene mircrosomes -------
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Figure 6-23 Binding spectra of ethoxycoumarin to phenobarbitone-
treated microsomes in the presence and absence of 
pentachlorophenol
Experimental details as for figure 6-21.
Control------  ; PcP-------
aFigure 6-24 Binding spectra of ethoxycoumarin to methylcholanthrene- 
treated microsomes in the presence and absence of 
pentachlorophenol
Experimental details as for figure 6-21.
Control ----- ; PcP------
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within the differences in the induced cytochromes, or in differences 
within membrane-cytochrome ultrastructure.
, ' f
Oxygen Radicals in Drug Metabolism
Thiourea and dimethylsulphoxide (DMSO) were used as hydroxyl radical 
trapping agents, and superoxide dismutase (SOD) was used to demonstrate 
the importance of superoxide anions and hydrogen peroxide.
In control microsomes (table 6-27), superoxide dismutase had no 
effect upon ethylmorphine and ethoxycoumarin metabolism, but slightly 
inhibited biphenyl hydroxylation. The hydroxyl radical scavengers 
inhibited all reactions by 20-60%.
In phenobarbitone-induced microsomes (table 6-28), superoxide 
dismutase again had no effect, whilst the hydroxyl radical scavengers 
inhibited most reactions, but caused a 10-25% increase in ethoxy­
coumarin O-deethylase. Thiourea and DMSO were tested with methyl- 
chdlanthrene-inducêd microsomes (table 6-29), and inhibited most 
reactions, however, thiourea stimulated ethoxycoumarin O-deethylase 
by 15%.
The stimulation observed in these cases was not statistically 
significant, but is comparable to the stimulation observed with 
pentachlorophenol.
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DISCUSSION
Hexachlorophene and pentachlorophenol were both shown to inhibit 
microsomal enzyme activities, but the effect varied according to 
the enzyme studied and the source of the microsomes. . The inhibitory 
effects generally correlated with the amount of cytochrome P-450 
present, rather than P-448; and also the inhibitory effect was greater 
in microsomes having the lower original activity.
The pattern may reflect the action of the inhibitor and the relative 
importance of different parts of the drug-metabolising system in 
oxidation reactions.
Developmental studies in the ferret have shown that different enzymes 
develop in parallel with different components of the system. 
Ethylmorphine N-demethylase parallels cytochrome P-450 content, and 
was shown to be strongly inhibited by pentachlorophenol.
Ethocycoumarin 0—deethylase was strongly inhibited in the cytochrome 
P-450 containing microsomes but not in the P-448-microsomes.
Biphenyl 4-hydroxylase which develops parallel to cytochrome c-reductase, 
was only moderately inhibited by pentachlorophenol.
If cytochrome P-450 were a universal terminal oxidase, it would be 
assumed that all the enzyme reactions studied would be inhibited 
equally by pentachlorophenol. The comparative differences in 
inhibition, together with the developmental aspects, tend to suggest 
that the cytochrome is not the only possible terminal oxygenase.
It is possible that uncoupling of the microsomal electron transfer 
chain occurs as well as direct binding inhibition of the cytochrome.
This could result in other components,such as the flavoprotein 
reductases, acting as a non-specific oxygenase with certain substrates, 
or may result in increased production of free oxygen radicals which 
could give non-enzymatic oxidation.reactions.
The production of superoxide radicals by the mixed-function oxidase 
system and the subsequent generation of hydroxyl radicals was discussed 
in chapter 1. It was found that superoxide dismutase did not inhibit 
or stimulate the reactions studied, with the exception of biphenyl 
4-hydroxylase in control microsomes. With this one exception, there
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is little evidence that superoxide anions are themselves involved 
directly in oxidation reactions.
r
Hydroxyl radical scavengers inhibited all the reactions studied, 
with the exception of ethoxycoumarin O-deethylase in phenobarbitone- 
and methylcholanthrene-induced microsomes. In these cases, a 
stimulation of 10-20% was observed. The results suggest that 
hydroxyl radicals may play some role in oxidation reactions in both 
control and induced microsomes. The results with ethoxycoumarin 
O-deethylase, together with the previously described results, suggest 
that this reaction is ,mechanistically different from the other 
reactions studied, and it is possible that trapping the hydroxyl 
radicals has led to the accumulation of other species which can react 
chemically with the substrate.
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Chapter 7
A  C o n s id e ra tio n  o f C a rc in o g e n e s is  and the ro le  o f M e m b ra n e
C o m p o n en ts
Metabolic activation of carcinogens by cytochrome P-450
Chemical carcinogens include a wide variety of structurally unrelated 
compounds, and therefore the exact mechanisms of carcinogenesis must 
also be varied.
Direct alkylating agents, such as the nitrogen mustards, may alkylate
the amino- and hydroxyl- substituents of the nucleic acid bases by
S.-l or S„2 reaction mechanisms, but are a reactive minority N N
(Hathaway, 1979). Alkylating agents may be produced 'in vivo1 from 
many other carcinogens (Grover and Sims, 1973), but after many studies, 
the relevance to tumorigenicity has yet to be proven.
If the physiological function of the drug-metabolising enzymes is to 
detoxify foreign compounds, then enhanced toxicity/activation would be 
relatively uncommon. Direct alkylating agents have been reported to 
inhibit drug metabolising enzymes, but many carcinogens induce their
Z
own metabolism to the active form, for example, 2-acetylaminofluorene 
(Felton, Nebert and Thorgeirsson, 1976). The activity of benzo(a)pyrene 
hydroxylase is induced by various aromatic carcinogens and also 
phenobarbitone. However, with phenobarbitone the activity is enhanced 
mainly in the microsomal fraction rather than in the nucleus, whereas 
hydrocarbon inducing agents cause an initial rise in activity in the 
nucleus which is greater than that in the microsomal fraction (Viviani, 
Lutz and Schlatter, 1978). This may be due to differences in rates 
of protein metabolism, but may also be due to different target receptors 
in these fractions.
The activation of benzo(a)pyrene has been greatly studied, and will be 
used as an example, although it is not representative of many types 
of carcinogen.
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The metabolism of benzo(a)pyrene may proceed via an epoxide to 
mercapturic acid derivatives (Knight and Young, 1958), a dihydrodiol 
(Sato et al, 1963), a phenol and sulphate and glucuronide conjugates. 
The 1K-region1 oxides of benzo(a)pyrene and benz(a)anthracene were 
shown to be highly reactive and caused malignant transformations in 
cultured cells (Grover et al, 1971) but had little activity in 
'vivo' (Levin et al, 1976). Subsequent studies showed that the
7,8-oxide was also carcinogenic, and the 7,8-dihydrodiol even mpreso. 
Reduction of the 9,10 bond of the 7,8-oxide or 7,8-dihydrodiol 
resulted in complete loss of carcinogenicity (Levin et al, 1977b).
The 7,8-oxide is itself reactive and may damage the endoplasmic 
reticulum, initiating the changes seen after carcinogen treatment 
e.g. degranulation. However, the membranes also contain various 
enzymes which can inactivate epoxides by various means and thus help 
maintain membrane integrity. One of these enzymes, epoxide hydratase, 
can convert the 7,8-oxide into the 7,8-dihydrodiol, thus increasing 
the tumorigenicity. Furthermore, the 7,8-dihydrodiol may be further 
metabolised by cytochrome P-448 to the 7,8-diol-9,10 epoxide 
(Chap.1, fig.1-4) which is not a substrate for the epoxide-inactivating 
enzymes due to steric hindrance at the 9,10 position.
It could be expected that epoxidation at the 9,10 position would also 
be sterically hindered, but whilst this is the case with cytochrome 
P-450 it is not the case with cytochrome P-448. This suggests that 
different oxidation mechanisms may be involved, and certainly that 
the cytochrome active sites differ.
The results of Thakker et al (1977) and Yang, Roller and Gelboin (1977), 
show that epoxide formation catalysed by the P-450 mono-oxygenase 
system is stereoselective and that different P-450 isoenzymes formed 
upon pre-treatment of rats with methylcholanthrene have stereo- 1. . 
selectivities different from those isoenzymes from untreated or 
phenobarbitone-treated rats. The different steroselectivities may 
be indicative of the different active sites of the cytochromes involved.
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It is of interest to note that the 9,10-oxidation of the
7,8-dihydrodiol can only'be performed by cytochrome P-448, as this 
is predominantly found after pretreatment with carcinogens, and 
thus the activation of benzo(a)pyrene may be considered to be self­
induced. It is thus comparable to the activation of 2-acetylamino­
fluorene, although the type of metabolism differs.
Epoxide-inactivating enzymes
Epoxidation is a common procedure in metabolic transformations 
(Reviewed by Garner, 1976) , and is concerned in the biological activation 
of both drugs and carcinogens. Epoxides are highly reactive compounds 
which react with nucleophiles, some being readily hydrolysed to give 
trans-diols, whereas others are substrates for hydration by the 
enzyme, epoxide hydratase (Oesch, 1973).
Epoxide hydratase is found in the microsomal membranes and hydrates 
epoxides to trans-diols (Oesch and Daly, 1971). Although epoxide 
hydratase may remove mutagenic epoxides, it may also provide the 
precursors of the highly mutagenic dihydrodiol-epoxides. Epoxide 
hydratase can be induced in rats by prior treatment with inducing 
agents (Oesch, Jerina and Daly, 1971). The role played by epoxide 
hydratase thus varies according to the route of metabolism. In 
untreated and phenobarbitone-treated animals, the main mutagenic 
metabolite of benzo(a)pyrene is the 'K-region* 4,5-oxide, of which 
epoxide hydratase may markedly reduce mutagenicity (Oesch, Bentley 
and Glatt, 1976). However, in carcinogen-treated animals the 
mutagenicity may be both increased or decreased (Bentley, Oesch and 
Glatt, 1977). In a purified reconstituted cytochrome P-450 system, 
addition of epoxide hydratase decreased the mutagenicity of 
benzo(a)pyrene but increased the mutagenicity of the 7,8-oxide (Wood 
et al, 1976).
A further enzyme system which can affect the tissue concentration of 
epoxides formed during metabolism is the glutathione S—transferases 
(Chasseaud, 1973). Epoxides may react with sulphur-containing proteins 
and may be non-enzymic or enzymically catalysed (Booth, Keysell and 
Sims, 1973; Jerina and Bend, 1977). These S-transferases are mainly
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cytoplasmic basic proteins and have been shown to have very broad 
and overlapping specificities (Jakoby et al, 1976), whilst epoxide 
hydratase is anchored in the membrane lipid, and its catalytic 
properties may therefore be influenced by changes in the lipid 
environment (Lu and Miwa, 1980).
The metabolism of carcinogens usually proceeds by several routes, 
yielding many metabolites. Those reacted with glutathione will be 
converted to premercapturic acids and are excreted in the urine 
(Boyland and Sims, 1965). However, it has been reported that 
glutathione conjugates are not formed in any appreciable quantities 
from benzo(a)pyrene 7,8-bxides and 9,10-oxides (Waterfall and Sims,
1972). A s  these compounds are not readily metabolised by epoxide 
hydratase, there is no readily available means of detoxification 
for the most mutagenic benzo(a)pyrene metabolites.
Reaction of carcinogen metabolites may lead to depletion of the
normal glutathione levels,;particularly as the glutathione S-transferase
system is inducible (Baars, Jansen and Breimer, 1978). Younes and
Siegers (1981) have reported that low levels of glutathione can
lead to spontaneous lipid peroxidation. The results give no
evidence that free oxygen radicals were involved in initiation,
which suggests that other endogenous molecules may be involved.
Microsomal lipid and enzyme function
Lipids form an important part of the cytochrome P-450 mono-oxygenase 
system, and phospholipid is a necessary part of reconstituted 
purified systems. Various studies have suggested that phospholipid 
may be required to maintain cytochrome P-450 in an optimal 
configuration (Ingelman-Sundberg, 1977). Arrhenius plots of mono­
oxygenase activity show breaks at 20-24°C (Yang, Strickhart and 
Kicha, 1979; Duppel and Ullrich, 1976) which are abolished if glycerol 
is added. Non-cytochrome dependent reactions do not show these breaks, 
indicating that the breaks are due to phospholipid phase-transitions 
in the membrane which affects the interrelation of the cytochrome 
with the reductase, since the individual components show no breaks 
in the respective Arrhenius plots. The effects can be explained by 
the lipid halo theory of Stier (1976).
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The exact lipid composition may partly determine enzyme activities 
as exogenous lipids added to the system may inhibit mono-oxygénase 
activity (Abbott and Mannering, 1979). Studies in pregnant female 
rats have shown that the decrease in hepatic microsomal drug 
metabolism accompanies a decrease in membrane total phospholipids, 
and a decrease in the proportion of high-spin cytochrome P-450, 
the proportion of phosphatidyl choline to total lipid decreased 
slightly, whilst the proportion of phosphatidylethanolamine increased 
'(Turcan et al, 1981).
Sex differences in microsomal phospholipids have been correlated with 
differences in drug metabolism (Belina et al, 1975). Changes in the 
phospholipid content has also been described during chemical 
carcinogenesis (Polyakov, 1977), and also after treatment with 
inducing agents (Davison and Wills, 1974). It was found that cholesterol 
content decreased after both phenobarbitone- and methylcholanthrene- 
treatment, and that the proportion of phosphatidyl choline was 
increased by phenobarbitone. Phosphatidyl choline has been noted to 
be the most important phospholipid necessary in reconstituted systems.
Inducing agents also cause changes in the fatty acid components of 
phospholipids. Phenobarbitone treatment resulting in increased 
linoleic acid incorporation into phosphatidylcholine and phosphatidyl­
ethanolamine, with decreased incorporation of oleic and arachidonic 
acids, whilst methylcholanthrene treatment resulted in increased
incorporation of oleic acid (Davison and Wills, 1974).
\
The properties of microsomal membranes are thus likely to differ after 
induction, simply due to phospholipid changes. Some lipids may form 
lamellae of a high fluidity which would allow rapid rotational 
mobility as well as a high rate of lateral diffusion. Other lipids 
may be present in a state of low fluidity where exchange is not so 
readable, and which undergo phase transitions at around 36°C.
Lipids exhibiting this kind of phase transition are associated with 
cytochrome P-450, which appears to impose a high degree of order on 
the attached lipid. The lipid state may determine assemblage of the
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cytochrome P-450 system, as well as the conformation of its components 
(Stier, Kuhnle and Rosen, 1977).
The lipoprotein complex exists in a metastable state at physiological
temperatures and structural changes in the membrane induced by
substrate binding, reduction of the cytochrome, or metabolite binding
might affect the phase equilibrium. As a consequence the subunits
of the oxygenase complex may be coupled or uncoupled (Stier, 1976).
Amongst the agents that may shift the equilibrium or cause alterations
2+in phospholipid metabolism are sex, age, nutritional status, Ca ,
2+Mg and endogenous steroids. The effect of lipids upon the kinetics 
of microsomal oxygenases has been discussed by Crumps, Razzouk and 
Roberfroid (1977) and Lenk (1976).
It is possible that the flavoprotein may act predominantly as a 
cytochrome reductase whilst in the coupled state, whereas in the 
uncoupled state the flavoprotein may provide electrones for non­
specific oxygenation, whilst the cytochrome acts as a peroxidase. 
Interactions with cytochrome P-450 would be different in the two states, 
and thus some of the multiple spectrally differentiated forms of 
cytochrome P-450 may actually represent different conformational 
states of a single cytochrome in coupled and uncoupled states.
Xenobiotics. may influence the phase equilibrium by binding either to 
cytochrome P-450 or to other sites within the membrane. Many of the 
products of phase I metabolism are stronger amphiphiles than the 
original substrate, and are therefore stronger phase-shifting agents. 
Depending upon the interaction with the membrane, product inhibition 
or product activation may occur.
Lipid peroxidation would also affect the coupling of cytochrome with 
reductase and has also been implicated as being responsible for 
ribosome degranulation (Shires, 1978). Studies have shown the 
necessity for cytochrome P-450 to be present for the initiation 
of lipid peroxidation induced by carbon tetrachloride (Masuda and 
Murano, 1978) . Benedetto, Slater and Dianzani (1976) also showed
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that the degree of lipid peroxidation correlated with the cytochrome 
P-450 content of the microsomal fractions. This suggests that lipid 
peroxidation may be initiated by the metabolism of chemicals by 
cytochrome P-450 to a reactive metabolite.
The effects of detergents on microsomal oxygenase function has been 
studied by Lotlikar and Dwyer (1976) using 2-acetylaminofluorene 
as a substrate. Deoxycholate was found to inhibit both C-oxygenation 
and N-oxygenation completely, whereas Triton X-100 inhibited 
C-oxygenation but only partially inhibited N-oxygenation. Of particular 
interest was the finding that the addition of Triton X-100 to a 
reconstituted system, containing Cytochrome P-448, stimulated 
N-oxygenation appreciably more than C-oxygenation.
These results suggest that N- and C-oxygenations are catalysed by 
different enzymes which are affected differently by changes in the 
lipid environment. .
Degranulation
The physical nature of ribosomal binding is complex and was reviewed 
by McIntosh and O'Toole (1976). Divalent cations, the nascent 
polypeptide chain, and specific ribosomal structural proteins appear 
to be involved. Whilst degranulation 'in vitro' can be initiated 
by the manipulation of any of these factors, the cause of degranulation 
'in vivo' is unlikely to be identical.
The differences in ribosomal structural proteins that have some role 
in binding appear to be relatively unaffected by degranulation.
Divalent cation bridges between macromolecules, are disrupted by high 
concentrations of monovalent ions 'in vitro' but under conditions 
unlikely to occur 'in vivo1. It is probable that ribosomal binding 
'in vivo' is determined by a) mRNA, b) ribosomal component proteins, 
c) the nascent peptide, or any combination of these.
Shires (1978) has suggested that degranulation is to some extent 
dependent upon lipid peroxidation initiated by carcinogens. The 
disappearance of the 'rough' membrane 'in vivo' in animals treated
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with agents that promote lipid peroxidation would appear to result 
not from ribosomal detachment, but rather from the inability of free 
ribosomes to reform polysomes on the membranal mRNA. Other studies 
(Lutz and Shires, 1978) suggest that the availability of mRNA to 
cytoplasmic ribosomes is reduced. It would appear that the lipid 
state is important for maintaining ribosomal recombination upon 
mRNA, which is the initial promoter of ribosomal binding.
The mRNA is anchored to the membrane, and ribosomes are drawn towards 
the membrane until they become bound both directly (nascent protein) 
and indirectly (mRNA).
The ribosomal binding proteins of the membrane have been studied by 
Takagi (1977), who describes the possible involvement of cytochrome 
P-450, and by Fujita et al (1977) who described the isolation of an 
R-fraction from solubilised membranes, which was further purified 
into R ^ R g  and R^ fractions. R^ binds polyribosomes and on SDS- 
polyacrylamide gel electrophonesis gave bands at 108,000; 99,000 and 
65,000. Fractions R^ and R^ appear to contain cytochrome P-450 but 
do not bind polyribosomes. The binding of ribosomes to the Re­
fraction was found to be affected by the KC1 concentration.. Other 
workers have described similar membrane proteins (Aulinskas and 
Scott-Burden, 1979; Kreibich, Ulrich and Sabatini, 1978).
Takagi (1977) also showed that partially purified cytochrome P-448 
bound polyribosomes, thus the conversion of cytochrome P-450 to P-448 
is not the direct initiator of degranulation.
Cells of all tissues appear to contain both free and membrane-bound 
polyribosomes, but those organs involved in the manufacture of 
secretory proteins have a greater proportion of their total ribosomal 
population bound to the intracellular membranes. Abundant evidence 
now indicates that most if not all secretory proteins are synthesised 
on membrane-bound ribosomes, whilst the bulk of free ribosomes are 
engaged in the synthesis of intracellular proteins (Redman and Sabatini, 
1966; Redman, 1968 ; Williams and Ganoza, 1970).
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This suggests that the membrane-bound ribosomes may permit the 
transfer of the newly-synthesised protein chains directly from 
the ribosomes to the lumen of the endoplasmic reticulum, and thence 
to the exterior of the cell via the Golgi apparatus. Most secreted 
proteins are linked to carbohydrate residues before leaving the 
endoplasmic reticulum. However, not all proteins synthesised on 
the 1 rough1 membranes are bound for secretion (see review, McIntosh 
and O'Toole, 1976), but the depletion of membrane-bound ribosomes 
will result in a decrease in protein secretion by most animal cells 
and this will in turn lead to altered cell-surface glycoproteins 
and an altered immune response.
Terminal Oxygenase Function and N-oxidation
The idea of cytochrome P-450 as the sole terminal oxygenase 
responsible for all xenobiotic metabolism is now under modification. 
Whilst it is true that cytochrome P-450 is the terminal oxygenase 
for many compounds, it may not be the sole oxygenase.
During induction by carcinogens, the metabolic changes to that of 
the new cytochrome, P-448. However, studies have increasingly 
shown that the observed reactions may be mediated by mechanisms other 
than by a cytochrome.
Chhabra et al (1976), investigated the relationship between the 
induction of aryl hydrocarbon (benzo(a)pyrene) hydroxylase and 
cytochrome P-448 in mice. They found that the enzyme activity 
increased before there was any detectable change in the reduced 
cytochrome P-450-CG spectrum. Together with the experiments presented 
earlier, this suggests that a change can occur rapidly that is not 
dependent upon protein synthesis.
Several studies have indicated that the sulphydryl groups of cytochrome 
P-450 are essential for maintaining its structural integrity and 
activity, and it has been suggested that the sixth ligand of the haem 
moiety is a mercaptide.
Kawalek et al (1977), however, found that sulphydryl groups were not 
required for0the catalysis of benzo(a)pyrene hydroxylation in a
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reconstituted system using rat cytochrome P-448. The multiplicity 
of cytochromes studied makes it difficult to reach conclusions 
regarding the role of sulphydryl groups in all oxidation reactions, 
however, it can be seen that a simple structural modification of the 
cytochrome can affect catalysis.
Whilst the cause of altered hydroxylation patterns can only be 
surmised at present, with the aid of specific inhibitors it is 
possible to distinguish differences in the inhibition patterns of 
cytochromes P-450 and P-448. Recently, inhibition studies have been 
reported using agents that appear highly specific for cytochromes 
P-450 and P-448 e.g. ellipticines (Lesca et al, 1979), hexachlorophene 
(Miller, Henderson and Buhler, 1978), and other chlorinated phenol 
derivatives (Condie and Buhler, 1979). Hexachlorophene bound strongly 
to cytochrome P-450, did not affect NADPH-cytochrome-c reductase 
activity and strongly inhibited both aminopyrine N-demethylase and 
aniline hydroxylase activities (Condie and Buhler, 1979).
Pentachlorpheno1 was shown to uncouple cytochrome P-450 from the 
reductase (Arrhenius et al, 1977) with a concomitant decrease in 
C-hydroxylation and increase in N-hydroxylation of N,N-dimethylaniline. 
These results should be considered with similar results obtained by 
the addition of Triton X-100 to a reconstituted mono-oxygenase 
system (Lotlikar and Dwyer, 1976). In both cases it is possible that 
the common factor is a disturbance of the coupled state of the 
cytochrome with its reductase. The resultant increase in N-oxygenation 
should be noted in view of the evidence that aromatic amines are 
activated to the ultimate carcinogen via N-hydroxylation.
It is generally accepted that primary amines are oxidised by 
cytochrome P-450, whilst secondary and tertiary amines are oxidised 
by the mixed function amine-oxidase system (Ziegler and Mitchell, 1972; 
Coutts and Beckett, 1977). N-demethylation reactions are assumed to 
be catalysed by cytochrome P-450 mediated oxidation of the carbon atom 
o< to the nitrogen. However, it is possible that N-oxidation may give 
rise to N-dealkylation as discussed by Beckett and Belanger (1976).
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Investigations by Prough and Ziegler (1977) confirmed that 
dealkylation of tertiary amines is catalysed solely by cytochrome 
P-450 mono-oxygenases, but that dealkylation of secondary amines 
may be catalysed by both cytochrome P-450 and amine-oxidase mono­
oxygenase systems. A species difference was also noted in the 
relative contribution of the amine-oxidase system to the total activity. 
In other studies on the metabolism of ethylmorphine, Thompson and 
Holtzman (1977) concluded that the O-deethylation and N-demethylation 
reactions were catalysed by different forms of cytochrome P-450.
The mechanism of N-oxidation of dimethylaniline has been studied by 
Hlavica and Kehl (1977), who showed that the reaction was catalysed 
by cytochrome P-450 and by amine-oxidase, but that at least two forms 
of cytochrome P-450 were involved in the N-oxidation reaction.
Studies using a reconstituted cytochrome P-448 system (Hlavica and 
Hulsmann, 1979) revealed that whilst the cytochrome and cytochrome 
reductase were required for optimal activity, there was some activity 
when the cytochrome reductase alone was used. The addition of lipids 
stimulated the N-oxidation reaction, but it appeared that the reaction 
was not controlled by electron transfer from cytochrome 65 to 
cytochrome P-448. It is, therefore, possible that the N-oxidation 
reaction catalysed by cytochromes P-450 does not follow the traditional 
redox cycle (Chapter 1, figure 1- 2).
It is possible that uncoupling of cytochrome P-450 from the reductase 
occurs during chemical carcinogenesis, and that some changes in the 
metabolic pattern may be due to the increased electron availability 
to other oxidases, and these changes may be mirrored by the action of 
pentachlorophenol. Poulson, Masters and Ziegler (1976), studied 
the N-oxidation of 2-napthylamine and found that whilst the activity 
correlates with amine oxidase content, the period of linearity of 
the reaction was dependent upon cytochrome C-reductase content.
Antisera to the reductase also decreased hydroxylamine production, 
but had no effect on the rate of N-oxidation. The role of the 
cytochrome reductase in electron transfer for N-oxidation reactions 
thus seems doubtful.
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The activation of amphetamine via N-oxidation has been found to lead 
to the formation of a 455nm-absorbing metabolite complex, and is 
similar to the carcinogen safrole in this respect. Mansuy et al 
(1978), found that N-hydroxylamines all react to form these metabolite 
complexes, which strongly inhibit other drug metabolising reactions 
(Franklin, 1977), and leads to enzyme induction and damage to the 
endoplasmic reticulum (Parke, 1979) .
2-Acetylaminofluorene induces its own N-oxidation (Maiejka-Giganti 
et al, 1978), but does not affect other drug metabolising activities. 
The induction may, therefore, be associated with a hitherto mechanism, 
or with the induction of some other enzyme. The possibility exists 
that the activity is due to the uncoupling of components of the 
microsomal oxidation systems.
Free radicals in biological oxidations
Superoxide and hydroxyl radicals are generated by the mixed-function 
oxidase system, by a cytochrome P-450 dependent process (Dybing et al,
1976) and by NADPH-cytochrome P-450 reductase (Kameda, Ono and Imai, 
1979; Lai, Grover and Piette, 1979). Radicals may also be involved 
in oxidations mediated by the xanthine-xanthine oxidase system 
(Ohnishi and Lieber, 1978).
Bartoli et al (1977), studied the contribution of different components 
of the mono-oxygénase system to the formation of superoxide anions 
in new-born and developing rats. They demonstrated that, at birth 
the formation of 0~ radicals was dependent upon the flavoprotein 
reductases, but that the contribution of the cytochromes became 
predominant within 20 days. The authors also noted that the close 
correlation observed between 0^ production and N-demethylase 
activity suggested that a portion of the superoxide production was 
directly involved in mixed-function oxidation reactions.
Superoxide radicals may give rise to hydroxyl radicals, and several 
possible mechanisms have been suggested (see Chapter 1). The 
production of these radicals may affect the pattern of metabolism 
of xenobiotics.
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The drug cC-methyldopa is metabolised by microsomes to reactive 
metabolites which- bind to microsomal proteins, but the drug is not 
a substrate for cytochrome P-450 (Dybing et al, 1976) . The activation 
is inhibited by superoxide dismutase and by ascorbate (which can 
reduce superoxide, semiquinones and quinones), and can also be 
carried out by a xanthine-xanthine oxidase system. Dybing et al 
(1976), suggest that the microsomal mono-oxygenase system produces 
superoxide anions which can oxidise catechols leading to activation. 
Bachur et al (1979), have studied the activation of quinone anti­
cancer drugs to free radicals, and have shown the reduction of several 
quinones to semiquinones or free radicals to be catalysed by cytochrome 
P-450 reductase, with NADPH^ as the electron donor. The authors suggest 
that this mechanism may be responsible for the cytotoxic action of 
quinone antibiotic drugs.
The possibility exists that naturally-occurring quinones within the 
microsomal membrane may be activated to free radicals. This is 
particularly likely if the flow of electrons is greater than that 
which can be utilised by cytochrome P-450, either due to uncoupling 
or due to metabolite-complex inhibition. The activated compounds 
may then be translocated within the cell membranes, and would be 
capable of initiating free radical activation at sites other than 
that of formation. Lipid peroxidation and membrane damage could thus 
occur at many unrelated sites. Carcinogens may themselves be 
metabolised to carbene ions, which can.become transportable free- 
radical generators by the formation of stable glutathione complexes 
(Stier, 1980).
Free radical formation may thus be responsible for activation of 
compounds which are not substrates for the microsomal mono-oxygénase 
system, and may also lead to membrane damage by the radical 
activation throughout the cell.
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Distribution and development of cytochromes P-450
Whilst P-450 cytochromes are found almost universally in animal cells, 
the type of cytochrome and its properties vary greatly. Even within 
one species the P-450 cytochromes can vary with age, sex and type of 
intracellular membrane. These differences may reflect developmental 
changes in the animal.
Mailman and his co-workers (1975, 1977a, 1977b) have studied the 
occurrence of multiple forms of cytochrome P-450 in both treated and 
untreated rats and mice. They found that in untreated animals the 
1rough' endoplasmic reticulum contained a P-450 type cytochrome whilst 
the 1 smooth1 contained a P-448-type. Treatment with either pheno­
barbitone or methylcholanthrene abolishes the differences between 
the two membrane fractions. The characteristics of the induced 
cytochromes were found to be different to those of cytochromes from 
control membranes.
Studies described herein showed that the differences between the 
membranes also varied with age and possible hormonal status. Foetal 
liver is refractive to phenobarbitone induction (Guenthner and Mannering, 
1977a) but not to methylcholanthrene induction. After parturition, 
it becomes phenobarbitone inducible. Kitada and Kamataki (1979) have 
purified cytochrome P-450 from human foetal liver and found it to 
be a low-spin species, but immunologically non-reactive with antibodies 
raised against phenobarbitone-indueed cytochrome P-450. The activity 
of cytochrome P-450 is "repressed" 'in utero1 (Klinger, Zwacka and 
Ankermann, 1968) by an extractable substance in foetal liver. After 
parturition the activity and inducibility of the cytochrome increases 
within days due to derepression. This system may prevent a xenobiotically- 
induced mono-oxygenase system 'in utero1 from inactiviting vital 
endogenous substances. It would appear that the "repressed" foetal 
cytochrome P-450 whilst of low-spin type, is capable of cytochrome 
P-448 type activities.
It has been shown in Chapter 4 that the spectral characteristics of the 
cytochromes change firstly in the 'rough1 endoplasmic reticulum, 
and that this change is completed during puberty in male rats,
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but remains incomplete in female rats, leading to sex-differences 
in drug metabolism.
The development from the "repressed" P-450 type to the adult 
cytochrome is reflected in the acute toxicity of methylglyoxal in 
rats. Peters, Hudson and Jurgelske (1978) found that the sensitivity 
to methylglyoxal was most acute in the neonate and least acute in 
the adult male. Weanling and adult females demonstrated intermediate 
sensitivities. It is of interest to note that the toxicity in females 
varied during, pregnancy, the animals becoming less sensitive as the 
term progressed. These findings correspond to the results reported 
by Guenthner and Mannering (1977b) of the inducibility of cytochrome 
P-450 in pregnant rats.
It would appear from the reported studies and those described herein 
that cytochrome P-450 in the pregnant rat is repressed in a similar 
manner to that in the foetus, and that the characteristics displayed 
are similar to those of cytochrome P-448 although not identical.
Van den Berg et al (1978) studied the development of sex differences 
in mice, which appeared 3-7 weeks post-parturn and were confined to 
the females. They conclude that the P-450 system is repressed by 
androgens during sexual maturation, and have shown that castration 
of male mice abolishes the 3sex differences (Van den Berg, 1979). 
However, in rats, the androgen effect is presumed to be stimulatory 
(Kato, 1974).
Kahl, Buecker and Netter (1977) have studied the sex differences in 
rats and suggest that the female cytochrome is of the P-448 type, 
however, some mono-oxygenase activities known to be preferentially 
mediated by cytochrome P-448 were found to be lower in females than 
in males. The authors report that it is unlikely that the P-450 
system is controlled by the female sex hormones since it is not 
influenced during the oestrus cycle.
The involvement of the pituitary hypophysis in sexual differentiation 
has been investigated (Burke, Orrenius and Gustafsson, 1978) and it 
was shown that an implanted pituitary not under hypothalmic control 
produces a basically female pattern of mono-oxygenation. It was also
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shown that the pituitary mediates the 3-methylcholanthrene induction 
of cytochrome P-448, which is probably due to the geometrical 
similarities between the inducing agent and steroid molecules.
Changes in steroid hormone metabolism following administration of
2,3,7,8-tetrachlorodibenzo-p-dioxin to male and female rats has been 
reported to be concomitant with changes in the liver microsomal 
cytochromes (Gustafsson and Ingelman-Sundberg, 1979). The situation 
may be posed where some carcinogens may affect hormonal metabolism 
directly as well as pituitary control of the mono-oxygenase system, 
both of which may be interlinked.
As cytochrome P-448 is the foetal form in mammalian liver, and is also 
the form in malignant tumours (albeit that they are not identical 
forms), it is possible that this represents a more primitive form of 
cytochrome P-450. Cytochrome P-448 is found more abundantly in extra- 
hepatic tissues than in mammalian livers, and appears to be the 
more abundant form in marine animals (Parke, 1981b). Its evolution 
from an enzyme primarily concerned with the detoxication of oxygen 
in bacteria (Wickramsinghe and Villee, 1975) can be envisaged.
Oxygen tension is higher and more difficult to control in unicellular 
organisms than in multicellular, and an oxygen detoxicating enzyme 
(O^ — > Og" — > 02 — ^HgO) would be advantageous. The primitive enzyme
would not have a highly specific effect oxygenating on endogenous 
substrates, and would be adequate for multicellular marine organisms 
where exposure to both 0^ and xenobiotic compounds are at low 
concentrations. As the organism evolves and becomes landborne, the 
need would be for an oxygenating enzyme of greater specificity, as 
not only would the external oxygen pressure be greater but exposure 
to xenobiotics is likely to be at higher concentrations. This may 
have resulted in the higher substrate specificity of cytochrome P-450. 
Without a suitable detoxicating system, the formation of oxygen 
radicals, and activation of xenobiotics to radicals, would endanger 
the organisms life. The reappearance of cytochrome P-448 may represent 
a disturbance of this system.
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Cytochrome P-448
The appearance of cytochrome P-448 after treatment of animals with
carcinogens is still under considerable study, mainly regarding
1) the mechanism of appearance and 2) the implications of its appearance.
The study of the mechanism of appearance is to some extent confused by 
the multiplicity of cytochromes found in hepatocytes. Whilst several 
forms of cytochrome P-450 (possibly isoenzymes) have been purified 
for study, there are also several forms of cytochrome P-448. It has 
been suggested (Klinger, Zwacka and Ankermann, 1968) that the 
cytochrome P-448 activities observed in neonated and pregnant rats 
may be due to a 'repressed' - P-450, which further confuses the. 
situation due to the inadequate nomenclature available.
It has been suggested that cytochrome P-448 is a genetically controlled 
variant of cytochrome P-450 that is synthesised 'de novo' (see Chapter 1 
for discussion). The evidence, however, does not prove that cytochrome 
P-448 is structurally a new protein, as the lack of response lies with 
the carcinogen receptor protein.
Several attempts have been made to demonstrate by the use of protein 
synthesis inhibitors that cytochrome P-448 is or is not synthesised 
'de novo'. The studies reported herein, whilst not disproving 
absolutely the necessity of synthesis 'de novo', indicate that the 
activities of cytochrome P-448 can be obtained from altered cytochrome 
P-450. The true answer may be that as in the foetal/maternal state, 
cytochrome P-448 may be a 'repressed' cytochrome P-450. .This repression 
could be steroid controlled in untreated animals, and the structural 
similarity of some carcinogens allows interaction with the same 
receptor. The results of Sato et al (1979) suggest that this binding 
could be directly with cytochrome P-450.
Alternatively, cytochrome P-448 may be a metabolite-complex of the 
carcinogen with cytochrome P-450 (Franklin, 1977). Whilst it is 
acknowledged that the untreated animal exhibits a multiplicity of 
cytochrome P-450's it is possible that there is a multiplicity of
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carcinogen-induced P-448's. Thus 'repressed' and 'metabolite-complexes' 
would be only two 'forms' of cytochrome P-448.
Attempts to show that cytochromes P-450 and P-448 are different 
proteins have centred around the use of SDS-polyacnylamide gel 
electrophoresis (e.g. Ivanetich and Bradshaw, 1977; Levin et al, 1977a; 
Guengerich, 1978; Warner, LaMarca and Neims, 1978). However, the 
results obtained vary greatly with the method used (see fig.2 in Levin,
1977) which makes comparison of results impossible. SDS also degrades 
the cytochromes, making the significance of the results difficult to 
interpret.
Immunological techniques used to investigate the multiplicity of rat 
liver cytochrome P-450 have shown that there are at least six different 
proteins (Thomas et al, 1976b). Furthermore, antibodies prepared 
against purified cytochrome P—448 gave three haem—staining precipitation 
lines with cytochrome P-450 isolated from phenobarbitone-induced 
animals. It would appear from the results that cytochrome P-450, homo­
geneous by gel electrophoresis, contains at least four cytochromes.
Whilst, in general, there is little cross-reactivity between 
'anti-P450' and cytochrome P-448, and vice-versa, this is of use only 
in distinguishing different animal species rather than different 
proteins. Cytochrome P—450 is a glycoprotein, and the glycosyl-portions 
may differ between the various forms, and are also likely to be 
antigenic determinants. Whilst monospecific antibodies have been 
produced (Thomas et al, 1979), they are monospecific only as far as it 
is currently possible to define homogeneity of a cytochrome species.
No one has yet managed to define all the forms that exist in a single 
animal species, and it is probable that this will only become possible 
when it is possible to synthesise a specific cytochrome (possibly by 
monoclonal cultures) and hence determine the precise primary structures.
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Perspective
Carcinogens are metabolised by microsomal enzymes to active 
metabolites. It was originally thought that those metabolites 
which can alkylate DNA were the ultimate carcinogens, however, this 
outlook has now been modified. Whilst alkylation of DNA leads to a 
mutant genotype, there are many excision/repair mechanisms that must 
be overcome before the expression of a mutant phenotype. It is also 
true that a mutant genotype is of little consequence until that 
portion of DNA is required for protein synthesis. Thus, whilst DNA 
may become alkylated, the important feature of carcinogenesis is the 
stimulation of protein synthesis, leading to uncontrolled cell growth 
and division.
To attempt to separate cause and effect in carcinogenesis is difficult. 
It can only be said that initiation appears to be metabolism of the 
carcinogen by cytochrome P-450. After the initial metabolism, further 
metabolism may take place. This may be mediated by cytochrome P—450 
or P-448. Cytochrome P-448 may appear due to the interaction of the 
initial metabolite with cytochrome P—450 or other macromolecules. 
However, the appearance of cytochrome P-448 may be an important step 
in the mechanism of carcinogenesis. From this stage, mono—oxygenase 
function is altered, and the formation of secondary metabolites that 
cannot be easily detoxified, together with a possible increase in 
free-radical formation leads to increased degranulation of the 
endoplasmic reticulum, lipid peroxidation and possibly DNA alkylation. 
This represents a breakdown of the normal ordered structure of the cell, 
and may even provide the stimulus for transformation. The effects of 
altered protein synthesis, altered glycoprotein synthesis, and 
uncoupling of the normal electron-transfer pathways would lead to cell 
proliferation, altered immune response and altered metabolic patterns. 
The sum of these changes being neoplasia.
Almost all of the reactions that occur during chemical carcinogenesis 
involve constituents of the endoplasmic reticulum, and represent the 
failure of the functional integrity of the membrane.
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The trigger to the series of events appears to be the initial 
activation by cytochrome P-450. In sub-mammalian orders where 
cytochrome P-448 predominates, drug metabolism patterns are different 
and of much lower activity, and the incidence of neoplasia is lower.
If cytochrome P-450 represents a state of higher genetic development 
from cytochrome P-448, as a response to the need for a more active 
detoxification system for oxygen," then the. appearance of the higher 
form has led to an increased susceptibility to carcinogenesis.
"Cancer arises as an accidental by-product of the 
very essence of life and evolution"
Sir Macfarlane Burnet 
(1969)
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